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ABSTRACT 
 
Bioengineered skin substitutes have been developed to treat burn and non-healing wounds; 
however limitations still hinder their clinical success rates.  Optimizing these current design 
strategies requires an understanding of how biochemical and topographical features of the 
native tissue modulate keratinocyte processes involved in tissue functionality. In this thesis, a 
novel bioengineered skin substitute was developed that contains a microfabricated basal 
lamina analog that recapitulates the native microenvironment found at the dermal-epidermal 
junction (DEJ).  In native skin, this microenvironment consists of both biochemical and 
topographical cues which play critical roles in maintaining tissue architecture and overall 
homeostasis with the external environment.   
  
Therefore, we hypothesize that microfabricated basal lamina analogs with extracellular 
matrix cues and three-dimensional features that mimics the cellular microenvironment of the 
DEJ will promote enhanced epithelialization and increase epidermal stem cell clustering on 
the surface of bioengineered skin substitutes.   
We determined that the extracellular matrix protein fibronectin (FN) found in the cellular 
microenvironment of the DEJ enhanced keratinocyte attachment, proliferation, and 
epithelialization of a collagen based basal lamina analog.  It was also found that the collagen 
material used to create the basal lamina analog as well as the FN conjugation strategy to this 
material significantly influenced the bioactivity of FN and its ability to modulate keratinocyte 
functions through integrin based mechanism.  To investigate spatial tissue organization and 
the role it plays in the cellular microenvironment of the DEJ on epithelialization and 
epidermal stem cell localization, we used photolithography coupled with materials 
processing techniques to create microfabricated basal lamina analogs.  It was determined that 
epidermal thicknesses found in narrow channels of microfabricated basal lamina analogs (50 
µm and 100 µm widths with 200 µm depths) were similar to cultures on de-epithelialized 
acellular dermis and native foreskin tissues after 7 days of in vitro culture.  We also 
determined that the microfabricated basal lamina analogs created an epidermal stem cell 
niche that promoted epidermal stem cell clustering in the channels which is critical for 
longevity of the tissue.   
Overall, we developed a platform technology that was specifically used to produce a highly 
functional bioengineered skin substitute with regenerative capacity that mimics native skin.  
We anticipate through the use of this technology, we can further improve bioengineered skin 
substitutes by incorporating epidermal structures of native skin including hair follicles and 
sweat glands as well as improve overall cosmetic appearance.  Additionally, this novel 
bioengineered skin substitute can serve as a model system to further our understanding of 
pathological conditions and diseases of the skin as well as facilitate robust preclinical 
screenings of epidermal responses to new therapeutic agents as well as to cosmetic and 
chemical products.   
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1.1 INTRODUCTION  
Every year in the United States 2.4 million burn injuries are reported and approximately 
12,000 people are burned severely enough to require skin grafting.1 Diabetic and venous 
ulcers, as well as pressure sores, affect an additional 3 to 4 million people and it is 
anticipated these figures will continue to increase with the rises in the average age of the 
population as well as the incidences of diabetes.2,3  A critical component in preventing 
infection, water loss, scarring, amputation, and death from severe skin wounds is the prompt 
restoration of skin integrity.  While autografts are considered the “gold standard” to treat 
localized skin injuries, a lack of available donor sites as well as donor site morbidity 
routinely hinders the recovery of patients with large burns or skin traumas.4-6 As such, the 
successful development of bioengineered skin substitutes that provide permanent coverage to 
the wound site and restore the anatomy and physiology of uninjured skin will have 
significant impact on the treatment of patients with serious skin injuries.5-7    
 
Over the past three decades, composites of cultured cells and biomaterials have been 
investigated for potential use as bioengineered skin substitutes.5,8-11  Regeneration of skin 
tissues, including neodermal formation and vascularization as well as reepithelialization of 
barrier layers, has been examined in a variety of engineered tissue analogs consisting of 
collagen-glycosaminoglycan (GAG) sponges,12-19 collagen gels,20-23 hyaluronic acid 
derivatives,24 and synthetic polymers.25  While bioengineered skin substitutes have achieved 
some clinical success restoring damaged skin, prolonged healing times, scarring, and 
mechanically induced graft failure remain persistent problems.5,23,26  In order to address these 
Chapter 1: Overview  
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limitations and improve the performance of bioengineered skin substitutes, it is critical to 
investigate how tissue scaffolds can be precisely tailored to present critical environmental 
cues that direct keratinocyte adhesion, proliferation and differentiation, and overall rapid 
epidermal formation.5,7-11   
 
A common design feature of current skin substitutes, composed of cultured cells and 
biomaterials, is a flat interface between the dermal and epidermal dermal components.  In 
native skin, the basal lamina is located at the dermal-epidermal junction (DEJ) and is not flat, 
but rather conforms to a series of three-dimensional ridges and invaginations formed by 
papillae located in the papillary region of the dermis.   Several studies have examined the 
role of native basal lamina topography on providing a microenvironment that has the 
capability of modulating keratinocyte functions.  Keratinocyte proliferation has been found to 
be affected with a higher percentage of proliferating basal and suprabasal cells found in deep 
rete ridges.27,28  It has also been shown that the expression of α2β1 integrin, a suggested 
marker for epidermal stem cells, can be found localized on the tips of the dermal papillae or 
at the bottom of the deep rete ridges.29-31  The complex microtopography of the basal lamina 
has been found to provide structural stability to the epidermis.  Analyses of areas of skin 
exposed to excessive friction such as the plantar and the palmar surfaces, indicate that dermal 
papillae and epidermal ridges are longer and more numerous in those locations.32   
 
The basal lamina is not only responsible for creating an interface between keratinocytes and 
the connective tissue of the dermal layer but it also provides instructive cues through 
extracellular matrix (ECM) proteins which direct keratinocyte polarity, proliferation, and 
differentiation, as well as preserving tissue architecture and organization.  The ECM of the 
basal lamina is composed of collagenous and non-collagenous molecules including type IV 
collagen, laminin, fibronectin, and heparin sulfate proteoglycans.32-34 
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1.2 OVERALL GOAL AND HYPOTHESIS 
The overall goal of this project is to enhance the performance of bioengineered skin 
substitutes by analyzing the effects of biochemical and microstructural cues on keratinocyte 
function, stem cell enrichment and localization, and the rapid epithelialization on the surfaces 
of tailored bioengineered skin substitutes containing microfabricated basal lamina analogs at 
the DEJ.   
 
We hypothesize that microfabricated basal lamina analogs with extracellular matrix cues 
and three-dimensional features that mimic the cellular microenvironments of the dermal-
epidermal junction will promote enhanced epithelialization and increase epidermal stem 
cell clustering on the surface of bioengineered skin substitutes. 
 
In this study, epithelialization is defined as keratinocyte attachment, proliferation, and 
differentiation, as well as cellular and graft morphology and graft thickness.  The expected 
outcome of this project is the identification of a series of parameters critical for improving 
the design of bioengineered skin substitutes, as well as for promoting the rapid regeneration 
of highly functional skin tissue with increased structural stability. 
 
To systematically test this hypothesis, this thesis was separated into two parts with a total of 
four objectives.   
 
1.3 PART I: EVALUATION OF ECM IN THE REGULATION OF KERATINOCYTE 
FUNCTION  
 
1.3.1 Objective 1: Establish Relationships Between Keratinocyte Attachment and ECM 
Proteins on the Surface of Basal Lamina Analogs 
 
The DEJ of skin contains ECM proteins that are involved in initiating and controlling 
keratinocyte signaling events such as attachment, proliferation, and terminal differentiation. 
To characterize the relationship between ECM proteins and keratinocyte attachment, Chapter 
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3 discusses a biomimetic design approach that was used to tailor the surface of basal lamina 
analogs with biochemistries that emulate the biochemical composition found at the DEJ.  A 
high-throughput screening device was developed by our laboratory that allows for the 
simultaneous investigation of the effect of ECM proteins, (types I and IV collagen (CI and 
CIV), laminin (LN), or fibronectin (FN)) passively adsorbed on the surface of an implantable 
collagen membrane, on keratinocyte attachment.  Fluorescence microscopy coupled with 
quantitative digital image analyses indicated that the ECM proteins adsorbed to the collagen-
GAG membranes in a dose-dependent manner and saturation was achieved.  To determine 
the relationship between ECM protein signaling cues and keratinocyte attachment, cells were 
seeded on collagen-GAG membranes treated with the ECM proteins and a tetrazolium-based 
colorimetric assay was used to quantify viable keratinocyte attachment.  Our results indicate 
that keratinocyte attachment was significantly enhanced on the surfaces of collagen-GAG 
membranes that were treated with FN.  These findings define a set of design parameters that 
will enhance keratinocyte binding efficiency on the surface of collagen membranes and 
ultimately improve the rate of epithelialization for dermal equivalents. Bush KA, Downing BR, 
Walsh SE, Pins GD. Conjugation of extracellular matrix proteins to basal lamina analogs enhances 
keratinocyte attachment. J Biomed Mater Res A 2007;80(2):444-52. 
 
1.3.2 Objective 2: Evaluate Keratinocyte Responses to Availability of FN Cellular 
Binding Domains 
 
Precisely engineering the surface chemistry of biomaterials to modulate the adsorption and 
functionality of biochemical signaling molecules that direct cellular functions is critical in the 
development of bioengineered scaffolds.  In chapter 4 of this thesis, we describe the use of 
functionalized self-assembled monolayers (SAMs) as a model system to assess the effects of 
biomaterial surface properties on controlling FN conformation and concentrations as well as 
keratinocyte function.  By systematically analyzing FN adsorption at low and saturated 
surface densities, we distinguished between SAM dependent effects of FN concentration and 
conformation on presenting cellular binding domains that direct cellular functions.   
   
Chapter 1 
Overview 
5 
   
 
Quantitative image analyses of immunostained samples showed that modulating the 
availability of the FN synergy site corresponded with changes in keratinocyte attachment, 
spreading, and differentiation, through integrin mediated signaling mechanisms.  The results 
of this study will be used to elucidate design features that can be incorporated onto dermal 
equivalents and percutaneous implants to enhance the rate of epithelialization and tissue 
regeneration.  Furthermore, these findings indicate that SAM based model systems are a 
valuable tool for designing and investigating the development of scaffolds that regulate the 
conformation of ECM cues and cellular functions that accelerate the rate of tissue 
regeneration.  Bush, K.A., Driscoll, P.F., Soto, E.R., Lambert, C.R., McGimpsey, W.G., and Pins, G.D.  
“Designing Tailored Biomaterial Surfaces to Direct Keratinocyte Morphology, Attachment, and 
Differentiation.”  JBMR Part A, 2008. July 24 [Epub]. 
 
1.3.3 Objective 3: Investigate FN Presentation on Basal Lamina Analogs and Evaluate 
Keratinocyte Morphology, Proliferation, and Differentiation.  
 
In order to improve the regenerative potential of biomaterials used as bioengineered 
scaffolds, it is necessary to incorporate biologically active molecules that promote in vivo 
cellular processes that lead to a fully functional tissue.  Research has shown that the surface 
characteristics of a biomaterial greatly influence the conformation of the biomolecules which 
directly influences its bioactivity.  In chapter 5 of this thesis, we evaluated the effects of 
strategically binding FN to collagen scaffolds to enhance keratinocyte function and 
epithelialization on basal lamina analogs for skin regeneration.  We found that FN enhanced 
epithelial thickness and keratinocyte proliferation when compared to non-treated basal 
lamina analogs at 3 days of air/liquid (A/L) interface culture.  Additionally we evaluated the 
availability of FN cellular binding site domains when FN was either passively adsorbed or 
conjugated to collagen scaffolds fabricated from collagen-GAG coprecipiate or self-
assembled type I collagen sources using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC).  It was found that EDC conjugation significantly enhanced FN binding 
site presentation as well as epithelial thickness.  Overall the results gained from this study 
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can be used to improve the regenerative capacity of basal lamina analogs as well as the 
development of other bioengineered scaffolds. Bush KA, Pins GD. Carbodiimide Conjugation of 
Fibronectin on Collagen Basal Lamina Analogs Enhances Cellular Binding Domains and Epithelialization.  In 
preparation 2009. 
 
1.4 PART II: ROLE OF SCAFFOLD MICROARCHITECTURE IN THE 
REGULATION OF KERATINOCYTE FUNCTION 
 
1.4.1 Objective 4: Incorporate Biochemical and Microtopographic Features Found at 
the DEJ onto the Surface of Bioengineered Skin Substitutes and Evaluate the Effects of 
the Microenvironment on Epithelialization and Epidermal Stem Cell Localization.   
 
In native tissues, the basal lamina provides cues to modulate skin architecture, cellular 
organization, and the regeneration of the epithelial layer.  In chapter 6 of this thesis, we 
developed a novel dermal scaffold that recapitulates biochemical and microtopographic 
features provided by the basal lamina to enhance epithelialization and epidermal stem cell 
(ESC) localization.  To create the complete microenvironment, we combined 
photolithography, collagen processing, and biochemical conjugation techniques.  After 3 
days of A/L interface culture we evaluated the epidermal layer of bioengineered skin 
substitutes and found that keratinocytes cultured in 50 µm width channels with 200 µm 
depths had statistically similar epidermal thickness values as keratinocyte cultured on de-
epithelialized acellular dermis (DED).  At 7 days of A/L interface culture the 50 µm width 
and 100 µm width channels with 200 µm depths exhibited the same epidermal thicknesses as 
keratinocyte cultured on DED and native skin samples.  Furthermore, these conditions were 
statistically different from cultures in 200 µm width and 400 µm width channels with 200 µm 
depths.  It was also found that the percentage of Ki67 positive basal keratinocytes, a marker 
for proliferative cells, was statistically similar for the bioengineered skin substitutes, DED 
cultures, and in native tissues at 7 days of A/L interface culture.  In addition to epidermal 
thickness and proliferation, we evaluated ESC localization by evaluating integrin expression, 
specifically β1. We determined that integrin-bright regions of cultured keratinocytes were 
found in the channels (rete ridges) in our bioengineered skin substitutes, whereas in native 
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foreskin tissue, these cells were identified at the tips of the papillary projections.  Based on 
the results of our epidermal thickness measurements, as well as keratinocytes proliferation 
and ESC studies, we have defined a set of criteria for the design of the next generation of 
bioengineered skin substitutes to enhance epithelialization rates and control stem cell 
localization, as well as the potential for increasing mechanical stability, based on the increase 
in cellular interaction surface area.  Additionally, our bioengineered skin substitutes are an 
excellent model system to evaluate the microenvironmental cues that provide an ESC niche 
on a bioengineered skin substitute and will ultimately lead to the enhanced regenerative 
capacity and overall performance of our scaffolds.   Bush KA, Toner, M., Pins GD. 
Microenvironments of the Basal Lamina Influence Epithelialization and Stem Cell Localization on 
Bioengineered Skin Substitutes.  In preparation 2009. 
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2.1 SKIN STRUCTURE AND FUNCTION 
Skin is the largest organ in 
vertebrate organisms and is 
responsible for many complex 
physiological functions that 
maintain homeostasis of the body 
with its surrounding environment.  
This includes protection against 
pathogens, acting as a physical 
barrier, absorption of harmful UV 
rays, sensory detection, and 
providing thermal and hydration 
regulation.  These functions are 
carried out through integration of 
specialized cells and structures 
found in the dermal and epidermal layers of the skin.1,2  Figure 2.1 displays a cartoon of the 
anatomy of human skin.3  
 
2.1.1 The Dermis 
The innermost layer of skin, the dermis, is predominantly composed of interwoven 
connective tissue containing collagen fibrils with elastic and reticular fibers interspersed to 
provide physical strength, elasticity, and scaffolding for accessory features.  The dermis has a 
three-dimensional organization with an upper papillary region and a lower reticular region. 
Chapter 2: Background 
Figure 2.1 Anatomy of Human Skin.  Skin is composed of two 
main layers, the epidermis and dermis.  The epidermis is 
responsible for providing a physical barrier, whereas the dermis is 
responsible for maintaining physical strength of skin.  Below the 
dermis is the hypodermis, which contains the source of blood 
vessels and is composed of adipose tissue.3   
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The upper region, the papillary dermis (PD: Figure 2.21), is composed of loose, small 
diameter collagen and immature elastic fibers. Exclusive to this layer are fingerlike 
projections called papillae, which extend toward the epidermis, and contain either capillaries 
that nourish the epidermis, or Meissner’s corpuscles which are sensory touch receptors.  
Fibroblasts, the major cell type of the dermis, are most abundant in this region, as well as 
having a higher rate of metabolic 
activity, an enhanced capacity for 
proliferation, and a longer replication 
life span in comparison to fibroblasts 
found in the lower dermis.4,5   
 
The lower region of the dermis, the 
reticular layer (RD: Figure 2.21), 
contains a much denser 
concentration of thick collagen fibers 
and mature elastic fibers that form a 
basket weave pattern than found in 
the upper region of the dermis. This 
layer is responsible for providing the mechanical stability of the dermis as well as containing 
specialized cells and receptors including, sebaceous glands, apocrine glands, blood vessels, 
nerve endings, lymph vessels, arrector pili muscles, hair follicles, and Pacinian corpuscles.4,5  
 
2.1.2 The Epidermis 
The epidermis is the outer most layer of skin.  This layer is responsible for providing the 
protective barrier against the surrounding environment and is in constant regeneration with a 
turnover of approximately 4 weeks.  The predominant cell type responsible for providing the 
barrier properties of the epidermis and in its repair and regeneration is the keratinocyte, 
representing approximately 80% of the total population of cells.  The other 20% of cells are a 
combination of cells that provide immunologic protection (Langerhans cells), absorption of 
Figure 2.2 Hematoxylin and Eosin Stained 
Histological Representation of the Dermis.  The upper 
region of the dermis, the papillary dermis (PD), contains 
small diameter collagen and immature elastic fibers.  
The lower region of the dermis, the reticular dermis 
(RD), is responsible for providing mechanical stability.1 
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ultraviolet light (melanocytes), and sense mechanical events within the epidermis and at the 
surface of skin (Merkel cells).6   
 
Within the epidermis, there are four distinct 
layers, with each layer being defined by 
position, morphology, and state of 
differentiation of the keratinocytes.6  The 
bottom layer, the stratum basal (also referred 
to as the stratum germinativum) (Figure 2.31 
SG), contains a single row of columnar 
undifferentiated basal keratinocytes, 
consisting of epidermal stem cells (ESCs) 
and transit amplifying (TA) keratinocytes 
that are attached to the underlying basement 
membrane.7,8  Epidermal stem cells are 
responsible for maintaining the entire 
population of keratinocytes by i) giving rise 
to additional ESCs by tissue demand or 
specific stimuli or by ii) giving rise to 
daughter TAs that amplify the number of cells derived from each ESC mitosis by undergoing 
3-5 rounds of division.9-11  Cells resulting from TAs do not proliferate and terminally 
differentiate as they move through the upper three layers of skin, the spinsosum (SS: Figure 
2.31), granulosum (SGR: Figure 2.31), and corneum (SC: Figure 2.31), through a process that 
involves down regulation of integrin expression and function.12,13 
 
As the cells progress through the upper layers of the epidermis, they begin to produce and 
organize specific keratin filaments responsible for structural integrity of the cytoskeleton as 
well as water proofing lipids responsible for the permeability barrier.  Although these 
peptides do not play any role in directing epithelial differentiation, their expression is specific 
Figure 2.3 Hemotoxylin and Eosin Stained 
Histological Representation of the 
Epidermis.  The epidermis is responsible for 
providing a protective barrier against the 
surrounding environment.  This layer of skin 
contains four layers, the stratum germinativum 
(SG), the stratum spinsosum (SS), the stratum 
granulosum (SGR), and the stratum corneum.1 
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to keratinocyte layer location as well as function of the keratinocyte.14 Keratinocytes found in 
the second layer, the stratum spinusom contain 50% more keratin than cells in the basal 
layer.  This additional keratin is responsible for increasing the ability of the cell to sustain 
mechanical stress.15   In the uppermost spinous cells and in the third layer of the epidermis, 
the granulosum, new organelles, lamellar granules, are present which contain a variety of 
lipids, carbohydrates complexes with protein and lipid, and hydrolytic enzymes.  Lamellar 
granules are exocytosed and generate a waterproof barrier.16  The stratum granulosum 
typically contains 1 to 3 rows of squamous cells with these granules and is the highest layer 
in the epidermis where living cells are found.  Above the stratum granulosum is the stratum 
corneum which is a multilayered zone of terminally differentiated keratinocytes suspended in 
an extracellular lipid matrix.17  The number of cell layers found in the stratum corneum 
varies on location of the body, with thicker skin regions of skin such as the soles and palms 
containing many more layers than skin regions such as the 
eyelids that are very thin.  Additionally, cornified 
keratinocytes are much different in morphology and larger in 
dimension than basal, spinosum, and granulosum cells.  A 
cornified keratinocyte has a more flattened morphology and 
is 30-40 µm in diameter, whereas a basal keratinocyte has a 
more square-like morphology and is only 6-8 µm in 
diameter.18,19 
 
2.1.3 The Basal Lamina  
Located at the dermal-epidermal junction (DEJ) is the basal 
lamina which conforms to a series of three-dimensional 
ridges and invaginations formed by papillae located in the 
papillary region of the dermis (Figure 2.420).21   The basal 
lamina is approximately 40-360 nm thick22 and is composed of collagenous and non-
collagenous extracellular matrix (ECM) molecules including type IV collagen, laminin, 
fibronectin, and heparin sulfate proteoglycans (Figure 2.523).  This specialized layer is 
Figure 2.4 The Topography 
Found at the Dermal-
Epidermal Junction.  At the 
dermal-epidermal junction 
there is a series of three-
dimensional ridges and 
invaginations formed by the 
papillae located in the 
papillary region of the 
dermis.20 
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responsible for creating an interface between keratinocytes and the connective tissue of the 
dermal layer, providing instructive cues to direct 
keratinocyte polarity, proliferation, and 
differentiation, as well as preserving tissue 
architecture and organization.  Additionally, the 
basal lamina acts as a barrier that prevents 
fibroblasts in the dermal layer from directly 
contacting epidermal keratinocytes, however, it 
does not prevent diffusion of macromolecules into 
or out of the epidermis, nor does it prevent the 
innervation of the epidermis.24   
 
Several studies have examined the role of basal 
lamina topography on regulating keratinocyte 
function.  In human palmar epidermis, the highest 
percentage of proliferating basal and suprabasal 
cells is in the deeper rete ridges (Figure 
2.625).25,26  It also has been shown that the 
expression of α2β1 integrin, a suggested marker of 
epidermal stem cells, varies with topography.  
High expression found in patches of basal 
keratinocytes located on the tips of the dermal 
papillae or at the bottom of the deep rete ridges 
suggest that cells in these microenvironments 
have high proliferation potentials.11,27,28 The complex topography of the DEJ also provides 
structural stability to the epidermis.  In areas of the skin exposed to excessive friction, the 
dermal papillae and epidermal ridges are longer and more numerous, suggesting that 
increased interfacial area between the epidermis and dermis helps provide additional 
mechanical stability.29 
Figure 2.5 A Model of the Molecular 
Structure of the Basal Lamina.  Model of 
interactions between the proteins CIV 
(red), laminin (blue), nidogen (yellow), and 
proteoglycans perlecan (green) found to 
make up the basal lamina.23   
Figure 2.6 [3H]thymidine Incorporation in 
Basal Keratinocytes in Bottom of Deep 
Rete Ridges.  [3H]thymidine was used to 
evaluate the location of highly proliferative 
basal keratinocytes.  Scale bar represents 50 
µm and arrows indicate [3H]thymidine 
incorporation.25 
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2.2 THE PROCESS OF WOUND HEALING 
When skin is injured, the body has the ability to regenerate dermal and epidermal tissues.  
This process is not linear, but is an integration of many complex events involving 
biochemical factors and multiple cell types.  These events overlap and follow a specific time 
sequence that can be temporally categorized into three separate steps: inflammation, cell 
proliferation and matrix deposition, and matrix remodeling (Figure 2.730). During 
inflammation, blood coagulation and platelet aggregation generate a clot that plugs severed 
vessels and provides a temporary repair of the injured skin.  The fibrin rich clot also provides 
a provisional matrix for neutrophils which are important for the removal of bacteria and 
debris from the wounded site.31,32     
 
Cytokines released by platelets found in the clot as well as the provisional matrix provided 
by the clot are important mediators involved in the tissue formation phase.  Within hours of 
injury, keratinocytes respond to chemotactic and mitogenic factors as well as the loss of 
contact with neighboring cells and begin to migrate laterally through the wound to reestablish 
Figure 2.7 Phases of Repair in Normal Cutaneous Wound Healing.  The 
process of wound healing is not linear, but is an integration of many complex 
events that can be temporally categorized into three separate steps: inflammation, 
cell proliferation and matrix deposition, and matrix remodeling.30   
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a cutaneous cover.33,34  As reepithelialization of the wound ensues, keratinocytes located 
behind the actively migrating keratinocytes begin to proliferate (1-2 days post injury)35 and 
basement membrane proteins begin to reappear from the margin of the wound inward.33,34  
 
Three to 4 days post injury, granulation tissue begins to form.  The fibrin clot provides a 
scaffold to promote contact guidance and acts as a reservoir for cytokines to promote the 
migration of fibroblasts, macrophages, and blood vessels into the wound site.36    
Macrophages are responsible for providing a continuing source of growth factors necessary 
to stimulate fibroplasias and angiogenesis,37 fibroblasts dynamically interact with the 
extracellular matrix to synthesize, deposit, and remodel the provisional matrix, 38,39  and 
blood vessels carry oxygen and nutrients to allow for new tissue formation.34   
 
Approximately 2 to 3 weeks post wounding, granulation tissue is well established.  In this 
tissue, TGF-β1 and other growth factors activate fibroblasts to transform into myofibroblasts 
which can be characterized by large bundles of actin containing microfilaments and the 
capacity to generate contractile forces.37  The appearance of myofibroblasts corresponds with 
connective tissue compaction and contraction of the wound.34  The remodeling of collagen 
during the transition from granulation tissue to scar is dependent on collagen degradation and 
synthesis as well as the interaction of the matrix with myofibroblasts.  Newly formed 
collagen fibrils have the ability to make covalent crosslinks with themselves as well as with 
the collagen bundles of the adjacent dermis.40,41  Myofibroblasts interact with these fibrils, as 
well as with themselves and a combination of the collagen-collagen, collagen-cell, and cell-
cell interactions provides the network which causes contraction across the wound and results 
in scarring of the tissue.42  By the third week after the initial injury, wounds only have 20% 
of their final strength and thereafter the rate at which the wound gains tensile strength is slow 
and correlates with the rate of collagen accumulation.  The maximum final strength of a scar 
never reaches maximum strength of uninjured skin, and at best is 70% as strong.43 
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2.3 SEVERE SKIN INJURIES  
Although the epidermis and dermis have the ability to heal on their own when injured, there 
are situations when the damage exceeds the capacity for normal regeneration, and if not 
treated may result in infection, scarring, amputation, or even death of the individual.  The 
most common cause of significant skin loss occurs from thermal injury.  In the United States, 
more than 2.5 million burn injuries are reported annually.44  Severe burns result in 60,000-
80,000 hospitalizations and costs for recovery from acute injuries range from $36,000-
1117,000 per patient.45,46 It is reported that 4,500 deaths occur annually,45 however, advances 
in the initial resuscitation phase of wound care have lead to a decline in mortality.47  
Currently, most patients survive burns that cover 50% of their total body surface area and 
half of children who receive burns that cover 98% of their total body surface area survive.48 
Other causes of skin loss include diabetic and venous as well as pressure sores which affect 
an additional 3 to 4 million people in the United States annually.  Sadly enough, the statistics 
for diabetic ulcers as well as venous and pressure sores are only expected to increase with the 
increase incidences of diabetes as well as the increase age of the average population. This 
predicted rise in statistics along with the increase in survival rate of increased total body 
surface burns, and a nearly epidemic increase in burn incidents has lead to an increase need 
for wound management products.  It is expected that the burn treatment market will grow in 
revenues reaching $2.6 billion by 2011, with a compound annual growth rate of 6.9% during 
that timeframe.49 
 
2.4 CURRENT THERAPEUTIC STRATEGIES  
Autografting, which has been considered the preferred treatment for coverage of excised 
wounds, consists of removing healthy skin from the patient’s body using a dermatome and 
placing in onto the wound bed.  At present, most full thickness wounds are best closed with a 
split thickness autograft that contains the dermis and portion of the epidermis.  While this 
option is considered the “gold standard” it is often limited for patients with large burns or 
skin traumas due to the lack of available donor sites as well as patients suffering from 
diabetes due to their already compromised wound healing ability.  Additionally, split 
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thickness autografts are also associated with donor site morbidity.50  The successful 
development of a tissue engineered skin substitute that provides permanent coverage to the 
wound site and restores the anatomy and physiology of uninjured skin will have an enormous 
impact on the care of patients with serious burns, chronic ulcers, and pressure sores. 
 
2.5 BIOENGINEERED SKIN SUBSTITUTES  
To address the limitations of autografts for serious skin injuries, tissue engineers have 
devised methods that combine cultured cells, biomaterials, or composites of these to provide 
a new alternative therapeutic approach to treating severe skin injuries.    The ultimate 
objective for these bioengineered skin substitutes is to reestablish the anatomy and 
physiology of native skin after placement in the wound bed.51 
 
2.5.1 Design Considerations  
In order to develop the ideal bioengineered skin substitute there are several clinical and 
engineering design criteria that must be met.  These bioengineered skin substitutes should be 
readily available off-the-shelf, inexpensive, possess physical and mechanical properties that 
facilitate easy handling, suturing, and adhesion to the wound bed, prevent water loss, and act 
as a microbial barrier. To minimize scarring and to actively promote regeneration of native 
skin functionality, engineered skin substitutes should also integrate with native host tissue, 
delivering growth factors, cytokines and ECM components that direct host cells to facilitate 
angiogenesis, neodermal, and neoepidermal regeneration. Specifically, the design of future 
skin substitutes must direct cellular migration, proliferation, and differentiation as well as 
cellular processes that mediate the morphogenesis of cells into analogs of functional skin that 
promote rapid barrier formation, reduce healing times, and restore the native tissue 
physiology.50,52  
 
2.5.2 Current Bioengineered Skin Substitutes  
To date no bioengineered skin substitute has been developed that replaces skin in its entirety.  
Conceptually, bioengineered skin substitutes offer either temporary, semi-permanent, or 
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permanent coverage, composed of epidermal, dermal, or a composite of the two, and are 
either made from biological or synthetic materials.50  Table 2.1 provides a summary of 
commercially available bioengineered skin substitutes including a cartoon schematic of the 
layers, the preservation technique used, and the development status of the product.   
 
2.5.2.1 Temporary Bioengineered Skin Substitutes-Wound Dressings 
Temporary bioengineered skin substitutes are designed to provide physiologic wound 
closure, protection from mechanical trauma and bacteria, and allow vapor transmission to 
occur between the wound bed and the environment.  Common uses of temporary 
bioengineered skin substitutes fall into the following categories: (i) a dressing for a donor site 
or for superficial wounds, (ii) to provide temporary wound closure while waiting for an 
autograft, and (iii) to test if an autograft would succeed in a questionable wound bed.  
Currently, there are three main types of temporary bioengineered skin substitutes available 
consisting of xenografts, synthetic membranes, and allogenic substitutes.50  
 
Skin xenografts are skin from one species grafted onto another species and have been used 
since 1500 BC to provide temporary cover of wounds.  The most commonly used species for 
xenografts for humans are domestic swine, however skin from frog, lizard, and dog have also 
been used. Although there have been many favorable reports using xenografts for wound 
closure, these tissues have many problems including availability, storage, rejection, and the 
short life of a living tissue.50  
 
Synthetic membranes for use as temporary bioengineered skin substitutes are designed to be 
semipermeable to provide protection against bacteria, while allowing for proper vapor 
exchange between the wound and the environment.  Additionally, synthetic membranes also 
help to control pain while the underlying superficial wound or donor site re-epithelializes.  
Biobrane® (Dow-Hickham, Sugarland, TX) is a commercially available temporary 
bioengineered skin substitute which was first developed in 1979.  This product consists of 
both a dermal and an epidermal analog.  The dermal analog is composed of a complex three-
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dimensional structure of trifilament thread to which bovine collagen has been chemically 
bound and allows for fibrovascular ingrowth.  The epidermal portion is composed of silastic 
that serves as a vapor and bacterial barrier.53  Biobrane® meets many of the important 
properties and is the most commonly used bioengineered skin substitute for partial thickness 
burns or excised wounds.  Although this product helps restore normal tissue architecture as 
well as preventing scar contracture, it is not a permanent solution, and autologous 
keratinocytes are required to provide an epithelial barrier.54   
 
Allogenic substitutes are another form of temporary bioengineered skin substitutes.  These 
bioengineered skin substitutes consist of split thickness human cadaver grafts that contain 
both dermal and epithelial cell layers.  Allogenic skin substitutes do not provide permanent 
coverage because of host rejection and are limited in use based on disease transmission and 
need for donated cadaver tissue.55-57 
 
2.5.2.2 Bioengineered Epidermal Skin Substitutes 
Restoring an epidermal layer that provides a barrier against fluid loss and infection is critical 
to wound healing and skin regeneration. In the mid 1970s, Rheinwald and his colleagues 
developed in vitro techniques to subculture keratinocytes into large confluent sheets of 
epithelial tissues.58,59 These cultured epithelial autografts (CEAs) are enzymatically removed 
from the culture substrate and placed onto the wound of the patient. This technique provides 
clinicians with large areas of epithelial wound dressing from small pieces of biopsy tissue.  
 
Clinical trials demonstrated that CEAs were a major surgical innovation, providing 
permanent coverage to large surface area burns as well as to acute and chronic wounds. 
Genzyme Tissue Repair is a commercially available CEA product that provides permanent 
wound coverage.60   While this product and other CEAs provide acceptable cosmetic results 
and eventually regenerate dermal tissue, there are several limitations.  Cultured epithelial 
autografts require biopsies from the patients and a 2-3 week interval to produce sufficient 
quantities of graft material. Additionally, CEAs are thin and fragile, very expensive, and they 
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require custom preparation. They also fail to provide adequate epithelial coverage, blistering 
often occurs, and engraftment rates are suboptimal.50,61-63 One of the primary reasons for 
suboptimal graft integration is the enzymatic treatment required to remove the cultured CEA 
from the culture plate. This treatment disrupts keratinocyte interactions with the underlying 
ECM proteins that are deposited on the substrate and causes contraction of the CEA. 
Furthermore, this process decreases mechanical stability of the grafts and hinders their 
attachment to wound beds.61,64 
 
To improve the durability and the engraftment rate of CEAs, several investigators have 
attempted to create carrier devices that support keratinocyte culture which can be transferred 
to the wound bed, eliminating the need for enzymatic treatment prior to implantation. 
Microfabrication techniques have been used to create support scaffolds with 
microenvironments that emulate native tissue properties and promote keratinocyte 
attachment as well as the deposition of cell-mediated ECM proteins.  Fidia Advanced 
Biopolymers, Inc., developed a 100% benzyl esterified hyaluronic acid derivative (HYAFF-
11®) that can be manufactured into thin transparent membranes with thicknesses of 20 or 200 
μm (Laserskin™).65  This product allows keratinocytes to grow to confluence and findings 
have demonstrated that CEAs cultured on Laserskin™ can be transferred to wound beds in a 
shorter time period, then culturing alone, substantially reducing the time required to wait for 
cultured autologous epithelial cells.66,67 Additionally keratinocytes have also been delivered 
to the wound intermixed with fibrin sealant as a spray68 or grown on fibrin glue and placed in 
the wound bed.69,70 
 
The results of studies using CEAs to transplant epithelial layers indicate that the presence of 
a dermal substitute pregrafted in the wound site enhances the function and the quality of the 
regenerating tissue. When full thickness wounds were treated with CEAs alone, or with 
CEAs on carrier devices, engraftment rates were less effective than when CEAs were applied 
to a dermal wound bed that was prepared with an allograft, autologous dermal tissue, or an 
engineered dermal substitute.50,65,66,71-75  A functioning dermal layer allows for increased 
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vascularization and improves initial engraftment rates and as well as long term durability. 
Additionally, a dermal component that contains fibroblasts provides a regulatory 
environment that contains both biochemical and structural cues to direct the growth and 
differentiation of keratinocytes in CEAs.76,77  These findings suggest that future research 
efforts should focus on the development of cell seeded dermal substitutes to augment the 
regenerative properties of epidermal scaffolds. 
 
2.5.2.3 Bioengineered Dermal Skin Substitutes 
To promote dermal regeneration, Yannas and his colleagues pioneered the use of a collagen-
glycosaminoglycan (GAG) sponge coupled with a silicone membrane barrier that acts as a 
temporary wound covering.78,79 The collagen-GAG sponge promotes vascularized neodermal 
formation and the silicone layer is eventually replaced with a thin epidermal autograft.80  
This dermal material has been successful in treating burns and has received FDA approval 
for this indication (Integra, LifeSciences Corporation, Plainsboro, NJ).60,80  Although Integra 
has achieved some clinical success, a second surgical procedure is necessary to 
reepithelialize the surface, and the cosmetic appearance of the regenerated skin is often flat 
and featureless.  
 
Additional acellular products that are on the market that serve as dermal substitutes are 
Alloderm® (LifeCell Corporation, Woodlands, TX) which is cadaver skin that has been 
chemically treated to decellularize and remove immunogenic cellular elements.  This product 
has been effectively used alone or in combination with cultured autologous keratinocytes for 
closure of burns and chronic wounds.  Decellularized allografts are advantageous because the 
dermal component retains the biochemical components of the basement membrane, the 
microtopology, and the porosity of native dermis,81,82  Although these analogs have proven 
successful in increasing the regenerative healing process, their limitations include the 
potential of disease transmission, high cost, second donor site, and the need for donated 
cadaver tissue.64,83-86 
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Hyalomatrix® (Fidia Advanced Biopolymers, srl) is another type of acellular dermal 
replacement that consists of an acellular hyaluronic acid matrix with esterfication.  Fidia 
Advanced Biopolymers, srl as well as Advanced BioHealing have developed cellular dermal 
replacement products that contain fibroblasts.   Hyalograft-3D® (Fidia Advanced 
Biopolymers) incorporates autologous fibroblasts into their esterified hyaluronic acid matrix, 
whereas Dermagraft (Advanced BioHealing) incorporates human foreskin fibroblasts into a 
biodegradable polyglactin mesh.  Currently, Dermagraft is off of the market and further 
production is ongoing to improve the product.    
 
While each of these design strategies has produced bioengineered skin substitutes that have 
achieved some clinical success in restoring damaged skin, the need for a second surgery, 
prolonged healing times, scarring and limited tissue functionality remain persistent problems. 
As such, future tissue analogs must incorporate both epidermal and dermal components in 
order to restore a fully functional tissue that is both anatomically and physiologically 
comparable to native skin. 
 
2.5.2.4 Bioengineered Composite Skin Substitutes 
Research has shown that when a CEA is engrafted onto a wound bed pretreated with a 
dermal substitute, the number of successful engraftments are increased, thus effort has been 
focused on developing a composite skin graft that consists of both dermal and epidermal 
layers.50,65,66,71-75  One of the first attempts to create a composite skin graft was by Bell et 
al.87 who combined a gel of type I bovine collagen with living allogenic neonatal fibroblasts.  
On the surface of the collagen gel, allogenic neonatal keratinocytes were cultured and over 
time created a stratified cornified barrier layer.  Apligraf (Organogenesis Inc, Canton, MA 
and Novartis Pharmaceuticals Corporation, NJ) is a commercially available composite 
bioengineered skin substitute that utilizes this technology. Its primary role is as a treatment 
for chronic ulcers. The efficacy of the product in healing venous ulcers was evaluated and it 
was found that the product was three times more effective than compression therapy alone in 
achieving complete wound closure at 8 weeks.88-91   
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OrCel is another composite skin graft.  This product was developed for the treatment of 
dystrophic epidermal bioloysis, and then further developed by Ortec International (New 
York, NY) and is now FDA approved for the treatment of burns.  This product, like Apligraf, 
consists of type I bovine collagen that contains fibroblasts and an epithelial layer on the 
surface.  The major difference between the two products is that the fibroblasts in OrCel are 
seeded into a preformed collagen sponge whereas Apligraf the fibroblasts are seeded within a 
collagen gel that then polymerizes.   
 
An additional composite system was developed by Boyce and his colleagues, who have 
modified the first approach taken by Yannas et al.78,79 Their modified approach to create a 
composite skin substitute consists of a porous collagen-GAG sponge with fibroblasts and 
then culturing a flat epidermal layer on the laminated surface of the sponge.92,93 In clinical 
studies, these composite skin substitutes showed some success for the treatment of full-
thickness burns, although engraftment rates were suboptimal.94,95  
 
2.6 CONCLUSIONS  
Overall, composite skin grafts offer an approach for an artificial full thickness skin graft that 
can be applied in one surgery for the treatment of chronic ulcers and burns.  The duration of 
these products however, is limited and they only persist for approximately 4 weeks.  
Additionally, prolonged healing times and mechanically induced graft failure remain 
persistent problems.  A design feature common to each of these skin substitutes is a flat 
interface between the epidermal and dermal components.  In native skin, this interface both 
topographically and biochemically, provided by the dermal papillae and basal lamina, 
respectively, is an important feature for maintaining homeostasis of skin.  The design of 
future skin substitutes must examine the mechanisms by which the three-dimensional 
architecture and biochemical composition of tissue scaffolds modulate cellular adhesion, 
proliferation and differentiation, as well as regeneration of dermal and epidermal tissues.   
 
    
Application Composition Product Schematic 
Representation 
Layers Preservation 
Technique 
Development Status 
    Epidermal Dermal   
Temporary 
Wound 
Coverage 
Acellular Biobrane® (Dow 
Hickman 
Pharmaceuticals, 
Inc., Sugarland, 
TX)  
 
 
Silastic layer.  
Need for 
autograft. 
 
Trifilament 
nylon fabric 
with bovine 
collagen 
chemically 
bound. 
Stored at 25ºC FDA approval for 
ulcers, lacerations, 
and full-thickness 
burns.  
TransCyte® 
(Advanced 
BioHealing, Inc., 
La Jolla, CA) 
 
 
 
Silicon 
covering. 
Need for 
autograft. 
 
 
 
 
Nylon mesh 
with human 
foreskin 
fibroblasts that 
undergo freeze 
thaw after ECM 
and growth 
factor 
production. 
Cryopreserved 
 
 
 
 
 
FDA approval for 
temporary wound 
coverage for burns 
and diabetic foot 
ulcers, however not 
on market and further 
development is 
ongoing. 
Cellular Cadaveric 
allografts (from 
nonprofit skin 
banks) 
 Epidermal 
layer of 
human skin. 
 
 
 
 
 
 
 
 
 
Dermal layer of 
human skin. 
 
 
Glycerolized FDA approval for 
burns and scar 
revision. 
 
 
 
 
 
 
 
 
Table 2.1 Summary of Commercially Available Bioengineered Skin Substitutes 
    
Application Composition Product Schematic 
Representation 
Layers Preservation 
Technique 
Development Status 
    Epidermal Dermal   
Epidermal 
Replacement 
Cellular Epicel™ 
(Genzyme 
Tissue Repair, 
Cambridge, MA) 
 
 
 
 
 
Cultured 
epithelial 
autograft. 
None. Placed 
onto wound 
bed. 
Stored at 37ºC FDA approved for 
treatment of burns, 
chronic ulcers, 
diabetic leg ulcers, 
donor sites, and scar 
revision. 
Laserskin™ 
(Fidia Advanced 
Biopolymers srl, 
Abano Terme, 
Italy) 
 
 
 
 
 
 
 
 
Cultured 
epithelial 
autograft on 
hyaluronic 
acid with laser 
perforations. 
None. Place 
onto wound 
bed. 
Stored in cool 
dry place 
FDA approval for 
biodegradable 
keratinocyte delivery 
system. 
Dermal            
Replacement 
Acellular Integra™ (Life 
Sciences 
Corporation, 
Plainsboro, NJ) 
 
 
 
 
 
 
 
 
Silicone 
covering.  
Need for 
autograft. 
Bovine collagen 
I and 
chondroitin-6-
sulfate from 
shark cartilage. 
Isopropyl 
alcohol at 2-8ºC 
FDA Approval for 
treatment of burns 
and scar revision. 
Alloderm® 
(LifeCell 
Corporation, 
Woodlands, TX) 
 
 
 
None.  Need 
for autograft, 
Acellular 
deepithelialized 
cadaver dermis. 
Lyophilized FDA Approval for 
burns and scar 
revision. 
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Application Composition Product Schematic 
Representation 
Layers Preservation 
Technique 
Development Status 
    Epidermal Dermal   
Dermal            
Replacement 
Cellular Dermagraft® 
(Advanced 
BioHealing, La 
Jolla, CA) 
 
 
 
 
 
 
 
None.  Need 
for autograft. 
Human foreskin 
fibroblasts 
cultured in 
biodegradable 
polyglactin 
mesh. 
Cryopreserved FDA Approval for 
burns and diabetic 
Foot Ulcers, however 
off the market and 
further production 
and marketing is 
ongoing. 
Hyalograft-3D® 
(Fidia Advanced 
Biopolymers srl,  
Abano Terme, 
Italy) 
 
 
 
 
 
 
 
Silicone 
covering.  
Need for 
autograft. 
Esterified 
hyaluronic acid 
matrix with 
autologous 
fibroblasts. 
Store in cool, 
dry place 
FDA Approval for 
burns and diabetic 
foot ulcers. 
Composite 
Replacement 
Cellular Apligraft® 
(Organogenesis, 
Canton, MA and 
Novartis 
Pharmaceuticals, 
East Hanover, 
NJ) 
 
 
 
 
 
 
 
 
Neonatal 
foreskin 
keratinocytes. 
Bovine collagen 
I with neonatal 
foreskin 
fibroblasts. 
Stored at 37°C FDA approval for 
burns, and venous 
and diabetic ulcers. 
OrCel™ (Ortec 
International 
Inc., New York, 
NY) 
 
 
 
 
 
Allogenic 
keratinocytes 
cultured on 
bilayered 
collagen 
matrix. 
Bilayered 
matrix of 
bovine collagen 
I with 
fibroblasts. 
Stored at 37°C FDA approval for 
burns. 
Table 2.1 Summary of Commercially Available Bioengineered Skin Substitutes - continued 
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3.1 INTRODUCTION 
Bioengineered skin substitutes composed of biomaterials and cultured cells offer an 
advanced wound therapy to patients suffering from severe burns and chronic ulcers.  Despite 
favorable results with these analogs, there is still a need to improve the rate at which 
autologous keratinocytes attach, populate, and epithelialize the surface of the biomaterial 
scaffold, as well as to improve the integration of the analog with the surrounding 
environment.1-4 Optimizing current design strategies requires understanding the underlying 
mechanisms by which the biochemical composition of native skin modulates keratinocyte 
adhesion, proliferation, and differentiation.5-7  Current knowledge indicates that during the 
initial phase of reepithelialization, basal and suprabasal keratinocytes interact directly with 
dermal collagens as well as with other extracellular matrix (ECM) proteins found in the 
wound environment.8,9  These initial cell-ECM adhesions are responsible for initiating and 
controlling subsequent cellular signaling events.10-12  
 
To elucidate relationships between ECM cues and keratinocyte functions related to epithelial 
morphogenesis, investigators have examined the mechanisms that modulate cell attachment, 
proliferation, and terminal differentiation in tissue culture models13-15  and on engineered 
scaffolds.16-19 Studies using bacteriological plastic have found that when type I collagen (CI), 
type IV collagen (CIV), laminin (LN), and fibronectin (FN) were present on the surfaces, the 
percentage of adherent keratinocytes depended on the concentration of the ECM protein 
used, with FN having a significantly greater effect on overall cellular attachment.21  Collagen 
type I, CIV, LN, and FN have also been investigated on polystyrene, and a higher percentage 
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of basal keratinocytes adhered to CIV than to polystyrene, indicating a potential use of ECM 
proteins in selecting for discrete populations of keratinocytes.  In addition to attachment 
studies, CI, LN, and FN have also been found to affect migration, proliferation, and 
differentiation of keratinocytes.  Adsorption of CI on both poly(lactide-glycolide) (PLGA) 
and polystyrene substrates enhanced keratinocyte migration,16,19  adsorption of LN on 
polystyrene stimulated keratinocyte migration and proliferation,19,22 and adsorption of FN on 
polystyrene promoted keratinocyte migration and inhibited terminal differentiation (Table 
3.1).16,23 Additionally, keratinocyte attachment to biomaterial surfaces that have been 
conjugated with bioactive sequences that mimic cell binding domains of ECM proteins have 
been investigated.  Sequences for LN were found to enhance keratinocyte attachment on 
polystyrene24 and collagenous material modified with arginine-glycine-aspartic acid (RGD) 
peptides greatly promoted keratinocyte attachment.18  Together, these studies demonstrate 
that biochemically modified substrates can be used to examine the mechanisms by which 
ECM proteins direct keratinocyte function.  These findings also suggest that precisely 
designed biomaterials can be used to enhance the performance of bioengineered skin 
substitutes. 
 
 
ECM PROTEIN SUBSTRATE RESPONSE 
Fibronectin • Tissue culture 
polystyrene25 
• Polyethylene glycol26 
• Attachment25 
 
• Attachment and 
migration26 
Collagen Type I • Poly(lactide-glycolide)19 • Migration19 
Collagen Type IV • Tissue culture 
polystyrene15 
• Attachment15 
Laminin • Tissue culture 
polystyrene22 
• Proliferation and 
migration22 
Table 3.1.  Effects of ECM on Keratinocyte Functions 
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In a recent study we developed collagen-glycosaminoglycan (GAG) membrane that 
functioned as basal lamina analogs, providing an interface that facilitates the formation of an 
epidermal layer on the surface of a dermal analog.27,28  A limitation of these membranes is 
that the surface biochemistry provides a limited number of cell-signaling cues that are known 
to promote reepithelialization.  We hypothesize that by incorporating ECM proteins onto the 
surface of a collagenous biomaterial substrate, we can control keratinocyte attachment and 
subsequent cell-signaling that leads to rapid morphogenesis of a robust epidermal layer.  
Characterizing the ECM environment that influences keratinocyte attachment will also 
facilitate the design of bioengineered skin substitute with surfaces tailored to promote 
increased epithelialization rates, thereby enhancing their performance. 
 
This chapter will discuss the methodology as well as results in establishing a quantitative link 
between keratinocyte attachment and ECM proteins coupled to collagen-GAG membranes.  
Briefly, a biomimetic design approach was used and we created basal lamina analogs that 
mimic the biochemical matrix composition of native tissue through passive adsorption of CI, 
CIV, LN, and FN.  To characterize the relationship between keratinocyte attachment and 
protein binding, a high-throughput screening (HTS) device was developed that allows for 
keratinocytes to be seeded on the surface of collagen-GAG membranes and for examination 
of the effects of individual proteins at various concentrations.  A tetrazolium-based 
colorimetric (MTT) assay was used to quantify attachment of viable keratinocytes.  
Comparative analysis of cellular attachment to the protein-conjugated surfaces suggests that 
keratinocyte attachment is enhanced when 0.1 mg/ml of FN is passively adsorbed to the 
surface of collagen-GAG membranes. 
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3.2 MATERIALS AND METHODS  
3.2.1 High Throughput Screening (HTS) Device  
To measure keratinocyte attachment on modified collagen-GAG membranes, a HTS device 
was developed by our laboratory (Figure 3.120).  This device consists of two machined 
DelrinTM plates that sandwich a rehydrated collagen-GAG membrane.  The top DelrinTM 
plate of the device contains an array of 4.5 mm diameter through-holes.  The through-holes 
are fitted with silicone o-rings to form sealed wells for protein and cell solutions when the 
plates and the membrane are sandwiched together. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.2 Collagen-GAG Membranes 
3.2.2.1 Collagen-GAG Dispersion 
To produce collagen-GAG membranes, a collagen-GAG dispersion containing type I 
collagen (5 mg/ml) and GAG (0.18 mg/ml) was prepared according to previously described 
methods.29  Briefly, 3.6 g of lyophilized bovine collagen (Semed S, Kensey Nash Corp., 
Figure 3.1.  High Throughput Screening (HTS) Device.  (A) Assembled HTS device unit 
with DelrinTM plates screwed together and sandwiching a rehydrated collagen-GAG 
membrane.  (B) Collagen-GAG membranes were modified using a design of experiment 
scheme  so that each concentration of collagen type I: CI, collagen type IV: CIV, laminin: LN, 
and fibronectin: FN were repeated in triplicate. (C) Schematic drawing of the assembly process 
with a) referring to individual wells, b) referring to silicone o-rings that form tight seals on c) 
collagen-GAG membranes when plates are screwed together.20   
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Exton, PA) was added to 500 ml of 0.05 M acetic acid (EMD Chemicals, Inc., Gibbstown, 
NJ) and blended at a constant temperature of 4°C for 90 minutes at 20,000 rpm in a 
refrigerated homogenizer.  The collagen-GAG coprecipitate was formed by adding 100 ml of 
a 0.11% w/v solution of shark cartilage chondroitin 6-sulfate (Sigma, St. Louis, MI) to the 
blending collagen dispersion, then blending the collagen-GAG copolymer for an additional 
90 minutes.  Once fully blended, the collagen-GAG dispersion was degassed by 
centrifugation and stored at 4°C. 
 
3.2.2.2 Production of Collagen-GAG Membranes 
The collagen-GAG dispersion was cast onto flat 148.5 cm2 molds made of 
polydimethylsiloxane silicone elastomer (PDMS, Sylgard 184, Dow Corning Corp., Midland, 
MI).  The dispersion was air-dried for 48 hours in a laminar flow hood at room temperature 
and the resulting dried collagen-GAG membrane was gently peeled away from the PDMS 
surface. 
 
3.2.2.3 Dehydrothermal (DHT) Crosslinking of Collagen-GAG Membranes  
To stabilize the materials, dried collagen-GAG membranes were wrapped in aluminum foil, 
placed in an oven at room temperature, and subjected to a vacuum of less than 200 mTorr for 
24 hours.  The temperature within the vacuum oven was then increased to 105°C for 24 
hours.  Before removing membranes from the oven, the temperature was decreased to room 
temperature and the pressure was relieved.  Membranes were then stored in aluminum foil in 
a desiccator.30 
 
3.2.2.4 Modification of Crosslinked Collagen-GAG Membranes 
Stock solutions (2 mg/ml) of human FN (BD Biosciences, Bedford, MA), rat tail collagen CI 
(purified by our laboratory by methods described by Elsdale and Bard31, rat tails were 
received from animals that were euthanized for other protocols, which were approved by 
Worcester Polytechnic Institute, Worcester, MA, Institutional Animal Care and Use 
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Committee), and mouse CIV and LN (BD Biosciences) were prepared as per manufacturer’s 
instructions.  Each protein was fluorescently labeled using a 594 Alexa Fluor Protein 
Labeling Kit (Molecular Probes, Eugene, OR) and purified by dialyzing against their natural 
buffer using a Slide-A-Lyzer cassette (Pierce, Rockford, IL).   
 
After the proteins were conjugated to the Alexa 
Fluor dye and purified, serial dilutions were made 
for final protein concentrations of 1 mg/ml, 0.3 
mg/ml, 0.1 mg/ml, 0.03 mg/ml, 0 mg/ml using 
Dulbecco’s phosphate buffer saline (dPBS, 
Hyclone, Logan, UT). Crosslinked membranes were 
placed on the HTS device as described, and 126 μl 
of each protein concentration or dPBS (control 
sample) were placed in the wells in triplicate 
(Figure 3.1C20) overnight at 4°C to facilitate protein 
adsorption.  After 18 hours, the wells were rinsed 
two times with dPBS to remove non-adherent 
protein. 
 
3.2.2.5 Detection of Protein Modification 
Fluorescent microscopy was used to evaluate the 
adsorption of the various concentrations of the 
proteins on the collagen-GAG membranes.  The 
membranes were visualized for fluorescent 
emission at 594 nm using an upright Nikon Eclipse 
E400 Microscope (Nikon, Melville, NY) with a 2x 
objective.  Images were captured with a RT Color 
Spot camera (Diagnostic Instruments, Inc Sterling 
Figure 3.2. Analysis of ECM Protein 
Conjugation to Collagen-GAG 
Membrane.  Extracellular matrix proteins 
were each conjugated to an Alexa Fluor 
dye, diluted, passively adsorbed to 
individual regions of a collagen-GAG 
membrane, and fluorescently imaged.  
Each photograph (A) was converted to 256 
gray scale image (B) and fluorescence 
intensity of a 726 pixels by 696 pixels or 
2.64 mm by 2.53 mm region of interest 
outlined in white was measured (C) using 
Scion Image.  Scale bar in A = 0.5 mm.20 
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Heights, MI).  All images in each protein group received the same exposure time using Spot 
Analysis 4.0.9 software (Diagnostic Instruments) in order to assess protein adsorption.   
 
To determine the fluorescence intensity for each protein, each digital image was converted 
from 24 bit color (red channel only) (Figure 3.2A20) to 256 levels of gray using Scion Image 
Analysis Software (Figure 3.2B20) (Scion Corporation, Frederick, MD).  Each image was 
scaled in the same manner, and a profile plot was taken of a rectangular region of interest 
(ROI) with dimensions of 2.64 mm by 2.53 mm (726 pixels by 696 pixels) (Figure 3.2B20) .  
The profile plot was then inverted in order to report fluorescent intensity values of 0 
representing black and 255 representing white (Figure 3.2C20).   
 
3.2.3 Keratinocyte Attachment Assay 
3.2.3.1 Modification of Crosslinked Collagen-GAG Membranes  
To modify the surfaces of the crosslinked collagen-GAG membranes, various concentrations 
of non-labeled solutions the individual ECM proteins; CI, CIV, LN, or FN, were adsorbed to 
the membrane in different wells.  Each protein was prepared at an initial concentration of 1 
mg/ml per manufacturer’s instructions, then passively adsorbed onto the membranes in 
triplicate overnight at 4°C at final concentrations of 0.3 mg/ml, 0.1 mg/ml, 0.03 mg/ml or 
0.00 mg/ml (dPBS controls).  After incubation, each well was rinsed twice with dPBS 
followed by addition of 200 μl of dPBS containing 0.5 mg/ml heat denatured bovine serum 
albumin (BSA, Sigma) for 1 hour.  Each well was then rinsed twice with dPBS.  
 
3.2.3.2 Culture of Human Cells 
To measure keratinocyte attachment to the modified collagen-GAG membranes, the wells of 
the HTS device were seeded with human keratinocytes isolated from neonatal foreskins. 
Neonatal foreskins were obtained from non-identifiable discarded tissues from UMass 
Memorial Medical Center, Worcester, MA and were approved with exempt status from the 
New England Institutional Review Board.   Keratinocyte isolations were performed using an 
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enzymatic treatment with a dispase (Gibco, Gaithersburg, MD) solution.  The cells were 
propagated on a feeder layer of 3T3-J2 mouse fibroblasts (generously donated by Dr. Stelios 
Andreadis, State University of New York at Buffalo, Buffalo, NY) and cultured according to 
methods previously described28,32 using keratinocyte media consisting of a 3:1 mixture of 
DMEM (high glucose) and Ham’s F-12 medium (Life Technologies, Inc., Gaithersburg, MD)  
supplemented with 10% fetal bovine serum (FBS, Hyclone), 10-10 M cholera toxin (Vibrio 
Cholerae, Type Inaba 569 B), 5 μg/ml transferrin, 0.4 μg/ml hydrocortisone (Calbiochem, La 
Jolla, CA), 0.13 U/ml insulin, 1.4*10-4 M adenine, 2*10-9 M triiodo-L-thyronine (Sigma), 1% 
penicillin/streptomycin (Invitrogen, Carlsbad, CA), and 0.01 μg/ml epidermal growth factor 
(EGF, BD Biosciences).  After 5 days of culture, cells were detached using 0.05% Trypsin-
EDTA (Invitrogen) and then rinsed with serum free and EGF free keratinocyte media.  
Passage 2 keratinocytes were used in all experiments. 
 
3.2.3.3 Quantification of Keratinocyte Attachment 
To determine the number of viable attached keratinocytes in each well, a tetrazolium-based 
colorimetric (thiazoyl blue tetrazolium bromide, MTT, Sigma) assay was performed.  The 
cells were seeded on protein modified collagen-GAG membranes (as previously described), 
with each well receiving 25,000 keratinocytes in serum free and epidermal growth factor free 
keratinocyte media for 3 hours at 37°C to facilitate attachment.  Before adding the MTT 
solution, each well was rinsed twice with PBSABC (EMD Chemicals) to remove non-
adherent cells.  MTT was prepared at a final concentration of 10 mg/ml and added to each 
well for 2 hours at 37°C.  After 2 hrs, the cells were rinsed twice with PBSABC and then 
dimethyl sulfoxide (DMSO, Sigma) was added to each well to lyse the cells.  A SpectraMax 
250 spectrophotometer (Molecular Devices, Sunnyvale, CA) was used along with Softmax 
Pro software version 3.1.2 (Molecular Devices) to determine the amount of dye absorbed by 
cells in each well using a protocol described previously by Ciapetti et. al.33 Absorbance 
values from the experimental groups were compared to absorbance values from a standard 
curve of keratinocytes plated on tissue culture polystyrene. 
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3.2.5 Statistical Analyses 
Sigma Stat Version 3.10 (Systat Software Inc., Richmond, CA) was used to determine 
statistical differences among the means of experimental groups.  To determine if the means 
of two different samples were significantly different, a Student’s t-test was performed when 
the samples were drawn from a normally distributed population with equal variance.  Sigma 
Stat uses the Kolmogorov-Smirnov test to test for a normally distributed population and a P 
value > 0.05 indicates normality.  For all parametric tests, Sigma Stat assumes equal 
variance.  When the data was not drawn from a normally distributed population (P value < 
0.05), a Mann-Whitney Rank Sum Test was used and a Levene Median test was used to 
determine equal variance with a P value > 0.05 indicating equal variance.  For both the 
Student’s t-test and the Mann-Whitney Rank Sum Test, a p value < 0.05 indicated a 
significant difference between the means of experimental groups.   
 
To determine statistical differences among the means of three or more experimental groups a 
One Way Analysis of Variance (ANOVA) was used when the samples were drawn from a 
normally distributed population with equal variance (Kolmogorov-Smirnov test for normal 
distribution and equal variance was assumed).  When the data was not normally distributed, a 
Kruskal-Wallis One way ANOVA on ranks was performed (Levene Median test to determine 
equal variance with a P > 0.05 indicating equal variance).  When a statistical difference was 
detected among the group means, a Tukey post-hoc analysis was performed for both the One 
Way ANOVA and Kruskal-Wallis One Way ANOVA on ranks.  A p value < 0.05, for both 
variance tests, indicated a significant difference between the groups. 
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3.3 RESULTS  
3.3.1 Protein Adsorption  
Examination of ECM proteins at each concentration through fluorescence microscopy 
allowed for the assessment of protein binding efficiency to the collagen-GAG membranes.  
To analyze the results we plotted the fluorescence intensity obtained at each concentration, of 
each protein (Figure 3.320).  A dose dependent increase in protein adsorption to the 
membranes was found for each protein examined. These increases are significantly different 
Figure 3.3. ECM Protein Conjugation to Collagen-GAG Membrane.  Plots showing 
the average fluorescence intensities for regions of interest that were analyzed for each 
protein conjugation condition.  Each data point represents the mean and standard error of 
the mean for two experiments, each having an n = 2. Statistical analyses were performed 
on membranes modified with collagen type I: CI, collagen type IV: CIV, laminin: LN, and 
fibronectin: FN amongst each concentration of 1 mg/ml, 0.3 mg/ml, 0.1 mg/ml, 0.03 
mg/ml, and for unmodified membranes.  * indicates p < 0.05 using One-way ANOVA 
with a Tukey Test and ** indicates p < 0.05 using Kruskal-Wallis one-way ANOVA on 
ranks with a Tukey Test.   Error bars indicate standard error.20 
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between protein concentrations of 0.3 mg/ml and non-modified membranes and between 1 
mg/ml and non-modified membranes for all proteins examined.   Fibronectin and CIV 
showed significant increases in protein binding efficiency between multiple concentrations, 
except between the two highest concentrations (0.3 mg/ml vs. 1.0 mg/ml).  This phenomenon 
was also observed during the CI and LN studies.   Based on this data, keratinocyte 
attachment studies were only conducted on adsorbed protein concentrations ranging from 0 
to 0.3 mg/ml. 
 
3.3.2 Keratinocyte Attachment to ECM Modified Collagen-GAG Membranes 
 
To characterize keratinocyte attachment to ECM proteins, cells were allowed to adhere for 3 
hrs to regions of collagen-GAG membranes that had been conjugated with a range of 
concentrations of CI, CIV, LN, and FN.  Attached viable cells were quantified through 
absorbance value measurements of solubilized tetrazolium crystals from the cell lysate. 
 
A standard curve of absorbance values from a given cell number was used to calculate the 
attached cells based on the absorbance value recorded.  The results of this study indicated 
that keratinocyte attachment was significantly enhanced by the type and concentration of 
ECM protein adsorbed to the surfaces of collagen-GAG membranes (Figure 3.420).  This 
effect was most pronounced when cells were attached to CIV and FN, when comparing the 
highest concentration studied (0.3 mg/ml) to unmodified membranes.  Cell attachment to 0.1 
mg/ml of FN was statistically greater than cell attachment to the unmodified membranes.  
There were no significant differences between keratinocytes attached to 0.1 mg/ml and 0.3 
mg/ml of FN.  Neither CI nor LN, at any studied concentration, promoted increased 
keratinocyte attachment to the collagen-GAG membrane over the baseline value for the 
unmodified membranes.   
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To compare the effects of protein concentrations on cell attachment, statistical analyses were 
performed at each of the varying concentrations.  At 0.03 mg/ml of protein modification, 
there were no statistical differences found between the various proteins or the unmodified 
membranes (Figure 3.5A20).  Increasing the protein concentration to 0.1 mg/ml induced 
changes from that seen for keratinocyte attachment on the unmodified membranes and the 
initial concentration examined (0.03 mg/ml) (Figure 3.5B20). At the protein concentration of 
Figure 3.4. Percent Keratinocyte Attachment on Biochemically Modified Collagen-GAG Membranes.  
Keratinocyte attachment values were measured on extracellular matrix modified collagen-GAG membranes.  
Each data point represents the mean and standard error of the mean for three experiments, each having n = 
6.  Statistical analyses were performed on membranes modified with collagen type I: CI, collagen type IV: 
CIV, laminin: LN, and fibronectin: FN amongst each concentration of 0.3 mg/ml, 0.1 mg/ml, 0.03 mg/ml, 
and for unmodified membranes.  * indicates p < 0.05 using One-way ANOVA with a Tukey Test and ** 
indicates p < 0.05 using Kruskal-Wallis one-way ANOVA on ranks with a Tukey Test.   Error bars indicate 
standard error.20 
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0.1 mg/ml, FN significantly increased 
keratinocyte attachment in comparison to 
the other proteins studied.  It was found 
that keratinocyte attachment was 13% 
greater on FN than on CIV, 18% greater 
than on LN, and 22% greater than on CI.  
When the protein concentration was 
increased to 0.3 mg/ml, cell attachment to 
LN was found to be significantly lower 
than FN (Figure 3.5C20).   Overall, a 
concentration of 0.1 mg/ml of FN induced 
the greatest keratinocyte attachment for all 
of the protein concentrations evaluated. 
 
3.4 DISCUSSION 
The goal of this study was to investigate the 
relationship between biochemical 
modifications of crosslinked collagen-GAG 
membranes and keratinocyte attachment as 
a function of protein composition and 
concentration in order to improve the rate 
of epithelialization of bioengineered skin 
substitutes.  A HTS device was developed 
by our laboratory to facilitate examination 
of passive adsorption of multiple proteins at 
varying concentrations on a collagen-GAG 
membrane as well as the attachment of 
viable keratinocytes.  This system allows for 
Figure 3.5. Effects of Protein Concentration on 
Percent Keratinocyte Attachment.  Keratinocyte 
attachment values were compared at 0.03 mg/ml 
(A), 0.1 mg/ml (B), and 0.3 mg/ml (C) CI, CIV, 
LN, and FN.  Three experiments, each having n = 6 
for each condition were evaluated.  The baseline 
value for percent keratinocyte attachment to 
unmodified collagen-GAG membranes was found to 
be 44.03% and the dotted lines represent the 
standard error of +/- of 1.3 from this baseline value.   
* indicates p < 0.05 using One-way ANOVA with a 
Tukey Test.  Error bars indicate standard error.20 
A
B
C
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a minimization in variability for each experiment since one membrane and keratinocytes 
from the same culture can be used to examine large numbers of cell-protein interactions 
simultaneously.  Protein binding efficiency to the collagen-GAG membranes was determined 
as a function of concentration by means of fluorescent microscopy coupled with image 
analysis.  Viable keratinocyte attachment was evaluated using a MTT-attachment assay.  The 
results of our study indicate that keratinocyte attachment to basal lamina analogs is enhanced 
by passively adsorbing FN at 0.1 mg/ml to the surfaces of the membranes. 
 
Previous studies have demonstrated that collagen-GAG biomaterials prevent wound 
contraction, enhance the growth rate of keratinocytes, and lead to the regeneration of 
connective tissue.34,35  Crosslinking collagenous biomaterials with DHT has shown to 
increase the strength and decrease the reabsorption rate of these implant materials without 
introducing cytotoxic chemicals into the system.30,36  However, a limitation of using DHT 
crosslinking is that cellular attachment is compromised.  It has been suggested that DHT 
masks integrin binding sites that promote cellular attachment.37  We found that passively 
adsorbing ECM proteins to the surface of the DHT crosslinked collagen-GAG membrane 
significantly increased its ability to support cellular attachment.   Collagen type IV and FN 
provided an increase of 10% and 18% cellular attachment, respectively.   
 
The results of this study demonstrate a strong relationship between the ECM protein 
conjugated to the surface of a collagenous biomaterial and the specific cellular-matrix 
interactions that occur during keratinocyte attachment.  Protein conjugation results show an 
increase in fluorescence intensity for each protein as the concentrations increased to 0.3 
mg/ml, however CI and LN were found to have no significant effect on increasing 
keratinocyte attachment even at the highest concentrations.  These trends are consistent with 
previous studies performed by Adams et al. on bacteriological plastic,21 and can be explained 
by the integrin expression profile of cultured keratinocytes that facilitates for cell-ECM 
attachment.  
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The principle integrins on the surface 
of keratinocytes in non-wounded skin 
are α2β1, which bind cells to dermal 
collagens,21,38-40 and α3β1, which bind 
cells to LN (Figure 3.6A).41  After 
wounding, changes in the expression 
profile of integrins on the wound edge 
keratinocytes allow for dynamic 
interactions with the dermal ECM as 
well as with components of the 
provisional matrix supplied by the 
fibrin clot and endogenous protein 
secretion (Figure 3.6B).9  During this 
reepithelialization process, 
keratinocytes located at the margin of 
the wound, transition from a stationary 
to a migratory phenotype characterized 
by a flat and elongated morphology, 
reorganization of cytoskeletal and 
junctional complexes, and a change in integrin expression.42-47 Most notably, the change in 
integrin expression can be characterized by the induction of α5β1, an integrin responsible for 
binding cells to FN via the RGD sequence in the central cell binding domain of the 
molecule.9,21,39,45,48  Concomitant with this transition, keratinocytes detach from the basal 
lamina and migrate laterally by dynamically interacting with the dermal ECM as well as with 
the components of the provisional matrix supplied by the fibrin clot and endogenous protein 
secretion, through integrin based mechanisms.8-11 Studies investigating wound healing 
phenomenon in vivo have found FN present under the tip of a migrating epithelial tongue and 
Figure 3.6. Reepithelialization of Wound in Native 
Skin.  (A) depicts native healthy skin with the two main 
layers, the epidermis and dermis uninjured.  At the dermal-
epidermal junction is the basal lamina.  When a wound 
occurs (B) a fibrin clot forms and keratinocytes at the 
wound margin become activated and undergo a change in 
integrin expression.  (C) The activated keratinocytes begin 
to migrate until a monolayer of cells is formed. When a 
monolayer is formed, keratinocytes begin to proliferate 
and differentiate to fill the wound site and native 
physiology is returned (D).  
A 
B 
C 
D 
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an absence of both LN and CIV, which are known to be present at greater levels in the basal 
lamina, of healthy tissue.  Once the wound surface has been covered with a monolayer of 
keratinocytes and migration has ceased (Figure 3.6C), native basement membrane proteins, 
notably LN and CIV, reappear in a very ordered sequence from the margin of the wound 
inward, and keratinocytes return to the standard proliferation and differentiation program of 
the cell (Figure 6D).49,50   When keratinocytes are harvested and cultured in vitro, they 
exhibit the same change in expression profile of integrins as wounded keratinocytes and 
develop the ability to attach to FN.51  Together these findings demonstrate that FN based 
cellular adhesions as well as interactions with dermal collagens can be used to direct the 
spatial organization, migration, proliferation, and differentiation of keratinocytes and 
enhance the rate of reepithelialization of crosslinked collagenous biomaterials.9,10,52  
 
Characterizing the composition of ECM proteins that enhance keratinocyte attachment on 
collagen-GAG membranes is an important feature that can be leveraged for the design of 
bioengineered skin substitutes.  Increased attachment of keratinocytes is thought to facilitate 
a more rapid regeneration of the wound environment through outside-in signaling events that 
are controlled by cellular-integrin-ECM adhesions.  These signals are responsible for 
triggering migration, proliferation, and differentiation.53  To further test the hypothesis of this 
study the next step in our research plan is to build on our current results by establishing a 
quantitative link between the ECM composition of our basal lamina analogs and the 
formation of an epidermal layer.  Before doing so, we will first investigate the presentation of 
FN on our dermal scaffolds and study the effects of modification strategies on its 
presentation and overall bioactivity.  We believe that understanding how to strategically 
modify a biomaterial surface to increase its bioactivity is of great importance for enhancing 
epithelialization as well for engineering other functional tissues.   
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4.1 INTRODUCTION 
The role of extracellular matrix (ECM) proteins in directing keratinocyte function has been 
studied extensively during the reepithelialization phase of wound healing,1-3 in tissue culture 
models,4,5 and on the surfaces of biomaterials.6-8  Specifically, the ECM protein fibronectin 
(FN) plays an integral role in the attachment of keratinocytes and the regeneration of an 
epidermal layer in the wound healing environment.  Fibronectin is part of the provisional 
matrix that interacts with dermal collagens and provides signaling cues to direct 
reepithelialization.  The FN interactions with collagen are mediated by specific domains on 
the surfaces of collagen molecules that produce oriented FN binding, in a manner that 
presents FN binding sites for 
cellular interactions.  Specifically, 
the principle collagen found in the 
dermis is collagen type I (CI), and 
the FN binding site is found on the 
α1(I) chain between amino acid 
residues 757-791.9    
 
Fibronectin is a high molecular 
weight glycoprotein that is found 
in the ECM as well as in blood 
plasma (Figure 4.110).  Fibronectin 
is composed of three types of 
Chapter 4: Fibronectin Cellular Binding Site 
Availability
Figure 4.1. Structure of FN Monomer. 
Fibronectin monomer with expanded view of the 
9th and 10th type III repeat.  Integrin binding motif 
is displayed in yellow.10 
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repeating modules.  There are 12 type I repeats (~45 amino acids long), two adjacent type II 
repeats (60 amino acids long), and 15-17 type III repeats (~90 amino acids long).   The 
repeating modules of FN fold independently with 20-35% β-structure and no α-helix.  When 
assembled in ECM fibrils, the subunits unfold into elongated forms 2-3 nm in diameter and 
each subunit 60-70 nm in length.11,12   
 
Fibronectin contains an arginine-glycine-aspartic acid (RGD) binding domain that acts as a 
ligand for integrin receptors found on the surfaces of keratinocytes and other cells.13,14  
Studies have demonstrated that the conformation of adsorbed FN affects the availability of 
these ligand domains for integrin binding.   Furthermore, the presence of these domains 
directs specific functions of fibroblast,15  osteoblast,16 myoblast,17 and endothelial cells.18  
Although many research efforts have elucidated the importance of FN in controlling 
keratinocyte attachment, migration, proliferation, and differentiation,19-22 little research has 
been conducted to evaluate the roles of biomaterial substrate properties, including chemistry 
and hydrophobicity, on FN conformation and subsequent FN mediated keratinocyte 
functions.   
 
Understanding how to engineer biomaterial surfaces with the appropriate properties to 
present tailored biochemical signaling cues to keratinocytes, will ultimately lead to the 
design of dermal scaffolds that promote rapid reepithelialization and improve the 
performance of tissue engineered skin substitutes.  Self-assembled monolayers (SAMs) of 
alkanethiols on gold substrates offer an excellent model system to evaluate the effect of 
biomaterial surface properties on protein conformation and subsequent cellular interactions, 
due to their ease of fabrication and ability to present homogenous surface chemistries.23,24  
Various surface chemistries can be created by modifying the terminal functional group of 
alkanethiol molecules without altering other surface variables, such as roughness or 
topology.  Previous studies have demonstrated that both the hydrophobicity and charge of a 
SAM surface directly affect protein conformation and concentration and modulate cellular 
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signaling and subsequent cellular functions.15,16,23,25-28 
 
The purpose of this chapter was to evaluate the effect of FN concentration and conformation 
on keratinocyte attachment, morphology, and differentiation.  Using SAMs as model 
biomaterial surfaces, we analyzed FN adsorption and conformation at both low and saturated 
FN surface densities, as a function of different surface chemistries. Low FN surface density 
experiments were conducted to compare the effects of each surface chemistry on FN 
conformation and subsequent cellular functions, since each surface had the same amount of 
protein adsorbed. Saturated FN surface density experiments were conducted to analyze the 
effects of surface chemistry on FN conformation and concentration as well as their roles on 
keratinocyte functions. The availability of cellular binding sites was evaluated and correlated 
with keratinocyte attachment, morphology, differentiation, as well as focal adhesion (FA) 
formation.  Comparative analyses of keratinocyte function on FN coated SAMs suggest that 
NH2 and CH3 terminated surfaces at saturated FN densities increase binding domain 
availability which correlates directly with increased control of keratinocyte attachment, 
morphology, and decreased differentiation through integrin mediated signaling mechanisms. 
 
4.2 MATERIALS AND METHODS  
4.2.1 Preparation of SAMs 
Gold surfaces on glass substrates were obtained commercially from Evaporated Metal Films 
(Ithaca, NY).  For monolayer formation, slides were cleaned and immersed in 1 mM 
alkanethiol solutions in absolute ethanol of dodecanethiol (CH3 surface, Alfa Aesar, Ward 
Hill, MA), 11-mercaptoundecanoic acid (COOH surface, Aldrich, Milwaukee, WI), 11-
mercapto-1-undecanol (OH surface, Aldrich), and 11-amino-1-undecanethiol, hydrochloride 
(NH2 surface, Dojindo Laboratories, Kumamoto, Japan) for 18 hours.  After a packed 
monolayer formed, the slides were removed from solution, rinsed with ethanol, and dried 
with nitrogen following protocols previously described.25,29  New films were prepared 
immediately prior to each characterization and cellular experiment. 
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4.2.2 Characterization of SAMs 
To measure the contact angle for each SAM surface, sessile drop measurements were 
obtained using a 100-00 Goniometer (Rame-Hart Netcong, NJ) with a protractor mounted in 
the eyepiece on 1 µl droplets of deionized water that were applied to the surface.  A 
minimum of four measurements were taken on each surface and the results were averaged.  
These measurements were repeated for each surface. 
 
To determine the thickness of the SAM layers on the surface of each substrate, ellipsometry 
measurements were obtained with a manual null ellipsometer (Rudolph, Denville, NJ).  Film 
thickness values were determined using regression algorithms with constant values of 1.457 
for the index of refraction of the film, 3.50 for the substrate absorption, and varying the index 
of refraction of the substrate from 0.15 – 0.30 in 0.05 increments.  For each SAM surface 5 
measurements were made.   
 
4.2.3 Culture of Neonatal Human Keratinocytes 
Neonatal foreskins were obtained from non-identifiable discarded tissues from UMass 
Memorial Medical Center, Worcester, MA and were approved with exempt status from the 
New England Institutional Review Board.   Keratinocyte isolations were performed using an 
enzymatic treatment with a dispase (Gibco, Gaithersburg, MD) solution.  The cells were 
propagated on a feeder layer of 3T3-J2 mouse fibroblasts (generously donated by Dr. Stelios 
Andreadis, State University of New York at Buffalo, Buffalo, NY) and cultured according to 
methods previously described30,31 using keratinocyte media consisting of a 3:1 mixture of 
Dulbecco’s Modified Eagle’s Medium (DMEM high glucose) and Ham’s F-12 medium (Life 
Technologies, Inc., Gaithersburg, MD)  supplemented with 10% fetal bovine serum (FBS, 
Hyclone, Logan, UT), 10-10 M cholera toxin (Vibrio Cholerae, Type Inaba 569 B), 5 μg/ml 
transferrin, 0.4 μg/ml hydrocortisone (Calbiochem, La Jolla, CA), 0.13 U/ml insulin, 1.4*10-4 
M adenine, 2*10-9 M triiodo-L-thyronine (Sigma, St. Louis, MI), 1% penicillin/streptomycin 
(Invitrogen, Carlsbad, CA), and 0.01 μg/ml epidermal growth factor (EGF, BD Biosciences, 
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Bedford, MA).  After 5 days of culture, cells were detached using 0.05% Trypsin-EDTA 
(Invitrogen) and then rinsed with serum free and EGF free keratinocyte media KCM(-S-GF).  
For all cellular experiments, keratinocytes were seeded in KCM(-S-GF) and passage 2-4 
keratinocytes were used for all experiments. 
 
4.2.4 FN Adsorption on SAM Surfaces  
To create individual wells for cellular assays, 9 mm inner diameter adhesive silicone isolators 
(Grace BioLabs, Bend, OR) were affixed to SAM surfaces or tissue culture polystyrene cover 
slips (positive controls) (TCPS, Thermanox, Nunc, Rochester, NY).  Fibronectin (FN, BD 
Biosciences) was then passively adsorbed at low surface density or saturated surface density 
for 1 hour at room temperature.  Based on the results of previous studies 40 ng/cm2 of FN for 
each surface was used as the low surface density to achieve the same surface density of FN 
on each SAM surface.  This density was achieved by using 10 µg/ml of FN for the OH 
surface, 2 µg/ml of FN for the CH3, COOH, and NH2 surfaces, and 1 µg/ml of FN for the 
TCPS surface.17,29  Saturated surface densities were achieved using 25 µg/ml of FN, based on 
our ellipsometry data as well as previously reported values for SAM surfaces.24,29  This 
concentration produced surfaces with FN surface densities of approximately 110 ng/cm2, 360 
ng/cm2, 280 ng/cm2, 410 ng/cm2, and 400 ng/cm2 for OH, CH3, COOH, NH2, and TCPS 
surfaces, respectively.17,29  After FN adsorption, each well was blocked for non-specific 
binding using 1% heat denatured bovine serum albumin (BSA, Sigma) in dPBS (Hyclone). 
 
4.2.5 Determining Saturation Density of Adsorbed FN using Ellipsometry 
The thickness of the adsorbed FN on the SAM surfaces was quantified using ellipsometry 
methods previously described.24  Self-assembled monolayer substrates were prepared and 
individual wells were created on each surface.  Stock solutions of 0, 5, 25, and 100 µg/ml of 
FN were added to each well in dPBS for 1 hour or 4 hours at room temperature.  Each well 
was measured three times and average film thickness was recorded and compared with the 
initial value, determined during characterization of the untreated surfaces, to give the 
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thickness of adsorbed protein on each SAM surface.  This analysis was performed on each 
surface in triplicate and averages with standard deviations were reported. 
 
4.2.6 SAM Mediated Changes in FN Conformation  
To measure SAM dependent changes in adsorbed FN conformation and the availability of the 
central cellular binding domain on FN, a monoclonal antibody directed towards this domain 
(HFN 7.1, Developmental Studies Hybridoma Bank, Iowa City, IA) was used.32   Low 
surface density and saturated surface density FN treated SAM surfaces as well as TCPS 
surfaces were blocked using 1% heat denatured BSA (in dPBS) then incubated with HFN 7.1 
for 1 hour in 10% CO2 at 37°C.  Each surface was then rinsed in blocking buffer (0.05% 
Tween-20 (Sigma) and 0.25% BSA in dPBS) and incubated with 546 Alexa Fluor conjugated 
goat anti-mouse IgG (1:200 in blocking buffer, Molecular Probes, Eugene, OR ) for 1 hour in 
10% CO2 at 37°C.  Slides were then rinsed with dPBS, and images were captured using an 
RT Color Spot camera (Spot Diagnostics, Sterling Heights, MI).  Image J Analysis software 
(downloaded from http://rsb.info.nih.gov/ij/) was used to determine the relative amount of 
cellular binding sites on each FN treated SAM and control surface.  The total area of 
fluorescent pixels was calculated, normalized against the total area of each well examined, 
and the values are reported as HFN 7.1 percent positive area.  This assay was performed four 
times for each surface at each surface density.  Results are reported as averages and standard 
deviations.   
 
4.2.7 Cell Spreading 
To quantify the effect of FN treated SAM surfaces on keratinocyte morphology, cell 
spreading was measured using fluorescein-5-maleimide, as previously described.33  
Keratinocytes were seeded at a density of 5000 cells/well in KCM(-S-GF) and allowed to 
attach for 3 hours in 10% CO2 at 37°C.  After attachment, the wells were rinsed using 
PBSABC (EMD Chemicals, Gibbstown, NJ), fixed using 16% formaldehyde (Ted Pella, Inc., 
Redding, CA), and then permeated using 0.1% Triton X-100 (Sigma).  Fluorescein-5-
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maleimide (Molecular Probes) at 0.6 mM was added to the cells for 1 hour at room 
temperature.  This fluorescent compound becomes covalently coupled to functional groups of 
proteins found in the cell membrane.  After 1 hour, cells were rinsed with dPBS and cell 
nuclei were stained with a 0.06 mM solution of Hoechst nuclear reagent (Molecular Probes) 
for 5 minutes at 37°C. All images of stained cells were thresholded using the same image 
analysis protocol to clearly define cellular areas.  Each cell was traced and its area was 
calculated with Image J software.  For each surface condition, 15 random cells were 
analyzed. 
 
4.2.8 Analysis of Keratinocyte Attachment 
Keratinocytes were seeded at a density of 5000 cells/well in KCM(-S-GF) and allowed to 
attach for 3 hours in 10% CO2 at 37°C on each FN treated surface.  The wells were then 
rinsed using PBSABC and the cell nuclei were stained Hoechst nuclear reagent.  Images 
were captured to determine the number of attached cells in a defined region.  Assuming the 
cells were homogenously dispersed in each well, this value was used to extrapolate the total 
number of attached cells per well and normalized to the initial number of cells seeded.  For 
each surface condition examined, 3 separate wells were imaged and each experimental 
surface condition was assayed in duplicate.  Values are reported as percent keratinocyte 
attachment. 
 
4.2.9 Analysis of Keratinocyte Differentiation  
The percentage of involucrin positive keratinocytes  was detected by immunofluorescence 
staining using methods previously described.34  Involucrin is expressed by keratinocytes that 
have committed to terminal differentiation.35,36  Keratinocytes were allowed to attach on FN 
treated surfaces for 3 hours in KCM(-S-GF) in 10% CO2 at 37°C.  Following incubation, the 
wells were rinsed with PBSABC, fixed with 4% formaldehyde, and then permeabilized with 
0.5% Triton X-100 in dPBS.  The cells were treated with a monoclonal mouse anti-human 
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involucrin antibody (Clone SY5, Sigma) (1:50 dilution in blocking buffer; 0.05% Tween 20 
and 0.25% BSA in dPBS) for 1 hour at room temperature. 
 
Cells were then rinsed with blocking buffer and incubated with an Alexa Fluor 546 
conjugated goat anti-mouse secondary antibody (1:200 dilution in blocking buffer) for 45 
minutes in 10% CO2 at 37°C.  Immunofluorescence images were converted to binary images 
by thresholding to 50% of maximum intensity.  Thresholded cells that exhibited a fluorescent 
area greater than 100 µm2 were marked 
involucrin positive.  The total cell number was 
also evaluated for each image and the 
percentage of involucrin positive cells for each 
image was reported.  For each surface condition, 
4 samples were evaluated and each experimental 
surface condition was assayed in duplicate. 
 
4.2.10 Fluorescence Assessment of FA 
Formation 
 
To further evaluate keratinocyte attachment on 
precisely tailored SAM surfaces, quantitative 
immunolocalization studies were used to 
evaluate the expression of the FA protein 
vinculin within the cells following a previously 
published method.37  Keratinocytes were seeded 
on FN treated surfaces for 3 hours in 10% CO2 
at 37°C.  Each of the cell seeded surfaces was 
then rinsed with PBSABC, treated for 10 
minutes with a solution to fix and permeabilize 
the cells (4% formaldehyde, 0.2% Triton X-100 
Figure 4.2. FA Validation on Tissue Culture 
Plastic.  An anti-vinculin antibody was used to 
determine presence of peripheral FAs.  
Keratinocytes were cultured on tissue culture 
plastic for 3 hours.  A and B represent cells that 
received both primary and secondary 
antibodies.  A is the brightfield image, and B is 
the fluorescent image to detect vinculin.  Note 
the punctuate staining at the cell peripheries in 
B.  C and D represent cells that received only 
the labeled secondary antibody.  C is the 
brightfield image, and D is the fluorescent 
image to detect vinculin. E and F represent 
cells that received neither the primary nor the 
secondary antibody.  E is the brightfield image, 
and F is the fluorescent image to detect 
vinculin. Scale bar represents 100 µm. 
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in dPBS), and then treated for 10 minutes with a blocking solution (1% BSA in dPBS) to 
minimize nonspecific binding.  The cells were then incubated with mouse anti-human 
vinculin primary antibody (Clone HVIN-1, Sigma) (1:100 dilution in blocking solution) for 
45 minutes in 10% CO2 at 37°C.  Following primary incubation, the surfaces were rinsed in 
1% BSA and incubated with Alexa Fluor 546 conjugated goat anti-mouse secondary 
antibody (1:100 in blocking solution) for 30 minutes in 10% CO2 at 37°C.  Figure 4.2 
displays validation of focal adhesion staining.  Figure 4.2A and 4.2B represent cells that 
received both primary and secondary antibodies.  In the fluorescent image (Figure 4.2B) 
punctate staining of vinculin is located at the edges of the cells, where focal adhesion are 
located.  Figures 4.2C and 4.2D represent cells that received only the labeled secondary, and 
it can be seen in 4.2D that there is no punctuate staining at the edges of the cells.  Figures 
4.2E and 4.2F are images that received neither primary nor secondary antibodies.  Images 
were all exposed to the same fluorescence intensity to allow for quantification of FAs.  Using 
Image J analysis software, the area of each individual FA was measured and the total area of 
FAs was summed for each individual cell.  This value was then normalized to the area of the 
corresponding cell to calculate the area density of focal adhesions for each cell.  For each 
surface condition, 10 cells were analyzed. 
 
4.2.11 Statistical Analyses 
Sigma Stat Version 3.10 (Systat Software Inc., Richmond, CA) was used to determine 
statistical differences among the means of experimental groups.  To determine if the means 
of two different samples were significantly different, a Student’s t-test was performed when 
the samples were drawn from a normally distributed population with equal variance.  Sigma 
Stat uses the Kolmogorov-Smirnov test to test for a normally distributed population and a P 
value > 0.05 indicates normality.  For all parametric tests, Sigma Stat assumes equal 
variance.  When the data was not drawn from a normally distributed population (P value < 
0.05), a Mann-Whitney Rank Sum Test was used and a Levene Median test was used to 
determine equal variance with a P value > 0.05 indicating equal variance.  For both the 
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Student’s t-test and the Mann-Whitney Rank Sum Test, a p value < 0.05 indicated a 
significant difference between the means of experimental groups.   
 
To determine statistical differences among the means of three or more experimental groups a 
One Way Analysis of Variance (ANOVA) was used when the samples were drawn from a 
normally distributed population with equal variance (Kolmogorov-Smirnov test for normal 
distribution and equal variance was assumed).  When the data was not normally distributed, a 
Kruskal-Wallis One way ANOVA on ranks was performed (Levene Median test to determine 
equal variance with a P > 0.05 indicating equal variance).  When a statistical difference was 
detected among the group means, a Tukey post-hoc analysis was performed for both the One 
Way ANOVA and Kruskal-Wallis One Way ANOVA on ranks.  A p value < 0.05, for both 
variance tests, indicated a significant difference between the groups. 
 
4.3 RESULTS  
4.3.1 Model Surfaces with Precisely Tailored Surface 
Chemistries 
 
Self-assembled monolayer surfaces presenting nonpolar 
hydrophobic (CH3), negatively charged (COOH), neutral 
hydrophilic (OH), and positively charged (NH2) surfaces were 
produced at physiological conditions (pH 7.4) (Figure 4.3).   
Contact angles obtained from this study were 112 ± 1° for 
CH3, 20 ± 2° for OH, 29 ± 2° for COOH, and 46 ± 2° for NH2 
(Table 4.1) and are comparable to previously reported values 
for the same or similar alkanethiols.29,38  
 
 
 
Figure 4.3 SAMs on Gold 
Surface.  Cartoon depicts 
alkanethiols with different 
functional end groups to obtain 
different chemistries on a gold 
surface.  The hydorphobicity of 
each alkanethiol increases going 
from left to right. 
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4.3.2 Determining Saturation Levels of FN 
 
At 1 hour, ellipsometry showed that 
the thickness of adsorbed FN 
increased between the surfaces 
treated with 5 µg/ml and 25 µg/ml 
and plateaued at a concentration of 
25 µg/ml on all SAM surfaces.  No 
statistical differences were observed 
between 25 µg/ml and 100 
µg/ml on any surface 
examined (Figure 4.439).  
When FN was adsorbed onto 
SAM surfaces for 4 hours, the 
thicknesses of the FN were 
comparable to those measured 
at 1 hr (data not included).  
When comparing the thicknesses of FN on each SAM surface after 25 µg/ml was adsorbed, 
no statistical differences were found.  Based on our ellipsometry data, we chose to use 25 
µg/ml as our FN concentration to saturate each SAM surface. 
 
 
Table 4.1 Contact Angle and Characteristic Properties of SAMs 
Figure 4.4. Relationship Between FN Concentration and 
Thickness on SAM Surfaces.  Ellipsometry was used to determine 
saturation levels of adsorbed FN on CH3, COOH, OH, and NH2 
terminated SAM surfaces.  FN concentrations of 0, 5, 25, and 100 
µg/ml were passively adsorbed for 1 hour. It was found that saturation 
was achieved for all surfaces at 25 µg/ml.  No statistical differences 
were found between 25 µg/ml and 100 µg/ml on each SAM surface or 
between different SAM surfaces at 25 µg/ml (One way ANOVA with 
Tukey post-hoc analysis).  For each surface condition 4 samples were 
evaluated at each concentration.  Data is plotted as mean ± standard 
deviations.39 
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4.3.3 Analysis of SAM Directed Changes in FN Conformation  
 
Analyses of fluorescent images indicated that at low surface density, FN treated OH surfaces 
exhibited a statistically greater HFN 7.1 positive area than the other surfaces evaluated 
(Figure 4.539).  When surfaces were treated with saturated surface densities of FN, HFN 7.1 
positive areas on CH3, and NH2 functionalized substrates as well as TCPS were statistically 
greater than the OH and COOH functionalized surfaces. 
 
 
 
 
 
 
 
 
 
 
 
4.3.4 SAM Dependent Changes in FN Treated Surfaces Direct Keratinocyte Attachment 
 
The percentage of keratinocyte attachment at low FN surface density was found to be 
significantly higher on OH terminated SAM surfaces (25%) than other surfaces evaluated (14 
– 18%) (Figure 4.639).  When comparing keratinocyte attachment at low surface density and 
saturated surface densities of FN for each surface condition, a statistically significant 
increase was found for all surfaces except for OH terminated surfaces.  At saturated surface 
densities of FN, keratinocyte attachment values on CH3, NH2, and TCPS surfaces were 
comparable to each other and significantly greater than on the other surfaces, 55% vs. 25%, 
Figure 4.5. Analysis of Changes in FN Conformation on SAM Surfaces.  To determine the relative quantity 
of cell binding sites of FN an antibody directed towards the RGD and PHSRN sites of was used.  At low FN 
surface density, OH terminated surfaces promoted a significant increase in positive HFN 7.1 area and at 
saturated FN surface densities, CH3, NH2, and TCPS surfaces facilitated a significant increase in positive HFN 
7.1 area.  For both low and saturated surface densities * indicates statistical difference using One way ANOVA 
with Tukey post hoc analysis p < 0.05.  Sample values of n = 4 and data is plotted as mean ± standard 
deviations.39 
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respectively.  These findings exhibit a trend that is consistent with the results of analyses of 
available cell binding epitopes for FN treated SAM surfaces.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.5 SAM Dependent Changes in Fibronectin Treated Surfaces Direct Keratinocyte 
Morphology  
 
At low FN surface densities, OH terminated SAM surfaces facilitated a statistically 
significant increase in cell spreading relative to all other surfaces analyzed (Figure 4.739). In 
comparing keratinocyte spreading at low surface density and saturated surface densities of 
FN for each surface condition, a statistically significant increase was found for all surfaces 
except for OH terminated surfaces.  When we evaluated the effects of FN treated SAM 
substrates at saturated surface densities, it was found that NH2, CH3, and TCPS surfaces 
mediated the same amount of keratinocyte spreading, and all of these surfaces promoted 
significantly greater keratinocyte spreading than OH and COOH functionalized surfaces. 
 
 
Figure 4.6. Keratinocyte Attachment on FN Treated SAM Surfaces.  Cell nuclei were stained to 
determine attachment percentage of keratinocytes on various SAM surfaces.  Results indicate that at low 
surface density OH terminated surfaces promoted a significant increase in percent keratinocyte attachment 
and at saturated surface densities there was a statistically significant increase in percent keratinocyte 
attachment on CH3, NH2, and TCPS surfaces.  For both low and saturated surface densities * indicates 
statistical difference using One way ANOVA with Tukey post hoc analysis p < 0.05.  Sample values of n =3 
and data is plotted as mean ± standard deviations.39 
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4.3.6 SAM Dependent Changes in 
FN Treated Surfaces Direct 
Keratinocyte Differentiation 
 
11-mercapto-1-undecanol SAM 
surfaces treated with low surface 
densities of FN exhibited a 
significantly lower percentage of 
involucrin positive cells when 
compared to the other surfaces, 
20% vs. 32-37% (Figure 4.839).  At 
saturated FN surface densities, 
Figure 4.7. Keratinocyte Spreading Area on FN Treated SAM Surfaces.  For morphological assessment 
of keratinocytes, cell spreading area was analyzed.  At low FN surface density, OH terminated surfaces 
promoted a significant increase in keratinocyte spreading and at saturated FN surface densities, CH3, NH2, 
and TCPS surfaces facilitated a significant increase in cell spreading.  For low surface density * indicates 
statistical difference using One way ANOVA with Tukey post hoc analysis p < 0.05 and for saturated 
surface density * indicates statistical difference using Kruskal-Wallis One way ANOVA on ranks with 
Tukey post hoc analysis p < 0.05.  Sample values of n = 15 and data is plotted as mean ± standard 
deviations.39 
Figure 4.8. The Effect of SAM Dependent Changes in FN on Keratinocyte Differentiation.  Keratinocytes 
expressing involucrin were considered differentiated and can be seen as the cells that are stained positive (open 
arrows), whereas keratinocytes that did not express the protein were considered to stain negative (closed 
arrows).  Fluorescent images of keratinocytes on NH2 surface at A) low surface density and B) at saturated 
surface densities.  A greater percentage of cells stained positive on the low surface density (A), in comparison 
to the percentage of cells that stained positive on the saturated surface densities (B).  At low surface density, 
the OH SAM has statistically lower amounts of positive involucrin expression than the other surfaces 
evaluated.  At saturated surface densities, CH3, NH2, and TCPS surfaces have statistically lower amounts of 
positive involucrin expression than COOH or OH terminated surfaces (C).  For both low and saturated surface 
densities * indicates statistical difference using One way ANOVA with Tukey post hoc analysis p < 0.05.  
Scale bar represents 50 µm.  Sample values of n = 4 and data is plotted as mean ± standard deviations.39 
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involucrin expression decreased significantly for all surfaces except OH terminated surfaces.  
Additionally, CH3, NH2, and TCPS surfaces were shown to have the lowest levels of 
involucrin positive expression (~11%). 
 
 
4.3.7 Quantification of FA on FN Treated SAM Surfaces  
 
Fluorescent images of keratinocytes on OH surfaces 
at low FN surface density suggest these cells had a 
greater spreading area and appeared to express more 
FAs than cells on the other surfaces.  At saturated 
FN surface densities, cells cultured on CH3, NH2, 
and TCPS surfaces displayed larger spreading areas 
and appeared to have more FAs than cells cultured 
on COOH and OH surfaces (Figure 4.939).  
Qualitative analyses showed that at a low FN 
surface density, the area density of FAs in each cell 
on OH terminated surfaces was statistically greater 
than on other surfaces At saturated FN surface 
densities, all surfaces except for the OH surface 
exhibited an increase in area density of FAs when 
compared to low FN surface densities and the area 
density of FAs on NH2, CH3, and TCPS surface was 
significantly greater than on the OH and COOH 
Figure 4.9. FA Analysis on SAM Surfaces.  An anti-vinculin antibody was used to determine presence of 
FAs.  Keratinocytes cultured on OH at low FN surface density appeared to have more FAs than on the other 
surfaces evaluated.  Cells cultured on CH3, NH2, and TCPS at saturated FN surface densities exhibited larger 
spreading areas and appeared to have more FA than the COOH and OH surfaces.  Additionally, when 
comparing FAs at low and saturated surface densities, CH3, COOH, NH2, and TCPS surfaces exhibited a 
difference in the size and number of FAs.  Scale bar represents 25 µm.39 
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surfaces (Figure 4.1039). Additionally, at saturated FN surface densities, we observed that the 
size and amount of FAs were greater on the NH2, CH3, and TCPS surfaces.   
 
 
4.4 DISCUSSION 
A critical component in the advancement of tissue engineered skin substitutes is the 
development of biomaterials that are tailored to include specific biochemical cues which 
direct cellular signaling and subsequent physiological functions.  In the present study, we 
used SAMs as model biomaterial surfaces to examine the role of surface chemistry on 
mediating the conformations and concentrations of adsorbed FN, as well as on directing 
keratinocyte functions that guide reepithelialization of dermal equivalents.  Overall, our 
results indicate the NH2 and CH3 functional groups at saturation densities facilitate the 
largest quantity of FN to be adsorbed, in a manner that promotes cell binding.  We also 
showed that the availability of synergy sites correlates with the number of FAs and 
Figure 4.10. FA Area Density Measurements. The area density of FAs was determined using 
immunostaining techniques coupled with fluorescent microscopy.  Keratinocytes cultured on OH at low FN 
surface density exhibited increased area density of FAs in comparison with the other surfaces examined.  At 
high FN surface density, increased area density of FAs were expressed on CH3, NH2, and TCPS surfaces in 
comparison with the OH and COOH surfaces.  For both low and saturated surface densities * indicates 
statistical difference using One way ANOVA with Tukey post hoc analysis p < 0.05.  Sample values of n = 
10 and data is plotted as mean ± standard deviations.39 
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hypothesize that integrin mediated mechanisms modulate keratinocyte spreading, attachment, 
and differentiation. 
 
The availability of the central cellular binding domain of FN, which spans the 9th and 10th 
type III repeats of the molecule, is known to play a major role in cellular attachment.  This 
FN domain encompasses the RGD and PHSRN binding sites which are critical for integrin 
binding and subsequent cellular signaling.40-42  Availability of this region, and the biological 
activity of the protein, is highly dependent on the proper structural orientation of the protein.  
The results of our studies indicate structural orientation and biological activity of FN is 
modulated by the surface chemistry of the substrate in a manner that is consistent with the 
results of previous research.17   
 
Low FN density experiments were carried out to evaluate the effects of conformation of FN 
since at low density the same amount of FN was adsorbed on each surface (40 ng/cm2). Our 
results indicate at low FN surface density, FN adsorbed on the OH terminated SAM 
exhibited a conformation that provided an increase in available cell binding sites, relative to 
the other SAMs and the control surface.  When evaluating keratinocyte spreading and 
attachment at the low surface density, we found a direct relationship between the number of 
available binding sites and keratinocyte spreading and attachment and an inverse relationship 
for keratinocyte differentiation.  
 
Saturated FN density experiments were also performed to analyze the effects of surface 
chemistry on conformation and concentration of FN.  At saturation densities, the OH surface 
exhibited the same amount of binding sites as the low density of FN on the OH surface, 
suggesting that the surface was saturated at both densities that were analyzed.  When 
characterizing the relative number of binding sites on FN on the CH3, NH2, COOH, and 
TCPS surfaces, an increase was found between low and saturated densities.  Fibronectin 
treated CH3, NH2, and TCPS surfaces at saturation densities exhibited a greater number of 
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binding sites than the COOH or OH surfaces. In a previous study, Keselowsky et al., reported 
that the density of FN on CH3 and NH2 surfaces was not statistically different from COOH 
SAM surfaces, at theoretical saturation densities.29  Our data indicates a less preferential 
cellular binding conformation was achieved on the COOH surface relative to the CH3 and 
NH2 surfaces. This study also showed that there was a significant difference between the 
density of FN on OH and COOH surfaces at saturation densities.  However, in our studies, 
there were no differences in available binding sites or functional measurements between 
these surfaces.  Together, these observations indicate that even though a greater FN density 
was achieved on the COOH surface, it does not yield a preferential cellular binding 
conformation in comparison with the NH2 and CH3 surfaces.  In addition, although the OH 
surface at the low surface density had increased cellular binding sites in comparison to the 
other surfaces, when the CH3 and NH2 surfaces received their saturation density of FN, they 
exhibited more binding sites.  It cannot be determined however, if the increased binding sites 
on the CH3 and NH2 surfaces in comparison to the OH surfaces were due to conformation or 
concentration, or a combination of the two, since more FN was adsorbed at the saturated 
densities on the CH3 and NH2 surfaces.   
 
One proposed mechanism to explain non-specific protein adsorption on well defined SAM 
surfaces is the hydrophobicity, or the wettability of the surface.  It has been reported that as a 
surface decreases in wettability (greater contact angle), an increase in non-specific protein 
adsorption occurs.23   Other findings suggest other mechanisms such as adsorption by charge-
charge interactions as well as specific structural features of the surface, are necessary to 
consider for the adsorption of high molecular weight proteins, such as FN.43-45  Evaluating 
the wettability and charge of the SAMs used in this study, we found the same relative amount 
of FN binding site presentation on CH3 and NH2 surfaces, which are hydrophobic (contact 
angle 112°) and neutral, and hydrophilic (contact angle 46°) and positive, respectively.  
These results suggest that a combination of mechanisms govern non-specific FN adsorption.  
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The differences in FN conformation and availability of binding sites coupled with variations 
in cellular responses on SAMs indicated that increased binding site presentation had a direct 
effect on controlling cellular processes on model biomaterial substrates.  To examine the role 
by which the surface properties contribute to directing cellular attachment, spreading, and 
differentiation, we measured changes in FA formations by probing the expression of vinculin 
in FA complexes.  Our FA data directly correlated with the number of binding sites as well as 
the up and down regulation of the cellular processes we examined.  Focal adhesion 
complexes facilitate the transmission of information between the intra- and extracellular 
environments through integrin based mechanisms.  Although we did not specifically probe 
for integrin subunits in this study, the strong correlations between FA expression and changes 
in cellular attachment, spreading, and differentiation to FN treated surfaces suggest these 
cellular functions were governed by integrin mediated signaling mechanisms.  Previous 
studies examining integrin expression profiles of activated keratinocytes, both in the wound 
environment and culture conditions, suggest that α5β1 is a principle integrin that interacts 
with the FN and transmits information that directs cellular processes involved in 
reepithelialization.5,46,47  These observations, together with the findings in this study, suggest 
that FN mediated regulation of keratinocyte functions is directed through the α5β1 integrin 
signaling pathway.  In future studies, we plan to develop quantitative relationships between 
keratinocyte functions, specific integrin signaling pathways, and the conformation of FN.  
These studies will yield a series of design parameters that will enhance the ability of 
biomaterials to control keratinocyte functionality for use as dermal equivalents.  Similarly, 
these design parameters will be applied to the development of percutaneous devices such as 
catheters and prosthesis attachments, which depend upon the rapid formation of a robust 
cutaneous seal with the surrounding epithelial tissue to prevent infections and implant failure.  
 
To improve the design of dermal analogs, it is essential to develop relationships 
characterizing keratinocyte interactions with FN moieties, presented at different surface 
densities and different conformations on the surfaces of biomaterials.  In the wound healing 
   
Chapter 4 
Fibronectin Cellular Binding Site Availability 
70 
   
 
environment, FN is part of the provisional matrix that interacts with dermal collagens and 
provides signaling cues to direct re-epithelialization.  These FN interactions with collagen are 
mediated by specific domains on the surfaces of collagen molecules that produce oriented FN 
binding, in a manner that presents FN binding sites for cellular interactions.  Specifically, the 
main collagen found in the dermis is collagen type I, and the FN binding site is found on the 
α1(I) chain between amino acid residues 757-791.9  In a study comparing the effects of 
adsorbed FN conformation on tissue culture polystyrene and collagen coated polystyrene, it 
was shown that the saturation density of FN on collagen was approximately half the amount 
of that on tissue culture polystyrene.  Additionally, when the surfaces were immunoprobed 
for quantities of cell binding domains at saturation densities, FN treated tissue culture 
polystyrene exhibited an increase in fluorescence intensity for HFN 7.1 binding relative to 
the values observed on FN treated collagen surfaces.  Furthermore, when equal surface 
densities of FN were adsorbed to tissue culture polystyrene and collagen surfaces, minimal 
myoblast differentiation was found on the tissue culture polystyrene surface in comparison 
with the collagen surface.17  These findings suggest that passively adsorbing FN to collagen 
surfaces and collagen membranes represents a promising, but suboptimal approach to 
directing keratinocyte functions on engineered biomaterials.  Additionally, the results of our 
present study suggest that strategically conjugating FN to the collagen membranes by 
functionalizing the surface of the collagen with a NH2 or CH3 terminated ligand will increase 
the availability of the FN synergy sites and will significantly enhance keratinocyte 
attachment and reepithelialization of collagen based dermal equivalents.  
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5.1 INTRODUCTION 
In the development of bioengineered skin substitutes for replacement of skin lost to trauma or 
disease, the addition of biologically active molecules, that promote key events in non-
scarring self-healing wounds, has the potential to guide epithelialization.  In the native 
wound environment, fibronectin (FN) is part of the provisional matrix that interacts with 
dermal collagens and promotes the migration of keratinocytes through granulation tissue of 
the wound.1-3  Fibronectin is also involved in basement membrane synthesis and organization 
of the wound site, which are critical for the reestablishment of a healthy functional tissue.4  In 
vitro studies have examined the effect of FN on keratinocyte functions necessary for 
reepithelialization. When FN was passively adsorbed on bacteriological plastic, an increase 
in percentage of adherent cells was obtained.5  Studies where polystyrene was coated with 
FN showed enhanced migration6  and inhibition of terminal differentiation on the FN 
surfaces.7  Fibronectin also has been passively adsorbed to biomaterials that have the 
potential for implantation. Studies incorporating FN on the surface of PLGA, through passive 
adsorption, found limited keratinocyte migration; however, it was found that when FN was 
passively adsorbed to collagen, migration increased.8  Research investigating passive 
adsorption of FN to collagen-glycosaminoglycan (GAG) membranes found an increase in 
attachment over non-modified collagen surfaces.9 
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In addition to investigating keratinocyte responses to full FN molecules, the modification of 
biomaterial surfaces with synthetic peptides located in the central cellular binding domain of 
FN, specifically the arginine-glycine-aspartic acid (RGD) sequence have been examined. 
Arginine-glycine-aspartic acid peptides have been covalently coupled to collagen-GAG 
matrices10 and to a hyaluronate synthetic matrix.11  Both studies found increased keratinocyte 
attachment and spreading in comparison to those on unmodified matrices.  Although this 
approach allows for more RGD sites to be expressed on the surface of the biomaterials, these 
short sequences lack full biological activity when compared with the native protein.12,13 
 
During wound healing, as well as in cell culture expansion from healthy skin, keratinocytes 
express an increase in the integrin receptor α5β1 which is specific for the central cellular 
binding domain of FN.4,6,14  The availability of this FN domain and its full biological activity 
is highly dependent on the structural orientation of the protein and has been found to be 
critical in modulating cellular functions.15-19 When FN adsorbs to a surface, it undergoes a 
conformation change, which is highly dependent upon the properties of the surface.20-22  
Recently, our laboratory investigated the availability of the central cellular binding domain of 
FN and its role on keratinocyte morphology, attachment, and differentiation using self-
assembled monolayers as model biomaterial surfaces.23  A direct relationship was found 
between keratinocyte spreading area and attachment, and an indirect relationship was found 
between cellular binding domain availability and cell differentiation.  When evaluating focal 
adhesion formation, it was found that the area density of focal adhesions in individual 
keratinocytes directly corresponded with the availability of the central cellular binding 
domain of FN, suggesting that the functions evaluated were integrin mediated.   
 
Although much is known regarding the advantages of using FN to enhance re-
epithelialization in the wound environment, little work has been performed investigating its 
presentation on dermal scaffolds.  Furthermore, understanding how to strategically modify a 
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biomaterial surface to increase the availability of the central cellular binding domain, which 
has been shown to promote attachment and subsequent intracellular signaling events, is of 
great importance for enhancing epithelialization of bioengineered skin substitutes as well for 
engineering other functional tissues. 
 
The purpose of this chapter was to evaluate the presence of the central cellular binding 
domain of FN on collagen membranes and to analyze how the presentation of this binding 
site effects epithelialization.  Using an in vitro skin model, keratinocyte and overall graft 
morphology, epidermal thickness, and proliferation were evaluated on the surface of 
collagen-GAG membranes.  Fibronectin was found to promote epithelial layers on dermal 
scaffolds that were found to be morphologically similar to that of native skin.  When 
evaluating proliferation in this model system, we found that FN treated surfaces enhanced the 
number of proliferative cells at 3 days of air/liquid (A/L) interface culture.  To correlate these 
findings with the presentation of FN on the surfaces, we evaluated the availability of the 
central cellular binding domain on collagen-GAG membranes.  In effort to further enhance 
the presentation of FN on the surfaces of basal lamina analogs, we developed self-assembled 
collagen membranes, fabricated from soluble type I collagen molecules (CI) and compared 
their performance to collagen-GAG membranes.   In this chapter we also describe a method 
to covalently modify the surfaces of self-assembled CI membranes with FN using a 
carbodiimide conjugation strategy, specifically (1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC). Finally, we evaluated the effect of EDC conjugation on 
the presentation and bioactivity of FN.  Overall, we demonstrated that the EDC conjugation 
strategy greatly enhances the availability of the central cellular binding domain of FN.  We 
also show that this modification strategy has the potential for increasing the rate of 
epithelialization on the surfaces of basal lamina analogs. 
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5.2 MATERALS AND METHODS 
5.2.1 A/L Interface Culture Devices  
To evaluate the effect of FN on epithelialization of bioengineered skin substitutes, a custom 
designed device was developed to analyze membranes which are precisely conjugated with 
FN and cultured at the A/L interface.  This system creates an individual well on the surface 
of a collagen membrane and allows for a tight seal to be made on the surface of the 
composite assuring that FN placement is in the center (Figure 5.124). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.2 Basal Lamina Analog Production 
5.2.2.1 Collagen-GAG Membranes 
A collagen-GAG dispersion containing type I collagen (5 mg/ml) and GAG (0.18 mg/ml) 
was prepared by placing lyophilized bovine hide derived collagen (Semed-S, Kensey Nash 
Corp., Exton, PA) in acetic acid (EMD Chemicals, Inc., Gibbstown, NJ) and homogenizing 
(20,000 rpm) at 4°C for 90 minutes resulting in a bovine-derived collagen suspension.25 
Figure 5.1.  Custom Built A/L Interface Culture Devices.  To culture keratinocytes on 
basal lamina analogs, a custom developed A/L interface culture device was developed by 
our laboratory to minimize the use of resources including cells and FN.  A) Computer-
Aided Design (CAD) drawing of individual parts of the device including the base and top 
pieces with posts on the base piece to allow for alignment of the two pieces and initial 
stability.  A screen sits on the base piece that the membrane is placed on.  This screen 
facilitates diffusion of cell culture medium from below the membrane and A/L interface 
culture.  A silicone o-ring is fit in the base piece to provide a tight seal that creates a well 
on the surface of the collagen membrane that allows for protein modification and cell 
seeding. The complete unit fits in a 6-well plate.  B) CAD drawing of device with base 
and top piece screwed together and C) shows a photograph of one of the devices with a 
collagen membrane placed on top of the screen during assembly.24 
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Shark cartilage chondroitin 6-sulfate (Sigma, St. Louis, MI) was dripped into the blending 
collagen dispersion and blended for an additional 90 minutes.  Once fully blended, the 
collagen-GAG suspension was degassed by centrifugation.  To produce membranes, the 
suspension was cast onto flat polydimethylsiloxane silicone elastomer (PDMS, Sylgard 184, 
Dow Corning Corp., Midland, MI) molds 9.62 cm2 in area, and allowed to air dry in a 
laminar flow hood at room temperature.  The membrane was then gently peeled from the 
PDMS surface and dehydrothermally (DHT) crosslinked according to previously published 
methods for 24 hours.9  Membranes were then stored in a desiccator until use.   
 
5.2.2.2 Self-Assembled Type I Collagen Membranes 
Acid-soluble type I collagen (CI) was extracted from rat tail tendons using protocols 
previously described.26  Rat tails were received from animals that were euthanized for other 
protocols, which were approved by Worcester Polytechnic Institute, Worcester, MA, 
Institutional Animal Care and Use Committee.  Briefly, rat tail tendons were extracted from 
the tails of 13 Sprague Dawley rats, rinsed in dPBS (Hyclone, Logan, UT), and dissolved in 
1600 ml of 3% acetic acid at 4°C overnight. The resulting solution was centrifuged at 8590 
rpm for 2 hours and 320 ml of a 30% NaCl (Sigma) solution was dripped into the supernatant 
at 4°C.  The resulting solution was allowed to sit for at least 1 hour at 4°C without disruption 
and then centrifuged at 4690 rpm for 30 minutes to separate precipitated and liquid material.  
The precipitated material was resuspended in 400 ml of 0.6% acetic acid and dialyzed for 4 
hours against 1 mM HCl (JT Baker, Phillipsburg, NJ) and the dialysis solution was changed 
every 4 hours until a clear collagen solution was obtained.  This solution was lyophilized and 
stored in a sealed container at 4ºC, until use.  Lyophilized collagen was dissolved in 5 mM 
HCl to obtain a working solution of 10 mg/ml.26 To produce self-assembled CI membranes, 
800 µl of the soluble CI solution was neutralized using 200 µl of 5x Dulbecco’s Modified 
Eagle’s Medium (DMEM, Invitrogen, Carlsbad, CA) with 0.22 M NaHCO3 and 40 µl of 0.1 
M NaOH (Sigma) at 37°C for 18 hours on circular PDMS molds. 
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5.2.3 FN Surface Modification of Collagen Membranes 
5.2.3.1 Passive Adsorption of FN to Collagen Membranes 
Fibronectin (BD Biosciences, Bedford, MA) was resuspended according to manufacturer’s 
recommendations in 1 ml of dH2O and diluted to desired concentrations (30, 100, and 300 
µg/ml) using dPBS.  For in vitro culture on basal lamina analogs, all collagen membranes 
were placed in A/L culture devices (Fig 5.124) and  FN (100 µg/ml) was placed in the well 
created on the surface of the collagen membrane and allowed to adsorb overnight at room 
temperature.  For FN cellular binding site evaluation of basal lamina analogs, collagen 
membranes were placed in a custom high throughput screening device9 and FN was placed 
into each individual wells at 30, 100, and 300 µg/ml for self-assembled CI membranes, and 
at 100 µg/ml for collagen-GAG membranes overnight at room temperature. 
 
5.2.3.2 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) Conjugation of 
FN to Collagen Membranes 
 
Using protocols previously described to crosslink collagenous materials,27,28 the molar ratio 
of 5:1 (EDC to carboxylic acid groups in collagen) was used to conjugate FN to the surfaces 
of collagen-GAG and self-assembled CI membranes.  The theoretical amount of collagen 
used for calculations assumed that 1 g of type I collagen contained 1.2 mmol COOH.27,28  
Collagen-GAG membranes contained 12.5 mg of type I collagen and self-assembled CI 
membranes contained 8 mg of type I collagen, thus receiving 0.075 mmol EDC and 0.048 
mmol EDC, respectively.  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(Sigma) was dissolved in 50 mM MES hydrate (Sigma) dissolved in 40% ethanol (Pharmco 
Products, Inc., Brookfield, CT) at a pH 5.5 and 1.25 ml of solution was placed on collagen-
GAG membranes and 0.8 ml was placed on self-assembled CI membranes for 4 hours.  For 
in vitro culture on basal lamina analogs, the membranes were removed from the EDC 
solution and immediately placed into the A/L culture devices and 100 µg/ml of FN was 
placed in the well created on the surface of the collagen membrane over night at room 
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temperature.  For FN cellular binding site evaluation, the membranes were immediately 
placed in a custom high throughput screening device9 and FN was placed into each individual 
wells at 30, 100, and 300 µg/ml for self-assembled CI membranes, and at 100 µg/ml for 
collagen-GAG membranes overnight at room temperature. 
 
5.2.4 Culture of Neonatal Human Keratinocytes 
Neonatal keratinocytes were cultured as previously described.9,29 Neonatal foreskins were 
obtained from non-identifiable discarded tissues from UMass Memorial Medical Center, 
Worcester, MA and were approved with exempt status from the New England Institutional 
Review Board.  Keratinocyte isolations were performed using an enzymatic treatment with a 
dispase (Gibco, Gaithersburg, MD) solution.  The cells were propagated on a feeder layer of 
3T3-J2 mouse fibroblasts (generously donated by Dr. Stelios Andreadis, State University of 
New York at Buffalo, Buffalo, NY) and cultured according to methods previously 
described29,30 using keratinocyte media consisting of a 3:1 mixture of DMEM (high glucose) 
and Ham’s F-12 medium (Invitrogen)  supplemented with 10% fetal bovine serum (FBS, 
Hyclone), 10-10 M cholera toxin (Vibrio Cholerae, Type Inaba 569 B), 5 μg/ml transferrin, 
0.4 μg/ml hydrocortisone (Calbiochem, La Jolla, CA), 0.13 U/ml insulin, 1.4*10-4 M 
adenine, 2*10-9 M triiodo-L-thyronine (Sigma), 1% penicillin/streptomycin (Invitrogen), and 
0.01 μg/ml epidermal growth factor (EGF, BD Biosciences).  After 5 days of culture, cells 
were detached using 0.05% Trypsin-EDTA (Invitrogen) and then rinsed with serum free and 
EGF free keratinocyte media.  Passage 2 keratinocytes were used in all experiments. 
 
5.2.5 In vitro Culture of Keratinocytes on Basal Lamina Analogs 
After FN adsorption or EDC conjugation of FN to membranes, the membranes were 
sterilized in composite culture devices using 70% ethanol.  Membranes and devices were 
removed from ethanol and rinsed in sterile dPBS, 3 times for 10 minutes each, and left 
overnight in sterile dPBS.  The composite culture devices were placed into individual wells 
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of a 6-well tissue culture plate and preconditioned for 30 minutes with seeding media 
consisting of 3:1 mixture of DMEM (high glucose) and Ham’s F-12 medium supplemented 
with 10-10 M cholera toxin, 0.2 µg/mL hydrocortisone (Calbiochem), 5 µg/mL insulin, 50 
µg/mL ascorbic acid (Sigma), and 1% penicillin/streptomycin (Invitrogen). Keratinocytes 
were seeded on the surfaces of the membranes at 500,000 cells/cm2 using this media, and 
allowed to adhere for 2 hours in 10% CO2 at 37°C.  After 2 hours, seeding media containing 
1% FBS was placed in each well, completely submerging the grafts.  After 24 h, the 
keratinocyte seeding medium was removed, and the grafts were submerged for an additional 
48 h in a keratinocyte priming medium composed of keratinocyte seeding medium (with 
FBS) supplemented with 24 µM bovine serum albumin (BSA), 1.0 mM L-serine, 10 µM l-
carnitine, and a mixture of fatty acids including 25 µM oleic acid, 15 µM linoleic acid, 7 µM 
arachidonic acid, and 25 µM palmitic acid (Sigma).31 After 48 h in priming medium, skin 
equivalents were cultured for 3 or 7 days with an A/L interface medium composed of serum-
free keratinocyte priming medium supplemented with 1.0 ng/mL EGF. 
 
5.2.6 Evaluation of Epithelialization 
To assess epithelialization on the basal lamina analogs, epidermal thickness and proliferation 
were evaluated after 3 or 7 days of A/L interface culture.  Grafts were fixed in a 10% 
buffered formalin solution (EMD Chemicals), dehydrated with increasing concentrations of 
ethanol, cleared with sec-butyl alcohol (EMD Chemicals), and embedded in Paraplast tissue 
embedding medium (McCormick Scientific, St. Louis, MO).  Sections of skin equivalents, 6 
µm in thickness, were cut in a plane perpendicular to the surface of the epithelial layer using 
a Leica RM 2235 (Leica Microsystems, Inc, Bannockburn, IL).  Sections were mounted on 
poly-L-lysine coated slides (Erie Scientific Company, Portsmouth, NH) for hematoxylin and 
eosin (H&E) staining and mounted on Superfrost Plus slides (VWR, West Chester, PA) 
coated with poly-L-lysine (Sigma) to evaluate proliferation.  To evaluate thickness of the 
epithelial layer, the slides were stained with Harris hematoxylin and eosin (Richard-Allan 
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Scientific, Kalamazoo, MI) and then viewed with a Nikon Eclipse E400 microscope (Nikon, 
Inc., Melville, NY).  Images were captured using an RT Color Spot camera (Spot 
Diagnostics, Sterling Heights, MI). Thickness measurements were taken in three areas of the 
image using Image J software (downloaded from 
http://rsb.info.nih.gov.ezproxy.umassmed.edu/ij/) and an average value was reported for each 
graft. For collagen-GAG membranes with and without passive adsorbed FN, at 3 day or 7 
day culture, 7 and 4 cultured basal lamina analogs were evaluated, respectively.  For self-
assembled CI membranes with no treatment, passive adsorption of FN, and EDC conjugation 
of FN, 3 grafts were evaluated for each condition.  
 
Keratinocyte proliferation was evaluated by detecting the presence of Ki67, a marker for 
highly mitotic keratinocytes.  The tissue sections were deparaffinized in reverse ethanol–
xylene washes, and the antigens were unmasked by placing the slides in boiling Vector 
Unmasking solution (Vector Laboratories, Inc, Burlingame, CA) in a Manttra pressure 
cooker (Manttra, Inc., Virginia Beach, VA) for 1 minute after maximum pressure was 
achieved.  Slides were then incubated with blocking solution (10% normal horse serum 
(Vector Laboratories) in dPBS) for 10 min at room temperature and treated with predilute 
mouse-antihuman Ki67 (Zymed Laboratories, South San Francisco, CA) overnight in a 
humidified chamber at room temperature.  Slides were incubated with biotinylated anti-
mouse IgG (Vector Laboratories) at 1:200 for 30 minutes at RT then washed with dPBS and 
stained with Vectastain Elite ABC Kit (Vector Laboratories) for 30 minutes at RT.  Stained 
slides were washed with dPBS and developed using a Vector NovaRed Substrate Kit (Vector 
Laboratories) for approximately 1 min.  Slides were rinsed in dPBS, followed by a 5 minute 
wash with tap water, and counterstained with Harris hematoxylin for 45 seconds. The slides 
were washed with tap water, rinsed with a series of ethanol-xylene washes and mounted with 
VectaMount permanent mounting medium (Vector Laboratories).  The slides were then 
viewed with a Nikon Eclipse E400 microscope and images were captured using an RT Color 
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Spot camera.  The number of Ki67 positive cells were counted and divided by the total 
number of cells in the basal layer to give a percentage of Ki67 positive cells.  At 3 days or 7 
days of A/L interface culture on collagen-GAG membranes passively adsorbed with FN, 3 
different sections of 5 grafts were evaluated.   
 
5.2.7 FN Cellular Binding Site Detection 
To measure the availability of the central cellular binding domain of FN, a monoclonal 
antibody directed towards this domain (HFN 7.1, Developmental Studies Hybridoma Bank, 
Iowa City, IA) was measured with fluorescence microscopy and image analysis.23,32 After 
passive adsorption or EDC conjugation of FN to CI membranes, the scaffolds were sterilized 
for cellular culture, and then blocked using 1% heat denatured BSA (in dPBS) for 1 hour at 
room temperature.  HFN 7.1 was added to each well for 1 h in 10% CO2 at 37°C.  Each 
surface was rinsed in blocking buffer (0.05% Tween-20 (Sigma) and 0.25% BSA in dPBS) 
and incubated with 546 Alexa Fluor conjugated goat anti-mouse IgG (1:200 in blocking 
buffer, Molecular Probes, Eugene, OR) for 1 h in 10% CO2 at 37°C. Slides were then rinsed 
with dPBS, and images were captured using an RT Color Spot camera. Image J Analysis 
software was used to determine the relative amount of cellular binding sites in each well. The 
relative fluorescence intensity was calculated over a region of interest and normalized against 
fluorescence intensity of non-FN modified membranes.  Eight samples were evaluated for 
collagen-GAG and self-assembled CI membranes that were treated with 100 µg/ml of FN 
using EDC conjugation or passive adsorption strategy.  For self-assembled CI membranes 
treated with 30 or 300 µg/ml of FN, 4 samples were evaluated.  Results are reported as 
averages and standard deviations and each experiment was repeated twice. 
 
5.2.8 Statistical Analyses 
Sigma Stat Version 3.10 (Systat Software Inc., Richmond, CA) was used to determine 
statistical differences among the means of experimental groups.  To determine if the means 
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of two different samples were significantly different, a Student’s t-test was performed when 
the samples were drawn from a normally distributed population with equal variance.  Sigma 
Stat uses the Kolmogorov-Smirnov test to test for a normally distributed population and a P 
value > 0.05 indicates normality.  For all parametric tests, Sigma Stat assumes equal 
variance.  When the data was not drawn from a normally distributed population (P value < 
0.05), a Mann-Whitney Rank Sum Test was used and a Levene Median test was used to 
determine equal variance with a P value > 0.05 indicating equal variance.  For both the 
Student’s t-test and the Mann-Whitney Rank Sum Test, a p value < 0.05 indicated a 
significant difference between the means of experimental groups.   
 
To determine statistical differences among the means of three or more experimental groups a 
One Way Analysis of Variance (ANOVA) was used when the samples were drawn from a 
normally distributed population with equal variance (Kolmogorov-Smirnov test for normal 
distribution and equal variance was assumed).  When the data was not normally distributed, a 
Kruskal-Wallis One way ANOVA on ranks was performed (Levene Median test to determine 
equal variance with a P > 0.05 indicating equal variance).  When a statistical difference was 
detected among the group means, a Tukey post-hoc analysis was performed for both the One 
Way ANOVA and Kruskal-Wallis One Way ANOVA on ranks.  A p value < 0.05, for both 
variance tests, indicated a significant difference between the groups. 
 
5.3 RESULTS 
5.3.1 FN Enhances Epithelialization of Keratinocytes on Basal Lamina Analogs 
 
5.3.1.1 Graft Morphology and Epidermal Layer Thickness on Collagen-GAG Basal Lamina 
Analogs 
 
The effect of passively adsorbed FN on graft morphology and epithelial layer thickness of  
keratinocytes was evaluated using custom built A/L interface culture devices (Figure 5.124). 
Fibronectin (100 µg/ml) was passively adsorbed to the surfaces of collagen-GAG membranes  
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and keratinocytes were cultured on these basal 
lamina analogs for 3 or 7 days at the A/L 
interface.  Figure 5.224 shows histological 
results of control grafts compared with grafts 
that were passively adsorbed with FN, cultured 
for 3 or 7 days and stained with H&E.  A 
thicker epidermal layer formed on 
membranes modified with FN when 
compared with control membranes at 3 or 7 
days of culture at the A/L interface.  At 3 
days, 17.7+/-0.9 and 52.4+/-6.3 µm were 
found for control and FN treated 
membranes, respectively and at 7 days, 
59.6+/-7.4 and 89.6+/-4.2 µm were found 
for control and FN treated membranes, 
respectively.   These differences in epithelial 
thickness between control and FN treated 
surfaces were statistically different at both time 
points (Figure 5.324).  
 
5.3.1.2 Keratinocyte Proliferation on 
Collagen-GAG Basal Lamina Analogs  
 
To analyze keratinocyte proliferation, the 
presence of Ki67 in basal keratinocytes was 
measured on the surfaces of cultured basal 
lamina analogs.  This protein is present during 
active phases of the cell cycle and absent from  
Figure 5.2.  Histological Representations of the 
Thicknesses of Epidermal Layers on Collagen-GAG 
Membranes.  Keratinocytes were cultured for 3 or 7 
days at the A/L interface on collagen-GAG control (non-
modified) membranes or collagen-GAG membranes that 
were modified by passively adsorbing FN to the surfaces 
of the scaffolds.  At 3 or 7 days of A/L interface culture 
the thickness of the epithelial layer on collagen-GAG 
membranes treated with FN was greater than that on 
untreated collagen-GAG membranes.  Scale bar 
represents 30 µm.24 
Figure 5.3. Quantitative Evaluation of Epidermal 
Thickness on Collagen-GAG Membranes. The 
thicknesses of the epithelial layers at 3 or 7 days of A/L 
interface culture were measured on control (non-
modified) collagen-GAG membranes or collagen-GAG 
membranes that were modified by passively adsorbing 
FN to the surfaces.    At both 3 and 7 days there was a 
significant difference between untreated and FN treated 
surfaces.  (* indicates p<0.05 Student’s t-test) Samples 
for 3 day culture are n = 7 and for 7 day culture n = 4.24  
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resting cells.33 Figure 5.424 shows 
histological images of control collagen-
GAG membranes and membranes that 
were passively adsorbed with FN, 
cultured for 3 or 7 days at the A/L 
interface and immunoassayed for Ki67.  
Quantitative analyses of these images 
are depicted in Figure 5.524.  At 3 days 
of culture, positive Ki67 basal 
keratinocytes were counted and control 
surfaces and FN treated surfaces had 
24.3+/-2.5% and 37+/-3.9% Ki67 
positive basal cells, respectively and at 
7 days control surfaces and FN treated 
surfaces had 23+/- 2.7% and 21.9+/- 
2.1% Ki67 positive basal cells, 
respectively. The percentage of basal 
keratinocytes expressing Ki67 on FN 
modified membranes was statistically 
different than on control membranes at 3 
days of culture, however at 7 days of 
culture no differences were detected. 
 
 
 
 
 
Figure 5.5. Quantitative Analyses of Ki67 Positive 
Basal Keratinocytes on Collagen-GAG Membranes. 
The percentage of positive Ki67 basal keratinocytes at 3 
or 7 days of A/L interface culture was measured on 
control (non-modified) collagen-GAG membranes or 
collagen-GAG membranes modified by passively 
adsorbing FN to the surfaces.  At 3 days statistical 
differences were found between keratinocytes cultured on 
control surface and FN treated surfaces (* indicates 
p<0.05 Student’s t-test).  For all experimental conditions, 
n = 5 samples were measured at both 3 and 7 days of 
culture.24 
Figure 5.4.  Histological Representations of Ki67 
Positive Keratinocytes on Collagen-GAG Membranes.  
Keratinocytes were cultured on collagen-GAG membranes 
for 3 or 7 days at the A/L interface on control (non-
modified) collagen-GAG membranes or collagen-GAG 
membranes modified by passively adsorbing FN to the 
surfaces. At 3 or 7 days of A/L interface culture Ki67 
immunostaining (brown stained nuclei) was used to 
evaluate proliferation of basal keratinocytes.  Scale bar 
represents 30 µm.24 
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5.3.2 Availability of Cellular Binding Domain of FN Corresponds to Keratinocyte 
Attachment on Collagen-GAG Basal Lamina Analogs 
 
The availability of the cellular binding domain of FN, specifically the domain that 
encompasses both the RGD and PHSRN 
binding sequences, was analyzed on the 
surfaces of collagen-GAG basal lamina 
analogs using an antibody directed towards 
this site.  Relative fluorescence intensity 
(RFI) measurements were made on several 
regions of interest and an average value was 
reported.  When FN was passively adsorbed 
to collagen-GAG membranes at 30, 100, or 
300 µg/ml, cellular binding sites plateaued at 
a concentration of 100 µg/ml (Figure 5.624).  
The fluorescence intensity values obtained at 
100 µg/ml and 300 µg/ml were statistically 
greater than those at 30 µg/ml of F.  his data 
directly corresponds with keratinocyte 
attachment measurements made on FN 
treated collagen-GAG membranes in a 
previously published study.23  
 
 
 
 
 
Figure 5.6. Availability of Cellular Binding 
Domains for FN Passively Adsorbed on Collagen-
GAG Basal Lamina Analogs.  The availability of 
the cellular binding domain of FN on collagen-GAG 
basal lamina analogs was evaluated using a 
quantitative immunofluorescent assay.   Fibronectin 
concentrations of 0, 30, 100, and 300 µg/ml were 
evaluated and it was determined that at a 
concentration of 100 µg/ml the average RFI was 
statistically different from 0, and 300 µg/ml, but did 
not statistically differ from 300 µg/ml indicating that 
a saturation plateau was achieved.  Data is reported 
as averages and error bars indicate standard error 
mean with n = 3.  (*Indicates statistical difference, 
one way ANOVA with Tukey post hoc analysis p< 
0.05.)24 
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5.3.3 EDC Conjugation of FN on Self-Assembled CI Basal Lamina Analogs Promotes 
Increased Cellular Binding Site Availability 
 
To determine whether we could increase the presentation of FN cellular binding sites on the 
surfaces of collagen-GAG basal lamina analogs, we analyzed the effects of covalently 
binding FN to the surface using an EDC conjugation strategy (Figure 5.724).  Since it was 
found that 100 µg/ml of FN saturated the surfaces of the collagen-GAG membranes, we 
chose to evaluate this concentration using both adsorption and EDC modification strategies.  
When analyzing collagen-GAG membranes, the difference between passive adsorption and 
EDC conjugation of 100 µg/ml of FN, was that EDC conjugation statistically increased the 
average RFI on the surfaces of FN treated membranes, suggesting that these membranes have 
a greater capacity for cellular binding (Figure 5.824).   
Figure 5.7. Schematic Representation of EDC-Mediated Conjugation of FN to Collagen.  The 
carbodiimide 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) was added to 
basal lamina analogs at a 5:1 molar ratio (EDC molecules to  carboxylic acids in collagen).   The EDC 
reacts with a carboxylic acid from the collagen molecule to form an unstable reactive o-acylisourea 
ester that can either couple with an amine group in collagen from the basal lamina analog or an amide 
group in FN that is added to the collagen membrane.  If the unstable reactive o-acylisourea ester does 
not interact with an amine, it hydrolyzes and the carboxyl group is regenerated, thus returning back to 
its native state.24 
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The availability of cellular binding 
domains on the surfaces of self-
assembled CI basal lamina analogs was 
evaluated for both passive adsorption 
of FN and EDC conjugation of FN.  
These findings were compared with 
both passive adsorption and EDC 
conjugation of FN on collagen-GAG 
collagen basal lamina analogs (Figure 
5.824).  When we compared the passive 
adsorption of 100 µg/ml of FN on 
collagen-GAG and self-
assembled CI membranes, a 
significant increase in 
average RFI was observed on 
the self-assembled CI 
membranes. Similarly, when 
we compared the binding 
efficiency of FN using an EDC conjugation strategy at a concentration of 100 µg/ml of FN 
on collagen-GAG and self-assembled CI membranes, a significant increase was found in 
average RFI on the self-assembled CI membranes.  Additional concentrations were analyzed, 
for both passive adsorption and EDC conjugation of FN on self-assembled CI membranes, to 
evaluate whether saturation levels of RFI were obtained.  When evaluating lower and higher 
concentrations of FN (30 and 300 µg/ml, respectively), we found that there were no 
statistical differences between FN concentrations of 100 µg/ml and 300 µg/ml and that the 
100 µg/ml concentration had statistically increased values over the 30 µg/ml concentration, 
regardless of the conjugation strategy that was used.  This data indicates that the presentation 
Figure 5.8. Availability of Cellular Binding Domain of FN on 
collagen-GAG and Self-Assembled CI Basal Lamina Analogs.  A 
quantitative immunofluorescent assay was used to measure the 
availability of the cellular binding domain of FN on the surfaces of 
modified collagen membranes.  * indicates p<0.05, Student’s t-test and 
** indicates p<0.05, One Way ANOVA with Tukey post hoc analysis.  
For collagen-GAG membranes, n = 8 for passive adsorption and EDC 
conjugation.  For self-assembled CI membranes n = 4 for 30 and 300 
µg/ml for both passive and EDC and n = 8 for 100 µg/ml for both 
passive and EDC.  Experiments were repeated and similar trends were 
found.24 
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of cellular binding domains on the surfaces of self-assembled CI membranes saturated at a 
FN concentration of 100 µg/ml, similar to the results obtained for collagen-GAG membranes.   
 
5.3.4 EDC Conjugation of FN on Self-Assembled CI Basal Lamina Analogs Enhances 
Epidermal Layer Thickness 
 
Fibronectin was 
covalently bound to 
the surface of self-
assembled CI 
membranes using 
EDC and 
keratinocytes were 
cultured on the 
surface of basal 
lamina analog for 3 
days at the A/L 
interface to 
determine whether 
increased cellular binding sites on our new model system promoted an increase in epithelial 
layer thickness.  Figure 5.924 shows a typical image of a cultured epithelial layer on an 
untreated self-assembled CI membrane (5.9A and 5.9D), a basal lamina analog with FN 
passively adsorbed to the surface (5.9B and 5.9E), and a basal lamina analog with FN that 
was EDC conjugated to the surface (5.9C and 5.9F).  These images suggest that the thickness 
of the epidermal layer on the scaffold corresponds to the presentation and availability of FN 
central cellular binding domains.  Morphometric analyses of these epidermal layers (Figure 
5.1024) showed that there were statistical differences between all surfaces analyzed. 
Figure 5.9. Low and High Magnification Histological Images of Self-
Assembled CI Basal Lamina Analogs Treated with FN. The surfaces of self-
assembled CI basal lamina analogs were treated with dPBS (controls) (A and D), 
passive adsorption of FN (B and E), or EDC conjugation of FN (C and F) and 
keratinocytes were cultured on the membranes at the A/L interface for 3 days.  
Conjugation of FN to the surfaces of the self-assembled CI basal lamina analogs 
using EDC caused an increase in epidermal thickness in comparison to control 
surfaces and surfaces treated by passively adsorbing FN to the scaffolds.  Scale 
bars represent 50 µm.24 
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5.4 DISCUSSION 
To improve the regenerative capacity of 
biomaterials scaffolds, biomolecules have 
been incorporated to present biochemical cues 
that direct cellular functions.  This approach 
requires that the biomolecules are precisely 
tailored to the surface of the biomaterial to 
ensure that the appropriate cellular binding 
domains are presented for maximum 
bioactivity.  To improve the 
compatibility and regenerative potential 
of biomaterials scaffolds, FN is a 
protein of interest to adsorb to the 
surfaces, based on its role in cell 
adhesions, migration, and 
differentiation.5,7-9,21 However, several 
studies indicate that when FN is 
passively adsorbed to the surface of 
biomaterials, its conformation is effected by surface properties, which modulate cellular 
binding site presentation as well as biological activity.21,22,34,35  In this work we evaluated the 
effect of passive adsorption of FN on epithelialization of a basal lamina analog.  Additionally 
we investigated the presentation sites of the central cellular binding domain of FN based on 
the preparation technique of the basal lamina analog and the conjugation strategy.  Overall 
we determined that EDC conjugation of FN to the surface of self-assembled CI membranes 
improved binding site availability.  
 
Fibronectin enhanced epithelial thickness and keratinocyte proliferation on the surfaces of 
Figure 5.10. EDC Conjugation of FN on Self-
Assembled CI Basal Lamina Analogs Enhances 
Epidermal Thickness.  Self-assembled CI basal lamina 
analogs were prepared and the surfaces were treated 
with dPBS (Control), passive adsorption of FN (Passive 
Adsorption), EDC conjugation of FN (EDC 
Conjugation) and keratinocytes were cultured at the A/L 
interface for 3 days.  All surfaces were statistically 
different from each other.  Surfaces treated with EDC 
conjugation of FN exhibited the greatest epidermal 
thickness values (* indicates p<0.05, One-Way ANOVA 
with Tukey post-hoc analysis).  Bars indicate mean 
values and error bars are standard error and sample 
numbers are n = 3 for control and passive adsorption and 
n = 5 for EDC conjugation.24   
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collagen-GAG basal lamina analogs.  When FN was passively adsorbed at a saturation 
density previously determined on the surface,9 epithelial thickness was enhanced in 
comparison to untreated membranes at both 3 and 7 days of A/L interface culture.   The 
morphology of basal keratinocytes on the FN grafts exhibited a more native columnar 
morphology than those on the scaffolds without FN.  When keratinocyte proliferation was 
examined using Ki67, a nuclear marker for proliferation, it was found that the percentage of 
Ki67 positive cells at 3 days of A/L interface culture on FN treated membranes  was greater 
than on untreated membranes, ~35% to ~20% of total basal cells, respectively.  At 7 days of 
A/L interface culture, no differences were found between percentages of Ki67 positive basal 
keratinocytes, with both membranes having ~20% of total basal cells. 
 
In unwounded epidermis, between 10 and 20% of basal keratinocytes are proliferative, based 
on the location of the skin.36-38  In an acute wound environment, keratinocyte proliferation is 
increased.  Within hours after injury, keratinocytes at the wound edge become activated and 
undergo a phenotypic change which facilitates migration over the wound bed6,16 A 
proliferative burst occurs 24 to 72 hours post injury and after wound closure, the proliferative 
capacity of the basal layer returns to normal status.39  Our results suggest that FN treated 
scaffolds closely mimic the wound environment, and provide the appropriate signals for 
proliferation to occur.  Once the cells sense that a monolayer is formed, proliferation returns 
to normal and the cells begin to undergo differentiation and migrate upward to create a 
stratum corneum that provides protection from the environment.   
 
After evaluating the effects of FN on graft morphology and proliferation, we investigated the 
presentation of the cellular binding domain of FN that was passively adsorbed on the 
collagen-GAG basal lamina analogs.  We determined that our FN cellular binding site 
presentation directly corresponded with previously published values for keratinocyte 
attachment to collagen-GAG membranes.9 We concluded that we were saturating our 
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collagen-GAG membrane surfaces using passive adsorption since there were no differences 
between membranes that were treated with 100 µg/ml or 300 µg/ml of FN.  To increase the 
number of FN presentation sites, we evaluated different sources of collagen to fabricate 
membranes as well as conjugation strategies to covalently link FN to the surfaces. 
 
In this study, we analyzed the presentation of FN cellular binding domains on collagen-GAG 
basal lamina analogs and compared it with the FN cellular binding domains on self-
assembled CI basal lamina analogs.  Our initial studies focused on the use of collagen-GAG 
membranes fabricated from an FDA approved, commercially available product, to facilitate a 
rapid translation from benchtop to bedside.40   Although this product has many advantageous 
properties; the starting collagen material is considered “insoluble” when place in an acidic 
environment and does not completely dissolve into individual collagen fibrils.  When a 
suspension of these collagen fibrils is air-dried, the aggregates of fibrils come together and 
form a membrane with random orientation.  In contrast, the self-assembled CI membranes 
developed for this study are fabricated from a solution of acid solution type I collagen 
molecules.  When neutralized, these collagen molecules self-assemble into individual fibrils, 
and aggregate laterally and linearly to form collagen fibers with structural morphology 
comparable to native tissue constructs.41 Our studies indicate that when 100 µg/ml of FN is 
passively adsorbed to the surfaces of the different collagen membranes, the self-assembled 
CI basal lamina analog has significantly more FN cellular binding site availability than the 
collagen-GAG basal lamina analog.  With CI, the FN binding site is found on the α1(1) chain 
between amino acid residues 757-791.42  When the soluble collagen self-assembles it exposes 
the FN binding site, similar to that in native tissue, unlike the collagen-GAG fibers that do 
not have all FN binding sites exposed, because of the random packing of the fibrillar 
aggregates.  Additional analysis was performed evaluating the cellular binding site 
availability of FN on self-assembled CI basal lamina analogs at varying concentrations of FN 
to determine the saturation limit.  We found that the availability of FN on the surfaces of the 
   
Chapter 5 
Carbodiimide Conjugation of Fibronectin on Collagen Basal Lamina Analogs Enhances Cellular 
Binding Domains & Epithelialization 
 
94 
   
 
self-assembled CI membranes at 100 µg/ml of FN was the optimal concentration for binding 
site availability, similar to the evaluation of binding site availability on collagen-GAG 
membranes. 
 
Various investigations have evaluated covalent conjugation strategies to improve the 
presentation and bioactivity of FN over passive adsorption on various surfaces.43-45  The use 
of a carbodiimide conjugation strategy was evaluated to crosslink our membranes as well as 
to covalently bind FN.  This crosslinking agent has been highly successful in crosslinking 
collagen and improving its degradation resistance and mechanical properties,46,47 as well as 
coupling chondroitin sulfate, heparin sulfate, and heparin to the surface of collagen 
scaffolds.48-50 We investigated its use as a potential method to covalently conjugate FN to the 
surface of both collagen based scaffolds and found a significant increase in cellular binding 
site availability of FN when compared to that of using passive adsorption.  When 
keratinocytes were cultured at 3 days at the A/L interface on self-assembled basal lamina 
analogs with no FN, passively adsorbed FN, and EDC conjugated FN, an increase in 
epithelial thickness was found between all surfaces.  This data also corresponds with the data 
from the FN cellular binding domain availability analysis.  Future studies will evaluate EDC 
conjugation of FN on epithelialization of a basal lamina analog laminated to a dermal 
scaffold to determine the effects of this conjugation strategy on proliferation and 
differentiation in a composite model of bioengineered skin substitute.   
 
Overall the results from these studies indicate that the cellular binding domain of FN can be 
enhanced on collagen-based biomaterials and directly influences functions important for 
epithelialization.  The information gained from this study can be applied to other model 
systems where the enhancement of cellular binding sites of FN on collagenous biomaterials 
would enhance tissue functionality.  Additionally this information can be used in the design 
of engineered tissues where the incorporation of a basal lamina analog is necessary to direct 
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epithelial polarity and functions as well as to separate cell types and act as a selectively 
permeable barrier, such as in the glomerulus of the kidney or the small intestine.   
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6.1 INTRODUCTION 
Bioengineered skin substitutes offer a promising approach in the treatment of severe burns or 
chronic wounds when autografts are not an option for the patient.   Clinically, these 
substitutes provide a barrier to prevent infection and water loss as well as therapeutic effects 
that induce dermal tissue repair and stimulate healing of chronic wounds. Although there has 
been clinical success with these grafts, limitations still exist including prolonged healing 
times, mechanically induced graft failure, poor graft take, and residual scarring. Additionally, 
current bioengineered skin substitutes only restore a subset of anatomical structures that play 
key roles in normal physiological functions of skin.1-3     
 
One design features common to current bioengineered skin substitutes is a flat interface 
between the dermal and epidermal components.  At the dermal-epidermal junction (DEJ) of 
native skin there is a basal lamina which contributes critical cues involved in regulating 
keratinocyte functions necessary for the maintenance of the tissue architecture, as well as 
skin’s overall homeostasis with the surrounding environment.4 The basal lamina is a thin 
membranous sheet composed of both collagenous and non-collagenous extracellular matrix 
(ECM) proteins including type IV collagen (CIV), laminin (LN), fibronectin (FN), and 
heparin sulfate proteoglycans.  The basal lamina is not flat, but rather conforms to a series of 
three dimensional ridges and invaginations formed by papillae located in the upper region of 
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the dermis that range from 50-400 µm in width and 50-200 µm in depth.5   It has been 
determined that in different regions of the body, the number and dimensions of dermal 
papillae and rete ridges differ.  In areas of skin exposed to excessive friction, such as the 
palms and soles, the basal lamina conforms to a series of longer and more numerous dermal 
papillae and deeper rete ridges, suggesting that the increased surface area provided by the 
topographical features also aids in enhancing mechanical stability.6 
 
Keratinocytes in direct contact with the basal lamina are the only population of cells in the 
epidermis with the capacity to proliferate.  The epidermis is in constant renewal, thus 
proliferation is necessary in order to provide proper barrier function.  The population of 
proliferating basal keratinocytes is heterogeneous and contains epidermal stem cells (ESCs) 
and transit amplifying (TA) cells that have different regenerative and differentiation 
capabilities. Epidermal stem cells are non-differentiated cells that are responsible for the 
assembly and maintenance of the epidermis as well as the rapid regeneration of damaged 
tissue.  They are capable of self-renewal and give rise to TA cells, which divide a finite 
number of times to amplify the basal layer and then undergo terminal differentiation.7   
 
Epidermal stem cells exhibit a high degree of spatial organization and clustering along the 
complex topography of the basal lamina.  Epidermal stem cells can be further classified 
based on their localization into bulge ESCs, found in the bulge region of the hair follicle and 
interfollicular ESCs found either in the bottom of rete ridges or tips of papillary projections.8-
10  Several studies have examined the localization of proliferating keratinocytes and 
interfollicular ESCs in the basal layer of native epidermis using cell cycling or integrin 
detection techniques.  In monkey palm epidermis, DNA label-retaining cells (LRCs) were 
found in the deep rete ridges;11 which is indicative of slowly cycling cells, a well accepted 
characteristic of ESCs.12       This cell-cycle kinetic analysis has been used to investigate the 
localization of ESC populations in other species and tissue sites such as hamster epidermis 
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and oral mucosa,13 the bulge region in hair follicles,7 and human embryonic and fetal 
epidermis.14  In addition to label retaining cells, research has been conducted evaluating the 
intensity of β1 integrin receptors and correlating the findings with interfollicular ESC 
localization.  All basal keratinocytes express β1 which mediates adhesion to the ECM of the 
basal lamina and regulates terminal differentiation.15-17  Enhanced β1 expression has been 
found to distinguish ESCs from keratinocytes with lower proliferative potential.18 The 
expression of β1 has been found to be distributed differently along the microtopography of 
the basal lamina, based on body site location.  These findings correspond with label-retaining 
experiments previously mentioned.  In human skin, β1-bright regions are found in deep rete 
ridges in the palms and soles; whereas in interfollicular epidermis of the scalp, foreskin, and 
breast, β1-bright regions were found at the tips of the papillary projections.12,19   
 
In addition to studies evaluating microtopographic features of the basal lamina in native 
tissues and interfollicular ESC localization, other researchers have focused their efforts on 
investigating the effects of the biochemical composition of the basal lamina that influences 
keratinocyte attachment and ESC selection, proliferation, and terminal differentiation.  
Keratinocyte attachment was investigated on CI, CIV, LN, and FN at varying concentrations 
and amounts of time.  It was determined that the percentage of keratinocytes that adhered to 
each surface was time dependent as well as ECM protein and concentration dependent with 
adhesion to FN giving the highest percentage of adherent cells.17  Studies have also 
investigated the ability to select for ESCs based on using rapid adhesion assays on ECM 
proteins.  Differences in colony forming efficiency (CFE), a metric that can be used to 
demonstrate the presence of an ESC population or proliferative potential of the population, 
have been detected based on this selection technique.8,18,20  Additionally, flow cytometry has 
been used to sort keratinocytes based on β1 integrin expression.  When evaluating the CFE of 
keratinocytes separated using this technique, a linear relationship was found between log 
fluorescence and CFE, which implies a log linear relationship between β1 integrin density on 
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the cell surface and proliferative potential.18  Studies have further examined the effects of 
ECM proteins of the basal lamina, specifically FN, on differentiation of keratinocytes.  It has 
been shown that when cells are induced to undergo differentiation in culture, they become 
less adhesive to FN, and no longer express the β1 integrin.16   
 
Understanding how the microenvironment found at the DEJ influences ESC localization and 
promotes the development of a functional tissue is critical in the development of the next 
generation of bioengineered skin grafts as well as for longevity of the tissue.  We hypothesize 
that by incorporating microfabricated basal lamina analog, containing biochemical and 
microtopographic features mimicking those found at the DEJ, we will promote enhanced 
epithelialization and epidermal stem cell clustering on the surface of novel dermal scaffolds.  
Previously, our laboratory has created basal lamina analogs on the surface of collagen-
glycosaminoglycan (GAG) dermal scaffolds that recapitulate the native topographical 
features found at the DEJ utilizing photolithography and material processing techniques.  It 
was determined that topographical features with the greatest aspect ratios enhanced 
keratinocyte stratification, proliferation, and differentiation.21,22  Additionally, we found that 
passively adsorbing the ECM protein FN, on the surface of flat collagen-GAG membranes 
increased keratinocyte attachment over non-modified control collagen-GAG surfaces by 
22%.23 When further investigating FN binding domains and conjugation strategies, we 
determined that through carbodiimide conjugation, we could enhance the presentation of the 
cellular binding site domain of FN on the surfaces of self-assembled CI membranes.24  In this 
chapter, we have developed a novel system that incorporates both microtopographic and 
biochemical features that have been previously defined by our laboratory to enhance 
epithelialization.  Using histological stains and immunohistochemistry coupled with 
quantitative morphometric analyses of microscopic images, we have determined the effect of 
this combined microenvironment on epithelial thickness, morphology, proliferation, and ESC 
localization.  Furthermore we have compared our bioengineered skin substitutes that contain 
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microfabricated basal lamina analogs with both native adult and neonatal tissues as well as 
de-epithelialized acellular dermis (DED) cultured under the same conditions as our 
experimental system.  Overall, we have developed a bioengineered skin substitute with a 
microfabricated basal lamina analog that imparts the ability to direct ESC localization, as 
well as a model system to further investigate advanced ESC markers and the mechanisms by 
which ESC localization occurs.   
 
6.2 MATERIALS and METHODS 
6.2.1 Production of Dermal Scaffold Containing a Microfabricated Basal Lamina 
Analog  
 
6.2.1.1 Photolithography of a Master Pattern and Negative Replicates 
To mimic the microtopography found at the DEJ, photolithography was used.  Master 
patterns consisting of parallel, three-dimensional channels with widths of 50-400 µm and 
depth of 200 µm were designed using Pro/Engineer software (PTC, Needham, MA).  The 
two dimensional drawing was then printed onto acetate film (CAD/Art Service Inc, Poway, 
CA) with a high resolution laser photoplotter (7008MF: 20,000 dots/inch, Orbotech, 
Billerica, MA).  The transparency masks were then aligned on the surface of silicon wafers 
coated with 200 µm thickness of SU-8 photoresist (Microchem Co., Newton, MA) and 
exposed to a collimated beam of UV light.  The wafer was immersed in propylene glycol 
methyl ether acetate (PGMEA; SU-8 Developer, Microchem Co.) and the unexposed regions 
were dissolved, leaving a three-dimensional pattern on the silicon wafer (Figure 6.1A25).  To 
create negative replicate molds, polydimethylsiloxane silicone elastomer (PDMS, Sylgard 
184, Dow Corning Corp., Midland, MI) was poured onto the surface of the wafer (10:1 base 
to curing agent), degassed to remove trapped air bubbles, and allowed to polymerize for 2 
hours at 65°C.  The PDMS was then carefully separated from the silicon wafer (Figure 
6.1B25). 
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6.2.1.2 Purification of CI 
Acid-soluble type I collagen (CI) was extracted from rat tail tendons using protocols 
previously described.26   Rat tails were received from animals that were euthanized for other 
protocols, which were approved by Worcester Polytechnic Institute, Worcester, MA, 
Institutional Animal Care and Use Committee.  Briefly, rat tail tendons were extracted from 
the tails of 13 Sprague Dawley rats, rinsed in dPBS (Hyclone, Logan, UT), and dissolved in 
1600 ml of 3% acetic acid (EMD Chemicals, Inc., Gibbstown, NJ) at 4°C overnight. The 
resulting solution was centrifuged at 8590 rpm for 2 hours and 320 ml of a 30% NaCl 
(Sigma, St. Louis, MI) solution was dripped into the supernatant at 4°C.  The resulting 
solution was allowed to sit for at least 1 hour at 4°C without disruption and then centrifuged 
at 4690 rpm for 30 minutes to separate precipitated and liquid material.  The precipitated 
material was resuspended in 400 ml of 0.6% acetic acid and dialyzed for 4 hours against 1 
mM HCl (JT Baker, Phillipsburg, NJ) and the dialysis solution was changed every 4 hours 
until a clear collagen solution was obtained.  This solution was lyophilized and stored in a 
sealed container at 4ºC, until use.  Lyophilized collagen was dissolved in 5 mM HCl to 
obtain a working solution of 10 mg/ml.26 To produce self-assembled CI membranes, 800 µl 
of the soluble CI solution was neutralized using 200 µl of 5x Dulbecco’s Modified Eagle’s 
Medium (DMEM, Invitrogen, Carlsbad, CA) with 0.22 M NaHCO3 and 40 µl of 0.1 M 
NaOH (Sigma) at 37°C for 18 hours on circular PDMS molds (Figure 6.1C24).  
 
6.2.1.3 Dermal Scaffold Production 
To create dermal scaffolds, a collagen-GAG coprecipitate containing collagen (5 mg/ml) and 
GAG (0.18 mg/ml) was prepared by placing lyophilized bovine hide derived collagen 
(Semed-S, Kensey Nash Corp., Exton, PA) in acetic acid and homogenizing (20,000 rpm) at 
4°C for 90 minutes resulting in a bovine derived collagen suspension.27 Shark cartilage 
chondroitin 6-sulfate (Sigma) was dripped into the blending collagen dispersion and blended 
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for an additional 90 minutes.  Once fully blended, the collagen-GAG coprecipitate was 
degassed by centrifugation.  Dermal scaffolds were created by placing 20 ml of the collagen-
GAG suspension in 70 mm diameter aluminum weigh boats (VWR, West Chester, PA) and 
freezing at -80°C for 1 hour.  Following the initial freezing, the tins were placed in a freeze 
dryer (Virtis Advantage, Virtis, Inc., Gardner, NY) pre-frozen to -45°C then lyophilized 
overnight at a vacuum of 100 mtorr.  Following lyophilization, the scaffolds were covalently 
crosslinked by thermal dehydration (DHT) at 105°C in a vacuum of less than 200 mtorr for 
48 hours.  Scaffolds were cut into rectangles approximately 7 cm2 (2.5 cm width x 3 cm 
height) in area and placed in desiccator until use.   
 
6.2.1.4 Production of Dermal Scaffolds with Microfabricated Basal Lamina Analogs  
The production of dermal scaffolds with microfabricated basal lamina analogs began with the 
fabrication of a self-assembled CI membrane.  Initially, a microfabricated self-assembled CI 
membrane was made by neutralizing 800 µl of 10 mg/ml CI using 200 µl of 5x DMEM 
containing 0.22 M NaHCO3 and 40 µl of 0.1 M NaOH (Sigma) at 37°C for 18 hours on 
PDMS molds containing the negative replicate of the desired channel topography (molds 
9.85 cm2) (Figure 6.1C25).  After incubation, 400 µl of 10 mg/ml of CI was neutralized using 
100 µl of 5x DMEM containing 0.22 M NaHCO3 and placed directly on the self-assembled 
CI membrane, and gently spread to cover the entire surface area.  Immediately following this 
step, a precut lyophilized dermal scaffold was placed on top of the neutralizing CI and then 
incubated at 37°C for 2 hours to facilitate complete self-assembly of the CI and lamination of 
the dermal scaffold to the basal lamina analog (Figure 6.1D25). 
 
6.2.1.5 FN Conjugation to Microfabricated Basal Lamina Analogs Laminated to Dermal 
Scaffolds  
 
Carbodiimide 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC, Sigma) 
was used to covalently conjugate FN to the surface of the microfabricated basal lamina 
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analog as well as chemically crosslink the basal lamina analog and dermal scaffold.  
Previously we have reported that this method increases cellular binding site availability of 
FN.24  Using protocols described previously, the mole ratio of 5:1 of EDC to carboxylic acid 
groups in CI was used.28  Theoretical calculations which estimated the amount of COOH in 
1000 amino acids of collagen were used to make the assumption that 1 g of CI contains 1.2 
mmol COOH based on amino acid composition of CI.28,29 Each dermal scaffold containing a 
microfabricated basal lamina contains 30 mg of CI for a total of 0.036 mmol COOH, thus 
requiring 0.18 mmol of EDC.  This amount of EDC was dissolved in 50 mM MES (Sigma), 
prepared in 40% ethanol (Pharmco Products, Inc., Brookfield, CT) at a pH of 5.5, and 3 mls 
of the solution was placed on the dermal scaffold containing a microfabricated basal lamina 
analog for 4 hours at room temperature (Figure 6.1E25).  Dermal scaffolds containing 
microfabricated basal lamina analogs were then removed from the EDC solution and 
immediately placed into air/liquid (A/L) interface culture devices24 and FN (BD Biosciences, 
Bedford, MA) at 100 µg/ml was placed in the well created on the surface of the collagen 
membrane over night at room temperature (Figure 6.1F25).  Control dermal scaffolds 
containing microfabricated basal lamina analogs without FN conjugation were also prepared.  
These controls received EDC and dPBS instead of FN.   
 
6.2.2 Preparation of De-Epithelialized Acellular Dermis 
Following methods previously described by Hamoen et al.,30 De-epithelialized acellular 
dermis (DED) was prepared to use as a control tissue scaffold. Cadaver skin was obtained 
from New England Eye and Tissue Transplant Bank and washed 3 times in sterile dPBS.  
From this point on, sterile conditions were maintained.  The cadaver skin was placed in an 
antibiotic cocktail containing 1x DMEM with 10 µg/ml Ciprofloxacin (Sigma), 2.5 µg/ml 
Amphoteracin B, 100 U/ml Penicillin, 100 µg/ml Streptomycin, and 100 µg/ml Gentamycin 
(Invitrogen) and kept at 4ºC for 1 day.  The following day, the skin was transferred to a 
cryopreservation solution composed of 1x DMEM with 15% glycerol (J.T. Baker) and placed 
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at 4ºC for 2 hours.  Following this step, skin was placed in sterile mesh gauze soaked in 
cryopreservation solution and wrapped in sterile aluminum pouches and plastic.  Wrapped 
packages of skin were transferred to -20ºC for 24 hours, and then moved to -80ºC for long 
term storage.   
 
To prepare the skin for tissue culture, pouches containing cryopreserved tissue were 
immersed in a tub of water at 15-20ºC until skin was pliable, then refrozen rapidly in liquid 
nitrogen.  This freeze-thaw cycle was repeated 3 times to devitalize the cells.  Skin was 
removed from pouches and washed 3 times in DMEM then placed in antibiotic cocktail for 1 
week at 4ºC.  After 1 week, the skin was transferred into new antibiotic cocktail and 
incubated for 1 week at 37ºC.  At the end of the incubation, the epidermis was separated from 
the dermis, and the dermis was placed into fresh antibiotic cocktail for 4 weeks at 4ºC.  After 
4 weeks, the DED was ready for tissue culture. 
 
6.2.3 In vitro Culture of Dermal Scaffolds Containing Microfabricated Basal Lamina 
Analogs 
 
6.2.3.1 Sterilization of Dermal Scaffolds Containing Microfabricated Basal Lamina Analogs 
Air/liquid culture devices containing dermal scaffolds with microfabricated basal lamina 
analogs were placed in sterile containers in 60 ml of 70% ethanol for 1 hour in a laminar flow 
hood.  After 1 hour, devices were transferred to new sterile containers and were rinsed 3 
times for 10 minutes each in sterile dPBS and then left overnight in dPBS under sterile 
conditions.   
 
6.2.3.2 Culture of Neonatal Human Keratinocytes 
Neonatal keratinocytes were cultured as previously described.22,23 Neonatal foreskins were 
obtained from non-identifiable discarded tissues from UMass Memorial Medical Center, 
Worcester, MA and were approved with exempt status from the New England Institutional 
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Review Board.  Keratinocyte isolations were performed using an enzymatic treatment with a 
dispase (Gibco, Gaithersburg, MD) solution.  The cells were propagated on a feeder layer of 
3T3-J2 mouse fibroblasts (generously donated by Dr. Stelios Andreadis, State University of 
New York at Buffalo, Buffalo, NY) and cultured according to methods previously 
described22,31 using keratinocyte media consisting of a 3:1 mixture of DMEM (high glucose) 
and Ham’s F-12 medium (Invitrogen)  supplemented with 10% fetal bovine serum (FBS, 
Hyclone), 10-10 M cholera toxin (Vibrio Cholerae, Type Inaba 569 B), 5 μg/ml transferrin, 
0.4 μg/ml hydrocortisone (Calbiochem, La Jolla, CA), 0.13 U/ml insulin, 1.4*10-4 M 
adenine, 2*10-9 M triiodo-L-thyronine (Sigma), 1% Penicillin/Streptomycin (Invitrogen), and 
0.01 μg/ml epidermal growth factor (EGF, BD Biosciences).  After 5 days of culture, 
keratinocytes were detached using 0.05% Trypsin-EDTA (Invitrogen) and passage 2-3 
keratinocytes, from multiple donors were used in all experiments. 
 
6.2.3.3 Culture of Dermal Scaffolds Containing Microfabricated Basal Lamina Analogs  
 
After sterilization of dermal scaffolds with microfabricated basal lamina analogs, A/L 
interface culture devices were transferred to sterile 6 well plates for immediate cell culture.  
Dermal scaffolds with microfabricated basal lamina analogs were preconditioned with 
seeding media consisting of 3:1 mixture of 1x DMEM (high glucose) and Ham’s F-12 
medium supplemented with  10-10 M cholera toxin, 0.2 µg/mL hydrocortisone (Calbiochem), 
5 µg/mL insulin, 50 µg/mL ascorbic acid (Sigma), and 100 IU/mL and 100 µg/mL 
penicillin–streptomycin. Keratinocytes were seeded using this media at 500,000 cells/cm2 
and allowed to adhere for 2 hours in 10% CO2 at 37°C. After 2 hours, seeding media 
containing 1% FBS was placed in each well, completely submerging the bioengineered skin 
substitutes.  After 24 h, the keratinocyte seeding medium was removed, and the 
bioengineered skin substitutes were submerged for an additional 48 h in a keratinocyte 
priming medium composed of keratinocyte seeding medium (with FBS) supplemented with 
24 µM bovine serum albumin (BSA), 1.0 mM L-serine, 10 µM L-carnitine, and a mixture of 
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fatty acids including 25 µM oleic acid, 15 µM linoleic acid, 7 µM arachidonic acid, and 25 
µM palmitic acid (Sigma).32  After 48 h in priming medium, the bioengineered skin 
substitutes were cultured for 3 or 7 days with an air liquid interface medium composed of 
serum-free keratinocyte priming medium supplemented with 1.0 ng/mL EGF (Figure 
6.1G25).    As controls, composites without FN treatment and DED were cultured in parallel 
using the same process; however, DED was not sterilized, but placed directly into sterile A/L 
interface culture devices and keratinocytes were seeded on the papillary surface. 
 
6.3.3 Quantitative Morphometric Analysis of Microfabricated Features of Basal 
Lamina Analogs  
 
The morphology of the microtopographical features of the surfaces of the basal lamina 
analogs were evaluated using histology coupled with quantitative image analysis.  The 
specified values for the channels were 200 µm depth and 50 µm, 100 µm, 200 µm, and 400 
µm widths.  To measure the surface features of the basal lamina analogs, a series of unseeded 
dermal scaffolds containing microfabricated basal lamina analogs were fixed with 10% 
buffered formalin solution (EMD Chemicals), dehydrated with increasing concentrations of 
ethanol, cleared with sec-butyl alcohol (EMD Chemicals), and embedded in Paraplast tissue 
embedding medium (McCormick Scientific, St. Louis, MO).  Six micron sections were cut 
using a Leica RM 2235 (Leica Microsystems, Inc., Bannockburn, IL) in a plane 
perpendicular to the surface of the basal lamina.  Sections were mounted on poly-l-lysine 
coated slides (Erie Scientific Company, Portsmouth, NH). Tissue sections were 
deparaffinized in reverse ethanol–xylene (Pharmco Products, Inc. and EMD Chemicals) 
washes and stained with Harris Hematoxylin (Richard Allen Scientific, Kalamazoo, MI) for 4 
minutes.  Slides were rinsed with dH2O and 1% acid alcohol and stained with Eosin (Richard 
Allen Scientific) for 30 seconds.  The slides were then cleared in a series of ethanol and 
xylene and cover slipped using Permount (Fisher Scientific, Hampton, NH) mounting 
medium.  Brightfield images were captured of each section using a Nikon Eclipse E400 
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microscope (Nikon, Inc., Melville, NY) coupled to an RT Color Spot camera (Spot 
Diagnostics, Sterline Heights, MI).  For each sample the depths of the channels and the 
widths of the channels were measured using Image J software (downloaded from 
http://rsb.info.nih.gov.ezproxy.umassmed.edu/ij/).  Values are reported as mean +/- SEM. 
 
6.3.4 Analyses of Epithelialization and Regenerative Capacity of Bioengineered Skin 
Substitutes Containing Microfabricated Basal Lamina Analogs 
 
6.3.4.1 Epidermal Thickness and Graft Morphology 
Epidermal thickness and graft morphology on the surfaces of the basal lamina analogs 
laminated to dermal scaffolds were evaluated after 3 or 7 days of A/L interface culture.  
Samples were embedded in paraffin wax, sectioned, and mounted as described previously in 
the Quantitative Morphometric Analyses of Microfabricated Features of Basal Lamina 
Analogs Laminated to Dermal Scaffolds (Section 6.3.3).  Paraffin sections were 
deparaffinized in reverse ethanol–xylene washes and stained with Hematoxylin and Eosin.  
Brightfield images were captured and using Image J measurements of channel depth, channel 
widths, and epithelial thickness in each channel.  Additionally the epidermal thickness of the 
flat region adjacent to the channels (papillary plateau) was measured (Figure 6.2A25 insert).  
Multiple measurements were made for each sample since each sample contained multiple 
channels.  For epithelialized DED and native tissues, the thickness of the epidermal layer was 
measured in the rete ridges and on the papillary plateaus.  The dimensions of the rete ridges 
were also measured.  
 
To characterize the effect of channel dimensions on epidermal thickness, the epidermal 
thicknesses were measured in channels with widths that were within +/- 2 SEM of the 
topography validation width measurements, for each specified channel width. Data points 
were excluded from all other channels from this analysis.   These data points were then 
individually normalized to the depth of their channel.  The normalized data from each 
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specified channel width was then averaged and reported as a mean value +/- SEM.  Sample 
values for the 50, 100, 200, and 400 µm width channels were n = 5, 5, 6, 11 at 3 days, 
respectively and n = 5, 6, 15, and 13 at 7 days, respectively.  At both 3 and 7 days n = 4 for 
DED and n = 4 for foreskin tissue.   
 
6.3.4.2 Keratinocyte Proliferation 
Keratinocyte proliferation was evaluated after 3 or 7 days of A/L interface culture by 
measuring the presence of Ki67, a cell cycle associated antigen. Samples were embedded in 
paraffin, sectioned, and mounted on Superfrost Plus slides (VWR, West Chester, PA) coated 
with poly-L-lysine (Sigma).  The paraffin sections were deparaffinized in reverse ethanol–
xylene washes, and the antigens were unmasked by placing the slides in boiling Vector 
UnMasking solution (Vector Laboratories, Inc, Burlingame, CA) in a Manttra pressure 
cooker (Manttra, Inc., Virginia Beach, VA) for 1 minute after maximum pressure was 
achieved.  Slides were then incubated with blocking solution (10% normal horse serum 
(Vector Laboratories) in dPBS) for 10 min at room temperature and then treated with 
predilute mouse-antihuman Ki67 antibody (Zymed Laboratories, South San Francisco, CA) 
overnight in a humidified chamber (Sigma) at room temperature.  Slides were incubated with 
biotinylated anti-mouse IgG (Vector Laboratories) at 1:200 for 30 minutes at RT.  The slides 
were washed with dPBS and stained with Vectastain Elite ABC Kit (Vector Laboratories) for 
30 minutes at room temperature.  Slides were washed with dPBS and developed using a 
Vector NovaRed Substrate Kit (Vector Laboratories) for approximately 1 min for 
bioengineered skin substitutes and epithelialized DED, and 5 min for native tissues.  Slides 
were with rinsed in dPBS, followed by a 5 minute wash with tap water, and counterstained 
with Harris hematoxylin for 45 s. The slides were washed with tap water and then went 
through ethanol-xylene washes and mounted with VectaMount permanent mounting medium 
(Vector Laboratories).  The slides were viewed with a Nikon Eclipse E400 microscope and 
images were captured using an RT Color Spot camera.  The number of Ki67 positive basal 
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cells and total basal cell number were counted over the length of the basal lamina in each 
channel and for control tissues, over the entire image.  The data from each specified channel 
width was averaged and reported as the mean value +/- SEM.  Samples for 50, 100, 200, and 
400 µm width channels were n = 5, 6, 7, and 10 at 3 days, respectively and n = 5, 6, 10, and 
11 at 7 days, respectively.  At both 3 and 7 days of A/L interface culture n = 4 for 
epithelialized DED.  Samples for foreskin tissue were n = 5.  Only one sample of breast 
control tissue was obtained and 3 images of the sample were evaluated and averaged reported 
as the mean +/- standard deviations.  Breast tissue was not included in statistical analyses.   
 
6.4.3.3 Beta-1 Analysis of Keratinocyte Colonies 
To evaluate keratinocyte expression of β1 integrins in routine keratinocyte co-culture, we 
utilized quantitative immunofluorescence staining on tissue culture substrates.  For the tissue 
culture substrates, keratinocytes were cultured in 6 well culture plates, using methods 
previously described.  After 5 days of culture, each well was rinsed with dPBS and treated 
for 10 minutes with a fixing and permeabilizing solution containing dPBS, 4% formaldehyde 
(Ted Pella, Redding, CA), and 0.2% of Triton X-100 (Sigma).  Wells were then rinsed to 
remove fixative and permeabilizing solution and blocked with a 1% BSA solution in dPBS 
for 10 minutes.  Silicone gaskets made from PDMS with inner diameter of ~2 cm2 were 
secured in the center of each well using silicone vacuum grease (Dow corning, Midland, MI). 
A primary antibody directed against β1 (Anti-CD29, BioGenex, San Ramon, CA) at a 
concentration of 1:100 in blocking solution was applied for 2 hours at 37º C.  Following 
incubation, each sample was washed with dPBS twice, 5 minutes each time.  Goat anti-
mouse (Alexa Fluor 546, Invitrogen) secondary antibody at a dilution of 1:100 in blocking 
solution was placed in each well and incubated for 1 hour at 37º C.  After incubation, the 
wells were rinsed and Hoeschst nuclear reagent (Invitrogen) was added at 0.06 mM (in 
dH2O) for 5 minutes at 37ºC.  The wells were rinsed with dPBS, the gaskets removed, and 
the wells were cover slipped using an aqueous mounting medium containing anti-fading 
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agents (Biomeda Corp, Foster City, CA).  Each image was captured using the same exposure 
time.  Using Image J software, the histogram function was used to determine the greatest 
fluorescence intensity.  Following previously published methods, the greatest fluorescence 
intensity recorded was subdivided into three regions, the dullest (bottom 1/3), the brightest 
(top 1/3) and the remaining (middle 1/3).  Cells that had intensity values in the top 1/3 around 
their perimeter were considered integrin-bright.19,33,34  The number of cells that were integrin 
bright were counted as well as the total number of cells in the colony.  The average percent 
of integrin-bright keratinocytes for 4 separate wells was reported as a mean value +/- SEM 
since multiple images were captured and analyzed for each well.     
 
6.3.3.4 Beta-1 Expression in Bioengineered Skin Substitutes, Epithelialized DEDs, and 
Human Tissue 
 
The expression of β1 for basal keratinocytes in bioengineered skin substitutes, epithelialized 
DED, and human tissues, was analyzed using immunohistochemistry and quantitative 
analyses of fluorescent microscope images. Tissue samples, 6 µm thick, were mounted on 
Superfrost Plus slides coated with poly-l-lysine.  Following the same procedure as for Ki67 
detection, all samples were deparaffinized and the antigens were unmasked.  The same 
procedure was then followed as for the analysis of β1 of keratinocyte colonies on tissue 
culture plastic, except samples were cover slipped with Vectashield Mounting Medium with 
DAPI (Vector Laboratories) to visualize nuclei.  Human foreskins and breast tissue were 
obtained from non-identifiable discarded tissues from UMass Memorial Medical Center, 
Worcester, MA and were exempt from New England Institutional Review Board review.  
The human tissues were processed the same way as the bioengineered skin substitutes and 
epithelialized DED.    
 
Using Image J software, the average relative fluorescence intensity (RFI) value of cell 
borders was mapped for basal keratinocytes for all tissues evaluated.  Previously, it has been 
determined that β1 intensities correspond with ESC populations and integrin-bright patches 
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have been used as an indicator of ESC localization areas.19,34  Once measured, the average 
RFI was plotted to evaluate integrin-bright and integrin-dull regions of the basal lamina.  
Similar to β1 expression in the colonies, cells that had intensity values in the top 1/3 were 
considered integrin-bright.19,33,34 
 
6.3.5 Statistical Analyses 
Sigma Stat Version 3.10 (Systat Software Inc., Richmond, CA) was used to determine 
statistical differences among the means of experimental groups.  To determine if the means 
of two different samples were significantly different, a Student’s t-test was performed when 
the samples were drawn from a normally distributed population with equal variance.  Sigma 
Stat uses the Kolmogorov-Smirnov test to test for a normally distributed population and a P 
value > 0.05 indicates normality.  For all parametric tests, Sigma Stat assumes equal 
variance.  When the data was not drawn from a normally distributed population (P value < 
0.05), a Mann-Whitney Rank Sum Test was used and a Levene Median test was used to 
determine equal variance with a P value > 0.05 indicating equal variance.  For both the 
Student’s t-test and the Mann-Whitney Rank Sum Test, a p value < 0.05 indicated a 
significant difference between the means of experimental groups.   
 
To determine statistical differences among the means of three or more experimental groups a 
One Way Analysis of Variance (ANOVA) was used when the samples were drawn from a 
normally distributed population with equal variance (Kolmogorov-Smirnov test for normal 
distribution and equal variance was assumed).  When the data was not normally distributed, a 
Kruskal-Wallis One way ANOVA on ranks was performed (Levene Median test to determine 
equal variance with a P > 0.05 indicating equal variance).  When a statistical difference was 
detected among the group means, a Tukey post-hoc analysis was performed for both the One 
Way ANOVA and Kruskal-Wallis One Way ANOVA on ranks.  A p value < 0.05, for both 
variance tests, indicated a significant difference between the groups. 
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6.4 RESULTS 
6.4.1 Development of Bioengineered Skin Substitutes Containing Microfabricated Basal 
Lamina Analogs  
 
In native skin, the DEJ is not flat, but rather has a microtopography that conforms to a series 
of ridges and invaginations that, in combination with the biochemical composition, provides 
a microenvironment to direct basal keratinocyte functions.  To investigate the role of this 
microenvironment on epithelialization and the regenerative capacity of bioengineered skin 
substitutes, we developed a process to create a dermal scaffold containing microfabricated 
basal lamina analogs composed of a defined starting collagen material EDC conjugated with 
FN (Figure 6.125).   
 
Figure 6.1. Production of Bioengineered Skin Substitute Containing Microfabricated Basal Lamina 
Analogs.  Photolithography (A) was used to create a master pattern on a silicon wafer containing channels 
with a depth of 200 µm and widths of 50, 100, 200, and 400 µm.  Polydimethylsiloxane (PDMS) was cast 
on the microfabricated silicon wafer (B) and allowed to polymerize.  The PDMS pattern was inverted and a 
collagen gel was cast onto the surface containing the negative replicate of the original pattern (C).  Once 
polymerized, another collagen gel was cast onto the back surface of the original collagen gel which acts as 
a glue to laminate a collagen-GAG sponge (D).  This composite was EDC crosslinked (E).  The composite 
was removed from the PDMS and FN was conjugated to the surface (F).  The composite was sterilized, 
seeded with keratinocytes (G), and cultured to create an engineered graft with a stratified epidermis.25 
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Photolithography was utilized to create a master pattern containing channels with specified 
depths of 200 µm and widths of 50, 100, 200, and 400 µm.  Type I collagen was cast onto a 
PDMS negative replicate of the master pattern and allowed to polymerize.  A collagen-GAG 
sponge was then adhered to the back of the microfabricated self-assembled type I collagen 
membrane and the composite was EDC crosslinked to provide 
mechanical and degradation stability,35,36 as well as to provide 
sites for chemical conjugation of FN to the topographical 
features.37   
 
The topographical features provided on the surface of the 
basal lamina analog were analyzed through histological 
techniques before cellular seeding. Depths and widths of the 
channels were measured using Image J (Figure 6.225).  It was 
found that the depths for each channel were approximately 
150 µm (Figure 6.2B25 and Table 6.125) and widths for 50 µm 
were 60.8+/- 3.8, 100 µm were 101.2 +/- 2.4, 197.1 +/-13.5, 
and for 400 µm 315.7+/- 27.9 (Figure 6.2C25 and Table 6.125).   
Figure 6.2.  Topographical Measurements of the Surfaces of Bioengineered Basal Lamina Analogs.  To 
determine the dimensions of basal lamina analogs created using photolithography, histological sections were 
analyzed.  A) represents a section stained with eosin.  The insert illustrates the measurements made for depths 
(D) and widths (W) of the channels as well as the papillary plateau (PP) which will be discussed in later sections.  
All channels in the bioengineered skin substitutes were measured.  These values were averaged and plotted in B 
(width) and in C (depth) against specified channel widths.  Values are reported as averages +/- SEM.  Sample 
numbers for the 50 µm width channels are n = 4 and for the 100, 200, and 400 µm width channels n = 5.25 
Table 6.1. Specified and Measured Topographical Features of Basal Lamina Analog25
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6.4.2 Microenvironments Provided By a Microfabricated Basal Lamina Analog 
Influence Epidermal Thickness and Morphology of the Epidermal Layer of 
Bioengineered Skin Substitutes 
 
The effect of the 
microenvironment on 
epidermal thickness was 
analyzed at 3 or 7 days of A/L 
interface culture on a 
bioengineered skin substitute 
containing a microfabricated 
basal lamina.  Epidermal 
thickness was evaluated using 
histological techniques and 
quantitative morphometric 
analyses of microscopy 
images. Figure 6.325 displays 
representative hematoxylin 
and eosin stained channels 
that were evaluated.  
Previously our laboratory has 
shown that the presence of 
FN conjugated to the surface 
of a self-assembled CI basal  
Figure 6.3. Histological Representation of Hematoxylin and Eosin Stained Bioengineered Skin 
Substitutes. To evaluate the effects of FN and topography on epithelialization, the epidermal thickness of 
the composite was measured without FN cultured for 3 days at the A/L interface (A and B), on composites 
with FN cultured for 3 or 7 days at the A/L interface (C and D, and E and F, respectively) and compared 
to keratinocytes cultured on DED cultured for 3 or 7 days at the A/L interface (G and H, respectively) and 
foreskin and breast control tissues (I and J, respectively). Composites without FN lacked a continuous 
layer of keratinocytes in all regions and only contained 1 to 3 cellular layers as well as cellular debris. 
Cells cultured on scaffolds containing FN had a continuous monolayer and comparable epidermal 
thicknesses and morphology to epithelial layers on DED and in native tissues. Scale bars = 50 µm.25  
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lamina analog enhances epithelialization.24  When comparing basal lamina analog surfaces 
without FN conjugation (Figure 6.3A25 and 6.3B25) with basal lamina analog surface with FN 
conjugation (Figure 6.3C25 and 6.3D25), it can be seen that the FN surfaces have a continuous 
multi-layer of cells, regardless of topographical geometry (Figure 6.3A-6.3D25) in 
comparison with the non-continuous multi-layers of cells found cultured on the surfaces 
without FN.  
 
 
When comparing grafts cultured with FN at various time points, it can be seen that the 
geometrical features play a role in epidermal thickness.  At 3 days of A/L interface culture, 
channels with widths of 50 µm have a noticeably thicker epidermis than channels with 
Figure 6.4.  Epidermal Thickness of Bioengineered Skin Substitutes Normalized to Depth of 
Channel.  Epidermal thickness was measured in each channel of each composite and normalized to the 
depth of the channel.  A) At 3 days of A/L interface culture, epidermal thicknesses measured in 50 µm 
channels were statistically increased over that of all other channels measured (* indicates p<0.05, One-
Way ANOVA, Tukey post-hoc analysis).  B) When evaluating epidermal thicknesses at 7 days of A/L 
interface culture the 50 µm width channels and the 100 µm width channels were statistically different than 
the 200 and 400 µm channels (* indicates p<0.05, One-Way ANOVA, Tukey post-hoc analysis.  Large 
dashed lines represent epidermal thickness of foreskin tissue and smaller dashed lines represent epidermal 
thickness on DED.  Values represent means +/- SEM.  Samples for 50 µm and 100 µm widths at 3 and 7 
days are n = 5 and for the 200 µm widths n = 6 and 15 at 3 and 7 days, respectively, and n = 11 and 13 for 
400 µm channels at 3 and 7 days, respectively.25   
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widths of 200 µm (Figures 6.3C25 and 6.3D25, respectively).  Epidermal thickness normalized 
to the depth of the channel at 3 days of A/L interface culture for the 50 µm channels, was 
statistically greater than the thickness measured for the 100 µm width, 200 µm width, and 
400 µm width channels (Figure 6.4A25) 
 
The epidermal layer on the bioengineered 
skin substitutes cultured in the 50 µm width 
channels was similar in thickness and 
morphology to the epidermal layer cultured 
on DED for 3 days at the A/L interface 
(Figure 6.3G25). When quantifying the 
epidermal thickness, no statistical 
differences were found between the 
decellularized dermis and the 50 µm width 
channels at 3 days (Figure 6.4A25).  At 
the 7 day A/L interface culture time 
point for bioengineered skin substitutes, 
the 50 µm width and 100 µm width 
(Figure 6.3E25) channels have similar 
morphologies and epidermal 
thicknesses and when compared to the 
200 µm width channels (Figure 6.3F25) 
are much thicker.   
 
Figure 6.5. Epidermal Thickness at Papillary Plateau.  
The thicknesses of the epidermal layers at the papillary 
plateau of bioengineered skin substitutes, epithelialized 
DED, and in native foreskin were measured.  The dashed 
line represents the epithelial thickness of foreskin tissue.  
No statistical differences were detected between the 
thicknesses of bioengineered skin substitutes and 
epithelialized decellularized dermis at 3 or 7 days of A/L 
interface culture (One-Way ANOVA with Tukey post-hoc 
analysis).  At 7 days there were no statistical differences 
between foreskin tissue (dashed line) and either the 
bioengineered skin substitutes or epithelialized 
decellularized dermis (Kruskal-Wallis One-Way ANOVA 
on Ranks).  Values represent mean +/- SEM.  For 
bioengineered skin grafts n = 14 and 15 at 3 and 7 days, 
respectively, n = 4 and 7 for epithelialized DED at 3 and 7 
days, respectively, and n = 4 for foreskin tissues.25 
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Epidermal thickness for  the 50 µm 
width and 100 µm width channels had 
similar values, and were both statistically 
different from the 200 µm width and 400 
µm width channels (Figure 6.4B25).  
When comparing the bioengineered skin 
substitutes at 7 days of A/L interface 
culture to the epidermal layer on DED 
(Figure 6.3H25) and native skin (Figure 
6.3I25 and 6.3J25), it can be seen that the 
50 µm width and 100 µm width channels 
have similar morphologies and thickness.  
No statistical differences were found in 
epidermal thickness between 50 µm 
width and 100 µm width channels.  
Additionally, no statistical differences 
were found in epidermal thickness 
between 50 µm width and 100 µm width 
channels and the epidermal thickness of 
cells cultured for 7 days at A/L interface 
on DED or foreskin tissue (Figure 
6.4B25).   
 
Figure 6.6. Histological Representation of Ki67 Expression of Basal Keratinocytes Present in 
Bioengineered Skin Substitutes.  To evaluate the effects of topography on the presence of proliferating 
basal keratinocytes, Ki67, a marker for highly mitotic cells was used.  The presence of Ki67 positive basal 
keratinocytes was evaluated on bioengineered skin substitutes. A and B represent channels with 50 µm 
widths at 3 and 7 days, respectively.  C and D represent channels with 100 µm widths at 3 and 7 days, 
respectively. E and F represent channels with 200 µm widths at 3 and 7 days, respectively.  G and H 
represent channels with 400 µm widths at 3 and 7 days respectively.  I and J represent epithelialized DED 
at 3 and 7 days.  K and L are foreskin and breast tissue.  Scale bars in all images = 100 µm.25 
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To compare the thicknesses achieved regardless of depth of channels or depths of rete ridges, 
we measured the epidermal thicknesses at the papillary plateaus for the bioengineered skin 
substitutes.  (Figure 6.525 see Figure 6.2A25 for papillary plateau measurement clarification if 
necessary).  The papillary plateaus between all channels were then averaged and compared to 
the epidermal thicknesses on the papillary projections for epithelialized DED and foreskin 
tissue. At 3 days of A/L interface culture, bioengineered skin substitutes and epithelialized 
DED were not statistically different from each other but different from native foreskin. At 7 
days of A/L interface culture, the epidermal thicknesses at the papillary plateau were not 
statistically different between 
any measured tissues. 
 
6.4.3 Proliferation Capacity of 
Bioengineered Skin Substitutes 
is Affected by the 
Microenvironment Provided by 
a Microfabricated Basal 
Lamina Analog 
 
To determine the effects of 
microtopography on cell 
proliferation bioengineered skin 
substitutes and epithelialized 
DED were evaluated after 3 or 
7 days of A/L interface culture.  
The samples were stained for 
the nuclear proliferation 
antigen Ki67 and 
counterstained with 
hematoxylin (Figure 6.625).  
Figure 6.7.  Percentage of Ki67 Positive Basal Keratinocytes in 
Bioengineered Skin Substitutes.  The number basal keratinocytes 
that were Ki67 positive cells were counted in each channel as well 
as total number of basal keratinocytes and the percentage positive 
was determined. For native tissues, basal keratinocytes that were 
Ki67 positive as well as total basal keratinocytes were counted over 
a length ranging from 650 µm to 950 µm based on topographical 
features.  Values are reported as averages +/- SEM.  For 50 µm, 100 
µm, 200 µm, 400 µm widths, and epithelialized DED at 3 days, n = 
5, 6, 7, 11, and 4, respectively.  For 50 µm, 100 µm, 200 µm, 400 
µm, and epithelialized DED at 7 days, n = 4, 5, 11, 10, and 4, 
respectively.  Samples for foreskin tissues are n =5.   For breast 
tissue 3 separate sections of the same tissue were evaluated.25 
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Foreskin and breast tissues were also evaluated as native skin controls (Figure 6.6K25 and 
L25).  The percentage of Ki67 positive cells was quantified in each channel, or over the entire 
basal lamina for epithelialized DED or native tissues (Figure 6.725).    
 
At 3 days of A/L interface culture, the 50 µm width channels had the lowest average 
percentage of Ki67 positive cells (approximately 7.5% Figure 6.725), and 40% of these 
channels had zero positive cells.  At 7 days of A/L interface culture, the 50 µm width 
channels had a slightly higher average 
percentage of Ki67 positive cells than at 3 
days, and 20% of the channels analyzed had 
zero positive cells (Figure 6.725). When 
analyzing the 100 µm width channels after 3 
days of A/L interface culture, it was found 
that all channels contained positive cells and 
an average of approximately 15% Ki67 
positive cells was found.  At 7 days of A/L 
interface culture, the percentage of Ki67 
positive cells was approximately the same 
as at 3 days and all 100 µm width channels 
analyzed contained positive cells (Figure 
6.725). 
 
The 200 µm width and 400 µm width 
channels had similar values and trends at 
both 3 and 7 days of A/L interface culture.  
At 3 days of A/L interface culture the 200 
µm width channels had approximately 15% 
Figure 6.8.  Keratinocyte Colonies with β1 and 
Nuclear Expression.  Keratinocytes after 4 days of 
co-culture were immunostained for β1 (red) and 
nuclei (blue) expression.  Images A and B represent 
phase contrast and merged fluorescent images 
obtained in control wells, respectively.  Scale bar = 
100 µm.  Images C and D represent phase contrast 
and merged fluorescent images, respectively 
captured at 10x to evaluate cells and expression in 
total colonies.  Scale bar = 100 µm. Images E and F 
represent phase contrast and merged fluorescent 
images captured at 40x to demonstrate perinuclear 
expression of β1. Scale bar = 5 µm.25 
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Ki67 positive cells and the 400 µm width channels had approximately 18% Ki67 positive 
cells.  At 7 days, both channels decreased in percentage Ki67 positive cells to approximately 
10% (Figure 6.725).  Epithelialized DED exhibited approximately 10% Ki67 positive cells at 
3 days of A/L interface culture and approximately 18% Ki67 positive cells at 7 days of A/L 
interface culture. When analyzing native tissues, it was found that the basal keratinocytes of 
neonatal foreskin were approximately 12% Ki67 positive and basal keratinocytes in breast 
tissue were approximately 10% Ki67 positive.  Overall our Ki67 data suggests that no 
significant differences exist among any sample evaluated at either 3 days or 7 days of A/L 
interface culture (Figure 6.725)  When performing a power analysis, it was found that P < 0.8 
for both the 3 and 7 day data, therefore to further support these findings, sample sizes need to 
be increased. 
 
6.4.4 Beta-1 Expression in Keratinocyte Colonies Detected in Edge Keratinocytes  
The expression of β1 in colonies of keratinocytes was evaluated after 4 days of co-culture 
with a feeder layer of J2s.  It was found that for all colonies in each culture well, β1 
expression was found in the periphery of keratinocytes on the perimeter of each colony.  To 
analyze the localization of β1 bright regions, the maximal fluorescence intensity was 
determined so that no saturation occurred in the image.  This value was then divided into 
three equal regions, thus giving three regions of integrin expression values (bright, medium, 
and dull). Any value in the top third was considered β1-bright similar to previously reported 
literature.19,33,34  When analyzing the percentage of cells were β1-bright it was determined 
that 25% +/- 0.1 of the colony were β1-bright.  Figure 6.8A25 and 6.8C25 are phase contrast 
images that display a representative colony at 10 and 40x and 6.8B25 and 6.8D25 are 
fluorescent images displaying β1 expression (red) and cell nuclei (blue) at 10 and 40x, 
respectively.   
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6.4.5 Microenvironments Control Spatial Localization of β1-Bright Basal Keratinocytes 
To determine localization of β1-bright keratinocytes in bioengineered skin substitutes, 
epithelialized DEDs, and in native foreskins, we utilized immunohistochemistry coupled with 
quantitative digital image analyses.  Fluorescent intensity values were determined for cell-
cell borders similar to previously reported literature for 3 day A/L interface cultures.19,33,34  
Figure 6.9 displays representative images of 100 µm width channels (Figures 6.9A25 and 
6.9B25), 400 µm width channels (Figures 6.9D,25 6.9E,25 6.9G,25 and 6.9H25), flat regions of 
bioengineered skin substitutes (Figures 6.9J25 and 6.9K25), epithelialized DED (Figures 
6.9M25 and 6.9N25), and neonatal foreskin (Figures 6.9P25 and 6.9Q25).   
 
It was found that in the 100 µm width (Figures 6.9A,25 6.9B,25 and 6.9C25) and 400 µm width 
(Figures 6.9D,25 6.9E,25 and 6.9F25) channels, there were no β1-bright cells in the flat sections 
next to the channels (papillary plateaus), but in the channels 16.7% and 23% of basal 
keratinocytes were β1-bright, respectively (dashed lines in 6.9C and 6.9F separate flat regions 
from channel regions).  Figures 6.9G,25 6.9H,25 and 6.9I25 are another representative image of 
the 400 µm width channels demonstrating β1-bright regions localized to the corners of the 
channels. In the corners of the 400 µm width channels we found that 50% of the total basal 
keratinocyte population was β1-bright. 
 
When β1 was evaluated on flat regions of the bioengineered skin substitutes, 30% of the basal 
keratinocyte population was β1-bright, however the cells were not localized, but 
heterogeneously distributed (Figures 6.9J,25 6.9K,25 6.9L25).  The expression of β1-bright 
basal keratinocytes on epithelialized DED was found to be 15.6% and the β1-bright cells 
were localized to the rete ridges.  Additionally, β1 expression was evaluated in native 
foreskin tissue. It was found that the β1-bright basal keratinocytes localized to the tips of the 
papillary projections.  Overall 6.8% of the total basal keratinocyte population was β1-bright. 
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Figure 6.9.  Beta-1 Expression of Basal Keratinocytes in Bioengineered Skin Substitutes.  To determine 
the localization of β1 bright basal keratinocytes, immunohistochemistry coupled with digital image analyses 
was used.  Figures 6.9A, 6.9D, 6.9G, 6.9J, 6.9M, and 6.9P are images with β1 expression in red and Figures 
6.9B, 6.9E, 6.9H, 6.9N, and 6.9Q are images with β1 expression in red and nuclear expression in blue.  
Figures 6.9C, 6.9F, 6.9I, 6.9M, and 6.9R are plots of the average relative fluorescence intensities (RFI) of 
cell-cell borders in the region evaluated.  Dashed lines in 6.9C, 6.9F, and 6.9I separate flat regions from the 
channel.  It can be seen that for the 100, 400, and DED  samples (Figures 6.9B, 6.9E, 6.9H, and 6.9N) β1 
bright cells localized to the rete ridges, whereas in native foreskin β1 bright cells localized to the tips of the 
dermal papillae.  Additionally when evaluating the flat region of the bioengineered skin substitute, β1 cells 
were heterogeneously distributed. Each cell was measured and the average RFI was reported.  Insert in A 
and B represent controls for β1and β1 and nuclear staining. Error bars represent 100 µm in all images.24 
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6.5 DISCUSSION  
Understanding how the biochemical and three-dimensional microenvironment of the basal 
lamina modulates keratinocyte proliferation and differentiation, as well as contributes to 
localization of ESCs, is of great importance when designing bioengineered skin substitutes.  
In native tissues, the basal lamina provides instructive cues that are critical in skin 
architecture, cellular organization, and the regeneration of the epidermal layer.4  The 
regeneration of skin is of great importance, because in order for skin to provide the protective 
barrier against the surrounding environment, the epidermis must be in constant renewal.  In 
this study we developed a novel dermal scaffold that contains both biochemical and 
microtopographical cues provided by the native basal lamina and investigated the role of the 
microenvironment on bioengineered skin substitutes morphology, epidermal thickness, 
keratinocyte proliferation, and ESC localization.  Additionally we compared our findings 
with epithelialized DED and native foreskin tissues. 
 
To create a microfabricated basal lamina analog produced from self-assembled CI, 
photolithography was used.  A master pattern was created on a silicon wafer to produce 
channels with specified features of 200 µm depth and 50 µm, 100 µm, 200 µm, and 400 µm 
widths.  A negative replicate was produced using PDMS and acid soluble type I collagen was 
self-assembled on the surface of the negative replicate PDMS pattern.  Previously, our 
laboratory has used a similar strategy to create basal lamina analogs using a collagen-GAG 
coprecipitate with different processing techniques to create a basal lamina analog laminated 
to a dermal scaffold.21,22  When comparing the two strategies to produce microfabricated 
basal lamina analogs, we found that the features of the microfabricated basal laminas when 
composed of collagen-GAG had a greater error associated with both the widths and depths 
(mean width error varied from 13-30% and mean depth varied from 7.4-16.2%), than the 
features on the self-assembled CI lamina analogs (mean width errors varied from 2-9% and 
mean depths varied from 0.9-2.5%).  Although the depths and widths of the self-assembled 
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CI membranes varied from the design specifications, our new method using self-assembled 
CI demonstrates improved fidelity for recapitulating topographical features as well as a 
defined starting biochemistry for enhanced FN EDC conjugation.24   
 
After analyzing the topography of the channels, we investigated the responses of 
keratinocytes cultured for 3 or 7 days at the A/L interface on the surfaces of microfabricated 
basal lamina analogs laminated to dermal scaffold and compared the results to keratinocytes 
cultured on DED as well as with native neonatal foreskin and adult breast tissue.  When 
evaluating histological images, we determined that the epidermal thickness varied based on 
the geometry of the channels.  We also determined that after culturing keratinocytes on the 
microfabricated basal lamina analogs, that the topographic features had greater errors 
associated with their dimensions, than when measured prior to cellular culture. Therefore to 
account for the change in channel width, we only analyzed channels with widths that 
deviated from the mean by +/- 2 SEM, and normalized the epidermal thickness values to the 
depths of the channel based on previous data that suggests depth plays a role in the 
microenvironment.21  
 
The observed changes in topographical features of the epithelialized microfabricated self-
assembled CI basal lamina analog can be explained based on in vivo analysis of MMPs in 
normal wound healing.  Matrix metalloproteinases (MMPs) are found in the wound 
environment and are responsible for the degradation and modification of ECM proteins at the 
wound site.38  Matrix metalloproteinase-1 (MMP-1), or collagenase-1, is keratinocyte derived 
and initially found at high levels in the wound to enable keratinocyte migration and 
monolayer formation.  Once a monolayer and basement membrane proteins are formed, this 
enzyme ceases (as well as other MMPs) to be produced at high levels, and returns to normal 
levels that contribute to the constant balance of matrix synthesis and breakdown and 
recycling of the ECM.39,40 Since the keratinocytes initially seeded on the microfabricated 
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basal lamina analogs exhibit similar characteristics to wounded keratinocytes, it is 
hypothesized that there was an upregulation of MMP levels similar to in vivo wounds which 
caused the change in the dimensions of the topographic features.41-45   
 
We evaluated the epidermal layer of bioengineered skin substitutes, after 3 days of A/L 
interface culture, and determined that keratinocytes cultured in 50 µm width channels had 
statistically similar epidermal thickness values as epithelialized DED.  At 7 days of A/L 
interface culture the 50 µm and 100 µm width channels exhibited the same epidermal 
thicknesses as keratinocyte cultured on DED and foreskin tissue and these conditions were 
statistically different from epidermal thickness values in the 200 µm width and 400 µm width 
channels.  
 
The morphology of the epidermal layer on the FN conjugated basal lamina analog surfaces, 
suggests well differentiated  epidermal layers, based on cellular size and loss of nuclei from 
the stratum corneum layer.  Keratinocytes found in the basal layer are cuboidal in shape and 
as the cells progress to the stratum corneum, exhibit a more flattened morphology, similar to 
what is found in native skin.  Furthermore, in native skin, these morphological changes are 
accompanied by changes in the expression of keratin proteins and water proofing lipids, 
which are both important in functionality of the skin in providing a protective barrier against 
the environment as well as  structural integrity of the epidermis.46 
 
Additionally, to demonstrate functionality of our bioengineered skin substitute, we 
determined the percentage of Ki67 positive basal keratinocytes.  Native skin is under 
constant renewal, thus having a bioengineered skin substitute with similar regenerative 
capacity is necessary in order to maintain a healthy tissue.  Ki67 positive basal keratinocytes 
were measured at the 3 and 7 day time points.  At 3 days of A/L interface culture, the 50 µm 
width channels contained a lower percentage of Ki67 positive basal cells than any other 
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channels and was similar to the percentage of Ki67 basal keratinocytes on DED.   At 7 days 
of A/L interface culture, the 200 µm width and 400 µm width channels had displayed a 
decrease in percentage of Ki67 positive basal keratinocytes, whereas the 50 µm width and 
100 µm width channels stayed relatively consistent.  
 
The data obtained from our Ki67 study helps to elucidate the trends from the epithelial 
thickness experiments and suggests that a space filling mechanism can be used to explain the 
data.  Our data suggests that after initial seeding, a monolayer of cells was present and that a 
proliferative burst occurred, similar to results seen during in vitro cultures of low-density to 
high-density keratinocytes47-50 as well as in the in vivo wound healing environment once a 
monolayer of keratinocytes is formed and contact inhibition occurs.41  This burst can be 
characterized by the basal cells undergoing two to four mitotic divisions and committing to 
terminal differentiation that leads to epithelialization.49-51  Since the 50 µm width channels 
have much smaller dimensions, they require a fewer number of cells to fill the topographic 
feature, followed by the 100, 200, and 400 µm width channels.  At 3 days of A/L interface 
culture (6 days of culture); the 50 µm width channels had a complete epithelial layer; 
however the 100, 200, and 400 µm width channels did not.  Our Ki67 data suggests that a 
proliferative burst occurred before the 3 days time point and this channel was in a steady 
state of proliferation between 3 and 7 day time points, whereas the other channels were still 
undergoing a proliferative burst to fill the channel.  At 7 days of A/L interface culture (10 
days of culture); the 100 µm width channels had the same epithelial thickness as the 50 µm 
width channels and native skin; however the 200 µm and 400 µm width channels contained a 
less thick epidermis.  The percentage of Ki67 positive cells for the 200 µm and 400 µm width 
channels both decreased at the 7 day time point but were not statistically different from the 3 
days, which could indicate that the epithelial thickness in these channels was as thick as it 
would form.   To further support the proposed mechanism, as well as to further explain the 
trends observed, future studies should focus on collecting data at the initial seeding time to 
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verify a monolayer as well as data at later time points to evaluate whether the epithelial 
thickness of the wider channels reaches similar thickness values as the 50 µm width and 100 
µm width channels, epithelialized DED, and native tissue.  
Although we evaluated the presence of Ki67 a marker for proliferative cells, this marker does 
not distinguish between the two types of proliferating cells, ESCs and TAs, found in the 
basal layer of the epidermis.  In order to create a bioengineered skin substitute that has the 
capacity for continuous renewal, it is necessary for ESCs to be present on the surface of the 
bioengineered skin substitute.  In the basal layer of the epidermis, keratinocytes express 
receptors of the integrin family that mediate adhesion to the basal lamina17,52,53 and also 
regulate the onset of terminal differentiation.52-54  Adhesion to ECM proteins and 
fluorescence activated cell sorting (FACS) have both been used to separate basal 
keratinocytes based on their integrin expression levels.  When plating the separated fractions 
of keratinocytes and examining CFE, the cells expressing a two- to threefold increase in β1 
levels were determined to have greater proliferative potential.  Additionally when using 
fluorescence microscopy, the location of β1-bright regions in native tissues was compared 
with the location of LRCs from previous studies, and it was found that they both resided in 
the same location, which was based upon tissue site.   
 
We first investigated the presence of β1 in colonies of cultured keratinocytes and determined 
that 25% of cells in the colony were β1-bright and these cells were located at the colony 
border.  This data corresponds with previously published literature that selected for 
keratinocytes using rapid adhesion to CIV.  In this study the keratinocytes that adhered were 
28% of the total starting population and had a higher modal α2β1 fluorescence than the total 
(unselected) basal population.19  Our finding of our keratinocyte population is important 
because this is the starting population of cells to be cultured on the surface of a dermal 
scaffold with a microfabricated basal lamina analog.   
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To evaluate the location of these β1-bright cells on bioengineered skin substitutes, we utilized 
immunofluorescent microscopy and image analysis of sections of the grafts.  For our 
bioengineered skin substitutes, we found that the β1-bright regions were located in the 
channels and not on the papillary plateaus.  Analyses indicated that for the 100 µm width 
channel, 16.7% of the total basal keratinocyte population in the channel was β1-bright.  
Similar analysis for the 400 µm width channel indicated that 23% of the total basal 
keratinocyte population in the channel was β1 bright.  Additionally it was found that the β1-
bright regions in the 400 µm width channels localized to the corners of the channels as seen 
in Figures 6.9G25 and 6.9H.25 When just evaluating the “corner” regions of the 400 µm width 
channels it was found that 50% of the basal keratinocytes in this region were β1-bright.   
When evaluating the papillary plateaus, it was found that there were no β1 bright cells (0%).  
When flat regions of the bioengineered skin substitutes were evaluated, we found that the β1-
bright cells were heterogeneously dispersed and that 30% of the total basal keratinocyte 
population was β1 bright. For epithelialized DED we found that 15.6% of the total basal 
keratinocyte population was β1-bright and these cells were localized to the rete ridges.  In 
native foreskin tissue, we found that 7% of the total population of basal keratinocytes was β1-
bright and these cells were localized to the tips of the dermal papillae.  This localization 
finding is consistent with literature; although our percentage of integrin bright cells was 
much lower.19,33  This could be caused by the variation of fluorescence intensities that the 
samples were exposed to.  In our study, care was taken to not overexpose the regions, thus 
lower values could be caused by this factor. 
 
In addition to identifying ESCs in bioengineered skin substitutes, an interesting finding is 
that the β1-bright cells were found primarily in the channels as well as in the rete ridges of 
epithelialized DED.   Also our analysis of β1 in foreskin tissue is consistent with previous 
studies indicating that β1-bright regions are localized to the tips of the papillary 
projections.12,19  In native skin the localization of integrin bright regions varies with location 
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in the body.  It has been thought that this localization is a mechanism to protect the cells that 
contribute to the maintenance of population of cells responsible for the continuous 
regeneration of the skin. The question of what are the cells being protected from has been 
addressed by previous investigators.11,55     There are many insults that can occur from the 
outside environment such as ultraviolet light or chemicals, which would make the deep rete 
ridges a more protective microenvironment for the ESCs, however insults can also occur 
from the dermal tissue as well.   Inflammation or a burst of oxidative stress could damage the 
cells in the bottom of the rete ridges and therefore the safer place would be in the tips of the 
papillary projects.  Neither of these groups of insults explains why in one location of the 
body, the ESCs in skin would be in the bottom of the rete ridges or in the tips since all insults 
mentioned can occur in all locations of the body.  Another possible explanation for the 
localization of ESCs is based on the occurrence of mechanical friction in different regions of 
the body.  The palms and soles of the human body are areas of skin that are exposed to 
excessive friction and contain more numerous dermal papillae and deep rete ridges.6,12  When 
investigating β1 expression in these tissues, it was found that the bright regions are in the 
deep rete ridges, unlike other areas of the body that experience less friction and have β1-
bright expression on the tips of the papillary projections.12,19   
 
In our study, we demonstrated a similar range of percentages of β1-bright basal keratinocytes 
that correspond with previous literature in suggesting that 25-50% of basal keratinocyte are 
β1-bright.19 However, other analyses suggest that only 10% of basal keratinocytes  are 
ESCs56 and another report suggest a much lower percentage (1%) of the basal cells are 
actually ESCs.57  It has been agreed that quantitative differences in the expression of one 
particular cell surface marker is not sufficient to uniquely define the stem cell population, 
since β1 is not unique to ESCs.  Consequently, our analysis of the effect of the 
microenvironment on ESC localization, necessitates that future studies investigate additional 
means of interfollicular ESC detection.19  A major caveat to these future studies is that there 
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is no universally accepted criterion to define interfollicular ESCs and that surface markers 
used to isolate a population may not isolate a distinct population, but one that has 
overlapping population of cells.  Until a detection technique is discovered, it will be 
necessary to compile evidence of “stemness” combining many techniques57 such as  the 
evaluation of the expression of β1,18 transferrin receptors,58,59 connexin 43,60 isoform of 
CD133,61 desmosomal proteins,62 and proteins mediating intercellular adhesions,34 as well as 
label retaining studies.7,11,13,14 Additionally, studies evaluating the transcriptional profiles of 
cells isolated using surface markers will have an impact on identifying a true interfollicular 
ESC population.63   
 
Overall this study has focused on developing a bioengineered skin substitute that 
recapitulates biochemical and microtopographical features found at the DEJ to enhance 
epithelialization and interfollicular ESC localization.  We have found that 50 and 100 µm 
width channels with approximate depths of 150 µm contain a full epithelial layer after 7 days 
at A/L interface culture.  When comparing these values to epithelialized DED or native skin, 
it was found that the epithelial thicknesses were not statistically different from one another 
and also contain similar values of proliferating basal keratinocytes. The information gained 
from this study will help with design features of the next generation of bioengineered skin 
substitutes that will overcome limitations such as prolonged culture times and healing times.  
In the future we will also evaluate if the increased surface area provided by the 
microfabricated basal lamina analog with the smaller width features will increase mechanical 
stability, thus helping to overcome mechanical induced graft failures.  Additionally, our 
bioengineered skin substitute containing a microtopographical basal lamina analog provides 
an excellent model system to evaluate the proper ESC niche through both surface markers 
and label-retaining studies in order to enhance the regenerative capacity of bioengineered 
skin substitutes. 
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7.1 OVERVIEW 
The work in this thesis describes the development of a bioengineered skin substitute that 
recapitulates features found in native skin critical for maintaining tissue integrity.  Unlike 
other current bioengineered skin substitutes, our system contains a basal lamina analog, 
containing biochemical and microtopographic features.  Similar to native tissue, our 
microfabricated basal lamina analog separates the dermal and epidermal layers of our 
bioengineered skin substitute and provides cellular microenvironments that direct 
epithelialization and epidermal stem cell (ESC) localization.   
 
7.2 RESULTS AND CONCLUSIONS 
7.2.1 PART I: EVALUATION OF ECM IN THE REGULATION OF 
KERATINOCYTE FUCNTION 
 
We began to develop our bioengineered skin substitute by investigating the biochemical 
composition of the extracellular matrix (ECM) that enhances keratinocyte attachment and 
subsequent cellular functions including proliferation and differentiation. Proteins present in 
native basal lamina, such as type IV collagen (CIV) and laminin (LN), as well as ECM 
proteins found in the wound healing environment, such as fibronectin (FN) and type I 
collagen (CI) from the underlying dermis, were passively adsorbed at various concentrations 
to collagen-glycosaminoglycan (GAG) membranes and keratinocyte attachment was 
assessed.  We found that a greater percentage of keratinocytes adhered to FN than on all 
other proteins investigated, similar to other in vitro studies investigating keratinocyte 
adhesion to ECM coated bacteriological plastic.1 When keratinocytes are cultured in vitro, 
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they express a similar phenotype to keratinocytes located at the margins of a wound.  These 
keratinocytes are considered “activated” in both scenarios.  This activated phenotype is 
characterized by morphological changes, reorganization of cytoskeletal and junctional 
complexes, and changes in integrin expression, most notably an increase in α5β1 the integrin 
for fibronectin.2-7  Therefore, we hypothesize that the increased levels of α5β1 played a role in 
the increased keratinocyte attachment to FN in our study. 
 
After identifying that FN enhanced the percentage of keratinocytes attached to the collagen-
GAG membranes, we cultured keratinocytes on collagen-GAG membranes for 3 or 7 days at 
the air/liquid (A/L) interface with passively adsorbed FN to investigate epithelialization 
parameters.  An increase in epidermal thickness and an increase in the percentage of Ki67 
positive basal keratinocytes were found at 3 days of A/L interface culture compared to 
membranes without FN modified surfaces.  At 7 days of A/L interface culture, the FN 
modified surfaces still had a thicker epidermis, although Ki67 values between FN-treated and 
non-treated membranes were similar.  Our results suggest that FN-treated scaffolds closely 
mimic the wound environment; providing the appropriate signals for proliferation and 
epithelialization to occur.  In an acute wound environment in vivo, keratinocyte proliferation 
is increased.  Within hours after injury, activated keratinocytes migrate over the wound 
bed,8,9  and approximately 24 to 72 hours post injury a proliferative burst occurs.  This burst 
is responsible for the reepithelialization of the wound bed,10 and after closure of the wound, 
the basal layer returns to normal status with 10 to 20% of basal keratinocytes proliferating.11-
13   
 
Although significant research has elucidated the roles of FN on epithelialization in the native 
wound environment, little work has been performed investigating its presentation on dermal 
scaffolds and the resulting effect on keratinocyte functionality.  Furthermore, characterizing 
strategies to modify a biomaterial surface to increase the availability of the central cellular 
binding domain of FN, which has been shown to promote keratinocyte attachment and 
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subsequent intracellular signaling events, is of great importance for enhancing 
epithelialization as well as for engineering other tissue functions on the surfaces of 
bioengineered scaffolds.   
 
To investigate methods to strategically modify dermal scaffolds, we initially evaluated the 
cellular binding domain of FN passively adsorbed to collagen-GAG surfaces and determined 
that the binding sites were saturated and a plateau occurred at a FN concentration of 0.1 
mg/ml.  In the native wound environment, FN interactions with CI are mediated by specific 
domains on the surfaces of collagen molecules that produce oriented FN binding and presents 
FN binding sites for cellular interactions.14  Based on results from a previous study 
comparing the effects of adsorbed FN conformation on tissue culture polystyrene and 
collagen coated polystyrene, it was shown that the saturation density of FN on collagen was 
approximately half the amount of that on tissue culture polystyrene.15  Additionally, when the 
surfaces were immunoprobed for quantities of cell binding domains at saturation densities, 
FN treated tissue culture polystyrene exhibited an increase in fluorescence intensity for HFN 
7.1 binding relative to the values observed on FN treated collagen surfaces.  Furthermore, 
when equal surface densities of FN were adsorbed to tissue culture polystyrene and collagen 
surfaces, minimal cellular differentiation was found on the tissue culture polystyrene surface 
in comparison with the collagen surface.  These findings suggest that passively adsorbing FN 
to collagen surfaces and collagen membranes represents a promising, but suboptimal 
approach to directing keratinocyte functions on engineered biomaterials.  Therefore we began 
to investigate how the properties of a biomaterial surface affect FN adsorption, and 
furthermore the affects of the FN conformation on keratinocyte functions. 
 
To investigate the effect of surface chemistries on FN conformations that could be translated 
to the surfaces of collagen membranes to enhance FN cellular binding site presentation, we 
used self-assembled monolayers (SAMs) of alkanethiols on gold surfaces as a model 
biomaterial surface.  We chose this model system since the hydrophobicity and charge of the 
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surface can be modified by changing the functional end groups of the alkanethiols without 
changing any other surface property.16,17   It was determined that when uniform quantities of 
FN were adsorbed to each surface, the OH terminated SAMs demonstrated the greatest 
increase in the presentation of the cellular binding domains relative to the other SAMs 
surfaces as well as tissue culture plastic.  When saturation densities of FN were evaluated on 
each surface, we found that increased FN densities did not always correspond with increased 
presentation of cellular binding domains, suggesting that surface chemistries modulated FN 
conformation.  When keratinocyte functions were measured on FN treated SAMs at low or 
saturated densities we found that the availability of the synergy binding sites correlated with 
keratinocyte spreading, attachment, and differentiation.  We also found that the density of 
focal adhesion complexes significantly increased on surfaces with increased presentation of 
FN cell binding domains.  Additionally, the density of focal adhesion complexes 
corresponded with keratinocyte attachment and spreading in a direct fashion, and the density 
of focal adhesion complexes corresponded with cell differentiation in an indirect fashion.  
These findings suggest that keratinocyte attachment, spreading, and differentiation were 
integrin mediated processes.  This data suggests that tailoring the surface chemistries of 
implantable biomaterials scaffolds, to enhance FN conformations which expose the cellular 
binding domains, will lead to improved control of cellular functions and enhance the rate of 
tissue regeneration on bioengineered skin substitutes.  
 
To begin to translate our findings from the SAMs model of a biomaterials surface to 
implantable scaffolds, we investigated the use of a new starting collagen material, and we 
compared the availability of FN cellular binding sites with collagen-GAG membranes using 
passive adsorption techniques.  We found that self-assembled CI membranes increased the 
presentation of FN cellular binding sites suggesting that the self-assembled CI membranes 
facilitate a more favorable binding interaction with FN.  Additionally we chose to investigate 
covalent conjugation strategies to improve the presentation and overall bioactivity of FN on 
the surfaces of collagen membranes.18-20  We chose a carbodiimide conjugation strategy, 
   
Chapter 7 
Conclusions and Future Work 
142 
   
 
specifically 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) because 
of previously successful outcomes.  This strategy has been used to crosslink collagenous 
biomaterials and improves their degradation resistance and mechanical properties.21,22 
Additionally EDC has been used to couple chondroitin sulfate, heparin sulfate, and heparin to 
the surface of collagen scaffolds.23-25  When FN was covalently conjugated to either type of 
collagen membrane using EDC, we found a significant increase in the presentation of cellular 
binding domains, however when comparing self-assembled CI membranes with collagen-
GAG membranes, a significant increase in the availability of cellular binding domains was 
observed on the surface of the self-assembled CI membranes.   
 
In conclusion of Part I: Evaluation of ECM in the Regulation of Keratinocyte Function of 
this thesis, we determined i) FN enhances keratinocyte attachment to collagen-GAG 
membranes more than CI, CIV, as well as LN, and ii) the presence of FN in an in vitro model 
enhances epidermal thickness and proliferation.  Additionally we conclude iii) when FN is 
covalently conjugated to collagen membranes through use of EDC enhanced FN cellular 
binding site availability is detected over passive adsorption, and iv) when FN is covalently 
conjugated through use of EDC to self-assembled CI membranes increased FN binding site 
presentation occurs over that on collagen-GAG membranes.  In conjunction with data 
obtained from the SAMs studies we conclude that v) providing a surface with increased 
presentation of the cellular binding domain of FN will enhance keratinocyte functions 
necessary for epithelialization. 
 
7.2.2 PART II: ROLE OF SCAFFOLD MICROARCHITECTURE IN THE 
REGULATION OF KERATINOCYTE FUNCTION 
 
 
In this section of this thesis, we incorporated the findings from PART I: EVALUATION OF 
ECM IN THE REGULATION OF KERATINOCYTE, onto the surface of a microfabricated 
basal lamina analog laminated to a dermal sponge.  This microfabricated basal lamina analog 
contains microtopographical features that mimic the native microenvironment found at the 
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DEJ.  We evaluated the effects of both surface biochemistry and topography on 
epithelialization as well as epidermal stem cell (ESC) localization and compared our results 
with keratinocytes cultured on de-epithelialized acellular dermis (DED) and native tissue.   
In order to recapitulate the topographical features found at the DEJ, we used 
photolithography to create a silicon wafer containing channels with features of 200 µm 
depths and widths ranging from 50-400 µm.  A negative replicate of the pattern was formed 
using polydimethylsiloxane (PDMS) and CI was self-assembled on the surface of the PDMS 
negative replicate.  A dermal sponge was laminated to the back surface of the self-assembled 
CI basal lamina analog.  Fibronectin was then covalently conjugated, through the use of 
EDC, to the surface of the self-assembled CI membrane containing the microtopography.  
Using this novel composite, we evaluated the epidermal layer of bioengineered skin 
substitutes, after 3 days or 7 days of A/L interface culture.  After 3 days, we determined that 
keratinocytes cultured in 50 µm width channels had similar epidermal thickness values as 
epithelialized DED.  At 7 days of A/L interface culture the 50 µm and 100 µm width 
channels exhibited similar epidermal thicknesses as keratinocytes cultured on DED and 
foreskin tissue.  These conditions were statistically different from epidermal thickness values 
in 200 µm width and 400 µm width channels.  The percentage of Ki67 positive basal 
keratinocytes was also measured at the 3 and 7 day time points.  At 3 days of A/L interface 
culture, the 50 µm width channels contained a lower percentage of Ki67 positive basal cells 
than any other channels and were similar to the percentage of Ki67 basal keratinocytes on 
DED.   At 7 days of A/L interface culture, the 200 µm width and 400 µm width channels had 
displayed a decrease in percentage of Ki67 positive basal keratinocytes, whereas the 50 µm 
width and 100 µm width channels stayed relatively consistent. 
The data obtained from the Ki67 study helps to elucidate the trends observed from the 
epithelial thickness experiments on the surfaces of the microfabricated basal lamina analogs 
and it suggests that a space filling mechanism can be used to explain the trends.  Our data 
suggests that a proliferative burst occurred before the 3 day time point for the 50 µm width 
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channels due to contact inhibition, similar to events that occur during in vivo wound healing 
after a monolayer of cells covers the wound bed.7  This proliferative burst can be 
characterized by the basal cells undergoing two to four mitotic divisions and committing to 
terminal differentiation to reepithelialize the wound surface.26-28  Since the 50 µm width 
channels have smaller dimensions; the cells in these channels likely experience contact 
inhibition before the cells in channels with the larger dimensions.  Additionally, the smaller 
width channels have smaller overall dimensions, thus it takes a less number of cells to fill 
these channels.  By the 7 day A/L interface culture time point, the 100 µm width channels 
had approximately the same epithelial thickness as the 50 µm width channels and native skin; 
however the 200 and 400 µm width channels contained a less thick epidermis.  The 
percentage of Ki67 positive cells for the 200 and 400 µm width channels decreased at the 7 
day time point but were not statistically different from the 3 days, which could indicate that 
the epithelial thickness in these channels had reached a steady state.  To further support the 
proposed model of a space filling mechanism, as well as to further explain the trends 
observed in this study, future studies should evaluate the microenvironments of the basal 
lamina analogs after initial seeding time as well as 14 days at the A/L interface.  These 
experiments will provide information regarding the initial distribution of cells, and if the 
epithelial thickness of the wider channels reaches similar thickness values as the 50 µm 
width, 100 µm width, epithelialized DED, and foreskin tissue. 
 
Additionally, we investigated the localization of epidermal stem cells (ESCs) on the surfaces 
of our bioengineered skin substitutes as well as in epithelialized DED and in native foreskin 
tissue.  Previous studies have demonstrated that the β1 integrin is a preliminary marker for 
ESCs using cellular separation techniques based on integrin levels in combination with 
colony forming efficiency studies.29  When investigating β1 expression in native human 
tissues, these studies found that β1-bright and dull regions of the basal layer have a non-
random distribution. Patches of integrin-bright cells were found at the tips of the papillary 
projections or tips of the rete ridges depending on location of the skin.29  When we evaluated 
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the presence of β1-bright regions on the surfaces of our microfabricated basal lamina analogs 
as well as on epithelialized DED, and we found that integrin-bright regions were localized in 
the channels, and in the bottom in the rete ridges.  In native foreskin tissue, the β1-bright 
regions were localized to the tips of the dermal papillae, similar to previously reported 
data.29,30  We also evaluated the localization of ESCs on flat regions of the basal lamina 
analog, and found a heterogeneously distributed population of β1-bright cells.   
 
Our data suggests that the microtopographical features of the basal lamina analog enhance 
ESC localization over that found on a flat basal lamina analog.  In native skin, ESCs in the 
epidermis, defined by integrin-bright analysis, are located in clusters of 9-14 cells.29  Based 
on our data, we have created a cellular microenvironment or ESC “niche” that promotes the 
localization of integrin-bright cells similar to that found in native skin.  Creating an 
environment that mimics the native ESC “niche” is critical for continual regeneration of a 
bioengineered skin substitute. Although the exact mechanism of localization in vivo as well 
as in our in vitro model is unknown, it is hypothesized that the cellular microenvironment or 
“niche” provides the conditions necessary for maintenance of ESC phenotype including the 
proper combinations of growth factors, ECM proteins, and neighboring cells. 
In conclusion of Part II: Roles of Scaffold Microarchitecture in the Regulation of 
Keratinocyte Function in this thesis, we developed i) a novel bioengineered skin substitute 
that contains FN covalently conjugated to the surface of a basal lamina analog that contains 
microtopographical features similar to the native DEJ.  Additionally we determined ii) after 
7 days of A/L interface culture that smaller width topographical features (50 and 100 µm 
widths with 200 µm depths) contain a morphologically and physiologically similar epithelial 
layer as epithelialized DED or native tissue and iii) provide microtopographic cues that 
facilitate enhanced ESC clustering in comparison with a flat basal lamina analog.  
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7.3 FUTURE WORK 
7.3.1 The Next Generation of Bioengineered Skin Substitutes  
The ultimate goal for bioengineered skin substitutes is to provide complete restoration and 
physiology of uninjured skin after the treatment and healing of wound sites.31 Researchers 
have agreed that in order to achieve optimal function and appearance of the treated wound, it 
is necessary to create a bioengineered skin substitute that consists of both dermal and 
epidermal components.32  In vivo the morphogenesis and homeostasis of human skin are 
maintained by cells interacting with specialized structures and biochemical cues provided by 
components found in the dermal and epidermal layers of the skin.  In this thesis, we 
investigated the role of ECM proteins and topographical features of the basal lamina on 
keratinocyte functions; however we did not examine the role of epithelial-mesenchymal 
interactions known to influence epithelialization and basement membrane synthesis through 
paracrine signaling.33-35 
 
In skin, the basal lamina acts as a barrier that prevents fibroblasts located in the dermis from 
directly contacting epidermal keratinocytes, but it does not prevent the diffusion of 
macromolecules into or out of the epidermis.36  This is an extremely important characteristic 
of the basal lamina and these diffusible molecules, specifically growth factors and cytokines 
have been found to play an important role in regulating tissue homeostasis of the epidermal 
layer.33,35,37  In co-culture systems containing keratinocytes and mesenchymal cells, as well 
as in skin, IL-1, IL-6, IL-8, granulocyte macrophage colony stimulating factor (GMC-SF), 
TGF α and β, NGF, PDGF, FGF, and KGF are present in the environment, and have been 
identified as potential mediators of keratinocyte growth and stimuli of wound repair.38-40    It 
has also been shown that keratinocyte growth is stimulated by factors produced by 
keratinocytes/fibroblast co-cultures, and that keratinocytes actively induce the expression of 
these factors.   Thus, it has been determined that epithelial maintenance is modulated by a 
two-way paracrine signaling mechanism.41,42     
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In vitro studies investigating the role of epithelial-mesenchymal interaction, by incorporating 
fibroblasts into the dermal component of cultured composite bioengineered skin substitutes, 
found enhanced performance of the grafts over culture systems without fibroblasts. In the 
presence of fibroblasts, it was found that keratinocyte proliferation was stimulated, cell 
differentiation was shifted toward the granulosum layer, and epidermal morphology was 
improved.43-47  A study utilizing keratinocytes seeded on a collagen with fibroblasts cultured 
at the A/L interface in serum free conditions, found that when the number of fibroblasts 
seeded into the dermal component was increased, the proliferation index of the epithelial 
layer also increased after 1 week of culture.  After 3 weeks of culture all conditions, ranging 
from 2-20*104 fibroblasts/cm2, contained the same percentage of positive Mb67 basal 
keratinocytes (10-13%) which is similar to native epidermis.  This study also investigated the 
proliferation index of keratinocytes seeded on collagen matrices without fibroblasts and 
found at 1 and 2 weeks a small percentage of basal keratinocytes were positive and by the 3 
week time point, no cells were positive for the proliferation marker.48 Although there were no 
significant differences in proliferation among grafts with varying number of fibroblasts at the 
3 week time point, it was found that at the high fibroblast density, differentiation markers 
were not properly expressed in the epidermis. Additionally, a murine implant study using 
keratinocytes cultured on DED with fibroblasts also showed that the addition of fibroblasts 
improved epidermal formation as well as enhanced dermal regeneration including 
vascularization and reduced graft contraction.49  These data suggests that fibroblasts are 
necessary for long term maintenance of bioengineered skin substitutes and that an optimal 
fibroblast density is required for proper epidermal morphogenesis.   
 
In addition to improving keratinocyte growth and proper morphogenesis of the epidermal 
layer, epithelial-mesenchymal interactions are important in mediating the synthesis of ECM 
proteins that contribute to the formation of the basal lamina.  Interactions between 
keratinocytes and proteins of the basal lamina are important in maintaining tissue integrity 
and modulating adhesion,1,29 differentiation,50 proliferation,37 migration,9,51 and gene 
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expression.37  Thus, the formation of a native basal lamina at the DEJ in bioengineered skin 
substitutes is important in providing the proper cues to enhance the longevity of the tissue.   
 
From in vivo studies, the deposition and assembly of the basal lamina proteins occurs 
concurrently with epithelial growth and differentiation52,53 and keratinocytes and fibroblasts 
both contribute proteins which include CIV, and types V and VII collagens, LN, FN, 
nidogen, and hemidesmosomal plaque proteins.54  During wound healing in vivo, studies 
have found FN present under the tip of a migrating epithelial layer and an absence of both 
LN and CIV.  Once the wound surface has been covered with a monolayer of keratinocytes 
by migration, LN and CIV reappear in a very ordered sequence from the margin of the 
wound inward, and keratinocytes return to the standard proliferation and differentiation 
program of the cell.55-57  
 
Additionally, in vitro culture systems have investigated the role of epithelial-mesenchymal 
interactions on the synthesis and organization of ECM proteins of the basal lamina.  Studies 
have used three-dimensional skin models such as collagen gels or DED with incorporated 
fibroblasts, and cultured keratinocytes on the surface at the A/L interface to evaluate the 
origin of basal lamina proteins and hemidesmosomal plaque protein formation.  It has been 
found in serum free conditions, by El Ghalbzouri et al., that cultured keratinocytes on the 
surface of fibroblast populated collagen gels constitutively produce hemidesmosomal 
proteins (plectin, BP230, BP180) and that laminins are expressed by keratinocytes only when 
fibroblasts or exogenous growth factors are present.  It was also found that the expression of 
CIV and type VII collagen are regulated by fibroblasts.58 Although multiple studies have 
been conducted, the information gained regarding which cell type, keratinocyte or fibroblast, 
synthesizes particular basal lamina proteins is still controversial because of the different 
model systems used, as well as if serum proteins or exogenous growth factors are present in 
the culture media.42,53,54,59 
 
   
Chapter 7 
Conclusions and Future Work 
149 
   
 
Collectively, the results of these studies strongly suggest that, our future efforts must include 
the incorporation of fibroblasts in the dermal component of our bioengineered skin substitute 
to provide the complete biochemical environment necessary to achieve optimal functionality 
and longevity of our tissue in the wound site.  
 
7.3.2 Model System 
After incorporating fibroblasts into the dermal component of our bioengineered skin 
substitutes, we believe that we will not only have developed a bioengineered skin substitute 
with improved tissue morphology and functionality, but we will have an excellent in vitro 
model system that provides spatial tissue organization to i) establish the interactive role that 
the microenvironment of the basal lamina has on ESC selection and localization, ii) 
investigate markers to distinguish between transit amplifying (TA) and ESCs located in 
microniches (specifically including label retaining studies) and iii) further investigate the role 
of ESCs in the wound healing environment by creating a wound in an epithelialized graft.   
Using this system we can also investigate epithelial-mesenchymal interactions and the origin 
of iv) growth factors and cytokines and their effects on morphogenesis and epithelialization 
as well as v) basal lamina protein synthesis, deposition, and organization in a controlled 
(non-serum) environment.  Additionally, this model system can also be used as an in vitro 
model system of skin to vi) study disease pathologies including skin cancer, psoriasis, and 
chronic wounds vii) further enhance percutaneous implants, and viii) evaluate benefits and 
harms of cosmetics and chemical products as well as ix) evaluate diffusion properties for 
transcutaneous drug delivery systems.  Furthermore, we could also x) use our model system 
to study other body systems which contain complex microarchitectures, such as in the 
glomerulus of the kidney, or the crypts of the small intestine.   
 
7.4 FINAL CONCLUSIONS 
In this thesis a novel bioengineered skin substitute was developed that recapitulates the 
topography found at the DEJ and provides a biochemical environment to direct tissue 
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functionality.  We investigated the role that spatial tissue organization had on epidermal 
thickness and proliferation in our model system by creating a basal lamina analog with 
microtopographic features.  We found that the geometry of cellular microenvironments 
played a role in the growth of the tissue, with small width features (50 and 100 µm widths) 
providing statistically similar results to that of cultures on DED as well as native tissues.  
Also we evaluated the localization of ESCs and determined their presence in the channels, in 
comparison to their distribution on flat basal lamina analogs.  Based on these findings we 
believe we have created an environment, or stem cell niche that promotes their localization.  
Future work should be performed investigating these findings as well as the mechanism by 
which the localization occurs using a variety of ESC markers. 
 
Additionally, we hypothesize that incorporation of fibroblasts into our dermal scaffold will 
further improve tissue morphology and functionality of our bioengineered skin substitutes 
through paracrine signaling mechanisms.  The addition of fibroblasts to our model system 
will also enhance the regeneration of a native basal lamina critical for structural and 
mechanical stability of the tissue and for directing cellular proliferation and differentiation 
through ECM cues.  To evaluate the longevity and functionality of the tissue, longer culture 
times should be evaluated as well as implantation studies in animal models combined with 
indicators of epidermal barrier formation through measuring surface electrical capacitance as 
well as differentiation markers distributed throughout the layers of the epidermis.   
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